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Mild Traumatic Brain Injury (mTBI) has the highest incidence of all brain injuries and can lead 
to symptoms in the physical, cognitive and mood domains. Most symptoms abate within 
weeks to months, however some individuals experience ongoing symptoms leading to longer-
term disruption of social and occupational functioning. Current mTBI management 
recommendations include providing early injury related education, and addressing symptoms 
in a multidisciplinary fashion as they arise. As with any injury, it is important to ensure 
treatments are effective in order to reduce the costs to both the health system and the 
individual. The studies presented in this thesis aimed to assess the effectiveness of fish oil – a 
novel treatment for mTBI symptoms, and the current practice for providing information to 
mTBI patients. Study One was a randomised placebo controlled trial of fish oil as an adjunct 
treatment for mTBI symptoms. This study was cancelled due to recruitment difficulties, 
nevertheless the literature review delineates the pre-clinical evidence of its potential to treat 
both cognitive and mood symptoms via various pathways. In addition, the outlined procedures 
and the researcher’s reflections highlight the unforeseen difficulties that will need to be 
addressed should a similar trial be conducted in future. Study Two surveyed New Zealand 
health practitioners on their current practice of information provision for mTBI patients. It 
aimed to assess whether practices have changed in the 16 years since similar research was 
published, and since the introduction of information sheets by the Accident Compensation 
Corporation (ACC). It also assessed the quality and accessibility of the information provided. 
The frequency of information provision after mTBI has improved since 2004, though the issues 
with variability and formatting of presented information remain similar. The majority of 
respondents provided information verbally and in writing, and had information available only 
in English and standard print formats, potentially disadvantaging those with visual impairment 
or whose first language is not English. Time constraints, patient concentration and distress, 







Conducting clinical research cannot be done singlehandedly. It requires the input and 
support of many people, perhaps even more so when things do not go according to plan. First, 
I would like to acknowledge the people suffering mTBI who participated in Study One. They 
kindly gave their time and energy during a time of illness and uncertainty when these personal 
resources were already scarce, and I am incredibly grateful for this. I hope that they obtained 
some benefit from their participation, and made timely and complete recoveries from their 
injuries.   
 Thank you also to the numerous psychologists, occupational therapists, and 
physiotherapists who undertook recruitment for Study One. They accommodated me in team 
meetings to discuss the project, stored materials and took responsibility for majority of the 
recruitment work. These professionals did their best to recruit participants in often trying 
conditions, and their enthusiasm for the research provided a much needed boost when our 
collective efforts struggled to bear fruit. Many of these individuals mourned the termination of 
Study One alongside me, and provided encouragement for Study Two as well as future fish oil 
research. For all of this and more, I am very grateful. 
   Thanks must also extend to the healthcare workers who completed the survey for 
Study Two. Without these people I would have had no data to work with. I appreciate them 
taking time out of their busy schedules to respond to what was likely one of many requests for 
research participation. Special thanks also to Mr Harvey Jones from the School of Psychology 
for providing all the necessary tools to conduct survey research, as well as plenty of guidance 
for using them.  
 Thanks goes to my partner, Bruce, who has been my calm amidst the chaos of the last 
four years. To our baby boy Tai, gaining this qualification is even more meaningful now that 
you are in the world; I hope this one day shows you that you too can achieve your dreams. 
vi 
 
Also to my family, colleagues and friends, particularly those special people I have undertaken 
the clinical programme with, thank you for listening, encouraging, and believing in me.  
 Finally, infinite gratitude goes to my research supervisors Professor Janet Leathem and 
Associate Professor Ross Flett. Ross, we may have had minimal direct contact, but having your 
research expertise to draw on was a great reassurance and I appreciated having you on my 
team. Janet, you have provided ideas, encouragement, condolences, and stern words when I 
needed them. You have shown me patience and compassion, and taught me to keep looking 











Table of Contents 
Abstract ......................................................................................................................................... iii 
Acknowledgements ........................................................................................................................ v 
List of Figures ............................................................................................................................... xii 
List of Tables ............................................................................................................................... xiii 
Overview ..................................................................................................................................... 14 
Chapter One: Mild Traumatic Brain Injury and Post-Concussion Syndrome .............................. 19 
Terminology ............................................................................................................................ 19 
Mild Traumatic Brain Injury .................................................................................................... 20 
Diagnosis. ............................................................................................................................ 20 
Incidence. ............................................................................................................................ 22 
Cost. .................................................................................................................................... 22 
Post-Concussion Syndrome .................................................................................................... 23 
Diagnostic criteria. .............................................................................................................. 23 
Prevalence and cost. ........................................................................................................... 25 
Post concussion syndrome as a diagnostic entity. .............................................................. 25 
Injury Processes ...................................................................................................................... 27 
Initial Injury. ........................................................................................................................ 27 
Secondary neuronal injury. ................................................................................................. 28 
Secondary glial involvement. .............................................................................................. 28 
Symptoms ............................................................................................................................... 30 
Acute symptoms. ................................................................................................................ 30 
Ongoing Symptoms. ............................................................................................................ 32 
Aetiology of ongoing symptoms. ........................................................................................ 36 
Assessment of Post-Concussion Symptoms ............................................................................ 41 
Treatment of Post-Concussion Symptoms .............................................................................. 42 
viii 
 
Summary .................................................................................................................................. 44 
Chapter Two: Omega-3 Polyunsaturated Fatty Acids ................................................................. 45 
A Brief History of Dietary Omega-3. .................................................................................... 47 
Omega-3 Fatty Acids and Brain Structure and Function. .................................................... 47 
Dietary Omega-3 Fatty Acids and Mortality and Morbidity .................................................... 49 
The Mediterranean Diet. ..................................................................................................... 49 
Fish Consumption. ............................................................................................................... 51 
Omega-3 intake in New Zealand ............................................................................................. 52 
Dietary recommendations. .................................................................................................. 52 
New Zealand population intake. ......................................................................................... 52 
Supplemental intake. ........................................................................................................... 53 
Supplemental Omega-3 PUFA Intervention Studies in Human populations ........................... 54 
Omega-3 PUFAs and cognitive function. ............................................................................. 60 
Omega-3 PUFAs and mood. ................................................................................................. 62 
Omega-3 PUFAs after brain injury. ...................................................................................... 63 
Supplemental Omega-3 PUFA Studies in Animal Models of mTBI .......................................... 65 
Summary .................................................................................................................................. 68 
Chapter Three: Study One Methodology .................................................................................... 70 
Design ...................................................................................................................................... 70 
Participants .............................................................................................................................. 71 
Power analysis. .................................................................................................................... 71 
Eligibility criteria. ................................................................................................................. 72 
Exclusion criteria. ................................................................................................................. 72 
Measures ................................................................................................................................. 73 
Questionnaires. ................................................................................................................... 74 
Cognitive tests. .................................................................................................................... 75 
ix 
 
Scoring. ................................................................................................................................ 79 
Materials ................................................................................................................................. 79 
Localities ................................................................................................................................. 80 
Procedure ................................................................................................................................ 80 
Randomisation. ................................................................................................................... 80 
Recruitment. ....................................................................................................................... 81 
Testing and Communications. ............................................................................................. 82 
Ethics ....................................................................................................................................... 83 
Statistical Analyses .................................................................................................................. 83 
Dissemination of Results to Participants ................................................................................ 84 
Chapter Four: Study One Cessation ............................................................................................ 85 
Study One Processes ............................................................................................................... 85 
Who was involved in recruitment. ...................................................................................... 85 
Alterations to Recruitment Processes .................................................................................... 87 
Flow of Participants Through the Study.................................................................................. 88 
Justification of Cancellation .................................................................................................... 90 
Limitations .............................................................................................................................. 90 
Recommendations .................................................................................................................. 91 
Conclusion ............................................................................................................................... 93 
Chapter Five: Information Provision after Mild Traumatic brain Injury ..................................... 94 
Information Provision as Treatment for MTBI ........................................................................ 94 
Information provision for adults. ........................................................................................ 94 
Information provision for young persons. .......................................................................... 97 
Recommendations for Information Provision ........................................................................ 99 
Issues with Information Provided Following MTBI ............................................................... 103 
Information Provision in the New Zealand Context ............................................................. 106 
x 
 
Summary ................................................................................................................................ 107 
Chapter Six: Study Two Methodology ....................................................................................... 109 
Design .................................................................................................................................... 109 
Hypotheses ............................................................................................................................ 109 
Participants ............................................................................................................................ 110 
Measures ............................................................................................................................... 110 
Survey questions. .............................................................................................................. 110 
Assessment of information sheets. ................................................................................... 111 
Ethics ..................................................................................................................................... 113 
Procedure .............................................................................................................................. 113 
Dissemination of Results to Participants ............................................................................... 114 
Chapter Seven: Study Two Results ............................................................................................ 115 
Respondent Characteristics ................................................................................................... 115 
Provision of Written Information Sheets .............................................................................. 117 
Format of Information ........................................................................................................... 119 
Content and Accessibility of Written Information ................................................................ 119 
General Advice Provision ....................................................................................................... 121 
Specific areas of concern. .................................................................................................. 121 
Medications & Supplements. ............................................................................................ 123 
Referral to concussion service. .......................................................................................... 124 
Barriers to Providing Information .......................................................................................... 125 
Further Information ............................................................................................................... 125 
Summary ................................................................................................................................ 126 
Chapter Eight: Information Provision Discussion ...................................................................... 128 
Usefulness of Information Provided ...................................................................................... 128 
Content guidelines. ............................................................................................................ 128 
xi 
 
Accessibility guidelines. .................................................................................................... 129 
Advice for Different Populations .......................................................................................... 131 
Barriers to Providing Information ......................................................................................... 132 
Flow of Patient Information Across Services ........................................................................ 133 
Conclusion ............................................................................................................................. 134 
Recommendations ................................................................................................................ 135 
Limitations ............................................................................................................................ 135 
Chapter Nine: Overall Discussion .............................................................................................. 137 
Terminology .......................................................................................................................... 137 
Diagnostic Difficulties ........................................................................................................... 138 
Flow of Information Through Services .................................................................................. 138 
Treatment ............................................................................................................................. 139 
Recommendations for Future Research ............................................................................... 141 
Reflections ............................................................................................................................ 142 
Bibliography .......................................................................................................................... 145 
Appendix A: Study One Contact Log ......................................................................................... 171 
Appendix B: Study One Self-Report Eligibility Questionnaire ................................................... 182 
Appendix C: Study Two Information Sheet and Survey ............................................................ 184 
Appendix D: DHB Research Approval Communications ........................................................... 189 




List of Figures 
Figure 1.1. The neurochemical cascade of concussion. .............................................................. 30 
Figure 2.1. The chemical structure of EPA and DHA. .................................................................. 46 
Figure 2.2. Potential points of DHA intervention on the concussion cascade. ........................... 68 
Figure 3.1. Recruitment process undertaken by the concussion services. ................................. 81 
Figure 3.2. Individual participants’ flow through the study. ....................................................... 82 
Figure 4.1. Flow of participants through the study. .................................................................... 89 
Figure 7.1. Percentage of respondents from each service area providing written information to 
mTBI patients.  ........................................................................................................................... 118 
Figure 7.2. Percentage of respondents from each service area providing written information 
for specific groups of mTBI patients. ......................................................................................... 118 
Figure 7.3. Percentage of practitioners in each service area providing information on specific 
areas of concern.  ...................................................................................................................... 122 
Figure 7.4. Symptom reported by patients as most concerning in each service area………….…123 
Figure 7.5. Medications and supplements advised by each service area. ................................ 124 










List of Tables 
Table 2.1 Randomised Placebo Controlled Trials of the Cognitive and Mood Effects of LC n-3 
PUFA Supplementation  ............................................................................................................... 55 
Table 3.1. Test Selection and Associated Cognitive Domains in Order of Administration  ......... 76 
Table 3.2 List of replacement terms used in the MR-IV .............................................................. 77 
Table 4.1. Concussion Service Involvement in Trial Recruitment  ............................................... 86 
Table 7.1 Number of Health Professionals and Regional Distributions of Respondents in each 
Service Area  .............................................................................................................................. 116 





 Mild Traumatic Brain Injury (mTBI) represents 70-90 percent of all TBI and a significant 
public health problem. Typical symptoms in the acute phase of mTBI include headache; 
dizziness; nausea; confusion; focal neurological signs such as tinnitus; and cognitive symptoms 
such as memory, attention, and executive function difficulties. These symptoms usually abate 
within days or weeks post-injury, however 20-30% of sufferers develop ongoing symptoms 
that can persist for many months, or even years (Barker-Collo et al., 2015; Heitger et al., 2009). 
Ongoing symptoms can delay an individual’s return to work, school, or other premorbid 
activities, and are associated with increased rates of anxiety and depression (Macleod, 2010; 
McCauley et al., 2008; Mickeviciene et al., 2002; Styrke, Sojka, Björnstig, Bylund, & Stålnacke, 
2013).  
 Post-concussion syndrome (PCS) is the common term for the experience of ongoing 
symptoms after mTBI, but is a contentious issue. Debate exists about both the classification 
and causation of post-concussion symptoms. Rates of diagnosis may differ greatly depending 
on the criteria used, and some studies have found persisting cognitive deficits in individuals 
who do not meet diagnostic criteria for any specific disorder (Barker-Collo et al., 2015; 
Oldenburg, Lundin, Edman, Nygren-De Boussard, & Bartfai, 2016). Regardless of diagnosis, 
symptoms may persist and cause distress for some individuals.  
Standard practice for treating mTBI in New Zealand involves taking a symptom-based 
approach within a bio-psycho-social framework, including offering reassurance and 
information regarding symptoms and their management (The New Zealand Guidelines Group, 
2006). For those ongoing, more severe or complex post-concussion symptoms, treatment such 
as occupational therapy or cognitive-behavioural therapy may be offered alongside medical 
intervention, through a concussion service (Accident Compensation Corporation [ACC], 2019). 
For the majority of individuals who suffer injury, returning to work and normal function as 
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soon as possible is desirable, and having a safe, non-invasive and readily available treatment 
option would be welcomed. 
Omega 3 polyunsaturated fatty acids (n-3 PUFA) have been found to have many health 
benefits and may have a role to play in the recovery of cognitive function following brain 
injury. Studies using rodent models of mTBI have demonstrated multiple possible pathways of 
injury attenuation. These include lowered neuroinflammation, axonal and neuronal damage, 
and apoptosis after injury (Barrett, McBurney, & Ciappio, 2014); lowered levels of beta 
amyloid precursor protein (APP; Trojian & Jackson, 2011); lowered expression of pro-
inflammatory cytokines, and prevention of microglial activation to their pro-apoptotic form, 
significantly lessening both neuroinflammation and the associated behavioural deficits 
(Zendedel et al., 2015).  
The few studies that have included n-3 PUFA as a treatment for TBI sequelae have 
utilised multiple supplements and medications thus precluding a causal inference of n-3 
PUFA’s role in participant improvement. As n-3 PUFAs have shown experimental efficacy in 
treating mTBI symptoms, they may have an additive effect in treating these symptoms within 
the current standard practice. Due to the dearth of research with human mTBI participants, 
high quality human trials are necessary to determine whether n-3 PUFA supplementation 
could be an effective treatment.  
 The opportunity to conduct the present research arose as I entered the Doctor of 
Clinical Psychology Programme. A PhD student under the same lead supervisor had a 
significant quantity of a high-quality fish oil supplement, and placebo, left over from a 
randomised control trial (RCT) with a different population, and after reading the research cited 
above, sufferers of mTBI were seen as a population who may benefit from further RCT 
research.  
 Despite the significant efforts of all involved, Study One did not attract enough 
participants to be a feasible trial. Due to this and the impending expiry date of the 
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supplements the timeframe could not be extended, and so the trial was ceased. Factors 
contributing to lower than expected participation are discussed in Chapter Four. Throughout 
the recruitment period and during practical placements, I noted that many mTBI sufferers 
expressed confusion and concern regarding their symptoms and recovery, and often did not 
possess written materials to refer to. These individuals were distressed by their uncertainty, 
which was concerning given the potential for such distress to maintain mTBI symptoms and for 
quality information to lower distress. It was clear that the provision of information to mTBI 
patients warranted investigation. As Study One drew to a close, information provision became 
the focus of a subsequent study, which replicated and extend previous survey research 
conducted by the lead supervisor and a former master’s student approximately sixteen years 
prior.   
 Moore and Leathem (2004) found that only 45.9% of the New Zealand Emergency 
Departments and General Practitioners that responded to their postal survey provided written 
information to patients who had a confirmed or suspected mTBI. These ranged from one to 
ten pages in length, and just over half met the criteria for being able to be read by 70% of the 
population. Since this study took place, at least two mTBI-specific patient leaflets have been 
produced by the ACC.  It is not known however, whether these are routinely provided to 
patients by their healthcare practitioners, how accessible they are, or which leaflets are most 
used.  
International studies have shown substantial variability in the written information 
provided to patients after mTBI (Baker, Unsworth, & Lannin, 2015; Kempe, Sullivan, & Edmed, 
2014; Macdonald, McMillan, & Kerr, 2010; Peachey, Hawley, Cooke, Mason, & Morris, 2011). 
Patients should be provided with written discharge information that advises about what to 
expect and what to do in the first few days post-injury, a description of which symptoms signal 
a medical emergency or require a reassessment, and a description of the symptoms that may 
be experienced in the post-acute period and how to manage these (Kempe et al., 2014; 
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Peachey et al., 2011). Given the New Zealand Guidelines Group’s (2006) recommendations for 
information and reassurance as a first-line treatment for mTBI, the lack of recent New Zealand 
research into mTBI information provision and the frequent uncertainty noted from mTBI 
sufferers, a replication of Moore and Leathem’s 2004 work was warranted. In addition, this 
would provide an indication of if and how practice has changed since 2004. 
 Chapter One provides a background for the two studies by presenting the definitions, 
diagnostic criteria, and epidemiology of both mTBI and PCS. It also includes a discussion of the 
contention surrounding PCS as a diagnostic entity. Evidence for biological and psychological 
aetiologies of post-concussion symptoms is presented, as are the current treatment guidelines 
for New Zealand.   
 As background to Study One, Chapter Two presents a history of dietary n-3 PUFA 
consumption and evidence of its benefits, before discussing several randomised controlled 
trials of n-3 PUFA supplementation in human populations with various cognitive difficulties. As 
there are currently no published trials of the specific effect on human mTBI, a discussion of 
rodent models of n-3 PUFA supplementation following mTBI is also presented, along with an 
outline of the possible mechanisms of effect.   
 Chapter Three draws together the evidence of n-3 PUFAs potential for effect on post-
concussion symptoms and presents justification for Study One as well as specific aims, 
hypotheses, and methodology. Chapter Four describes alterations made to Study One’s 
methodology in response to operational challenges, and its ultimate cessation. It also outlines 
the key limitations and recommendations for future research. 
 Chapter Five reviews literature relating to the importance of providing information to 
those who have suffered mTBI. The measures for assessing the quality of information are 
presented and common issues with post-mTBI information provision are discussed. Chapter Six 
contains the hypotheses and methodology for Study Two. Chapter Seven presents the results 
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from the Study Two survey, and Chapter Eight discusses these results in relation to prior 
research and future recommendations. 
 Finally, Chapter Nine provides a discussion of the research as a whole and sets out 
limitations and recommendations for further research in the area of treatment following mTBI. 
The thesis concludes with researcher reflections on the process, difficulties, and highlights of 





      Chapter One: Mild Traumatic Brain Injury and Post-Concussion Syndrome 
 This chapter reviews the current literature on mild traumatic brain injury (mTBI) and 
post-concussion syndrome (PCS). It includes an examination of the differing terminology within 
this field of research before presenting incidence rates and diagnostic criteria for both mTBI 
and PCS. The review then proceeds from a more integrated standpoint, considering the 
symptoms experienced after suffering mTBI rather than specific diagnoses. Research relating 
to the acute and chronic symptoms suffered after mTBI is presented, as is the aetiology of 
symptoms, and their assessment and treatment in current practice. The purpose of this review 
is to provide a background for both Study One and Study Two. For Study One it will address the 
rationale for the recruitment criteria adopted, and the possible mechanisms of effect of a fish 
oil supplement on mTBI related symptoms. For Study Two, it will provide an overview of 
symptoms and their potential duration, which comprises part of the information patients may 
benefit from receiving.  
Terminology 
 Many different terms have been used to describe mTBI and the symptoms 
experienced afterwards. Some alternative terms include mild head injury, minor head injury, 
concussion, and post-concussion disorder. New terms are also being suggested, such as post-
inflammatory brain syndrome (Rathbone, Tharmaradinam, Jiang, Rathbone, & Kumbhare, 
2015), as evidence for similar symptoms across differing trauma aetiologies is discovered. The 
New Zealand Guidelines Group (2006) used ‘head trauma’ or ‘head injury’ to describe the 
initial injury to the head, rather than the brain, because head injuries do not always cause 
brain injuries and individuals who have had an injury to the head may not always consider 
‘brain injury’ information applicable to them. This group also noted that while classification of 
the initial severity of the injury can be useful for predicting some short- and long-term 
outcomes, some terms (e.g., mild) may not be acceptable to the injured individual, as the 
impact on their functioning may be far from mild.  
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 The term concussion is common in research as well as everyday language, however 
most recent research instead uses the term mild traumatic brain injury or mTBI.  Concussion 
and mTBI are considered synonymous, though as outlined in the next section, mTBI is 
sometimes considered more severe than concussion. The term concussion is frequently used 
in the context of sport related head injury, and is often considered to be at the milder end of 
the mTBI spectrum as while the acute symptoms are the same as any other injury mechanism, 
recovery reportedly occurs within a shorter timeframe (Carroll, Cassidy, Holm, Kraus, & 
Coronado, 2004; Karr, Grindstaff, & Alexander, 2012; Reuben, Sampson, Harris, Williams, & 
Yates, 2014). In line with previous research, the present study will use the terms concussion 
and mTBI synonymously.  
 The differing diagnostic criteria used to categorise PCS have led to some confusion 
within the literature. The Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition 
– Text Revised (DSM-IV-TR; American Psychiatric Association [APA], 2000) stipulates that 
symptoms must have been present for a minimum of three months after sustaining mTBI, 
while other classification systems do not clearly state a required timeframe. In line with this, 
many studies use the term post-concussion syndrome to describe any symptoms occurring 
after mTBI, without considering a specific timeframe, thus there may be overlap between mTBI 
and PCS. Definitions and classifications of both mTBI and PCS are explained in more detail in 
the following two sections.  
Mild Traumatic Brain Injury 
 Diagnosis. Traumatic brain injury (TBI) is sustained when a direct external mechanical 
force, or acceleration and deceleration forces, are applied to the head and result in a 
disruption of brain function. There are countless scenarios in which such injuries can occur, 
though some of the most common are motor vehicle accidents, falls, and assaults (Feigin et al., 
2013). The severity of TBI is usually classified using the Glasgow Coma Scale (GCS) score from 
the initial emergency room presentation, the duration of loss of consciousness (LoC), and/or 
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the duration of post-traumatic amnesia (PTA), and may be considered mild, moderate, or 
severe. Seventy to 90 percent of TBI fall into the ‘mild’ category (Cassidy et al., 2004);  this end 
of the spectrum  is the focus of the present studies.  
 The World Health Organisation (WHO) Collaborating Centre for Neurotrauma Task 
Force on Mild Traumatic Brain Injury recommend the following criteria as an operational 
definition of mTBI, based on the American Congress of Rehabilitation Medicine (ACRM) and 
their own literature review: 
MTBI is an acute brain injury resulting from mechanical energy to the head from 
external physical forces. Operational criteria for clinical identification include: (i) 1 or 
more of the following: confusion or disorientation, loss of consciousness for 30 
minutes or less, post-traumatic amnesia for less than 24 hours, and/or other transient 
neurological abnormalities such as focal signs, seizure, and intracranial lesion not 
requiring surgery; (ii) Glasgow Coma Scale score of 13–15 after 30 minutes post-injury 
or later upon presentation for healthcare. These manifestations of MTBI must not be 
due to drugs, alcohol, medications, caused by other injuries or treatment for other 
injuries (e.g., systemic injuries, facial injuries or intubation), caused by other problems 
(e.g., psychological trauma, language barrier or coexisting medical conditions) or 
caused by penetrating craniocerebral injury. (Carroll, Cassidy, Holm, Kraus, & 
Coronado, 2004, p. 115). 
Variations of these criteria, including one or more of the listed signs and symptoms but 
excluding others, can be found throughout the literature. It is because of such discrepancy in 
the previous research that the above-listed criteria were published, however as Levin and Diaz-
Arrastia (2015) note, neither WHO nor ACRM specified any minimum duration for LoC or PTA, 
nor did they specify how practitioners should differentiate between extreme stress caused by 
a traumatic event, and confusion caused by trauma to the head.  The possibility of 
misclassification remains.   
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Incidence. Cassidy and colleagues (2004) reviewed 121 studies from around the world 
and found that the annual incidence of mTBI was approximately 100-300 cases per 100,000 
population. These researchers acknowledge that while most research comes from hospital 
settings, many cases of mTBI are not treated in hospitals, thus the true incidence is likely closer 
to 600 per 100,000 population. In a population based study in the Waikato region of New 
Zealand Feigin et al. (2013) reported 790 traumatic brain injuries per 100,000 person years. Of 
these 790 injuries, 749 - almost 95% - were considered mild, classified by a GCS score of 13 – 
15 or a period PTA less than 24 hours in duration. This incidence rate is likely more accurate 
than the vast majority reported in the literature, owing to sampling techniques that involved 
review of hospital and general practitioner records, contact with sports clubs and schools, and 
offered individuals the chance to self-refer through responding to advertisements.  
 Cost. Traumatic Brain Injury (TBI) is a major public health concern both abroad and in 
New Zealand. The Accident Compensation Corporation1 (ACC; 2016) recorded 13,519 new 
claims for head injuries/concussion in the year leading up to June 2015, and the 17,416 active 
claims during this time cost a total of $75,616,367. These costs represent rehabilitation, 
compensation for being incapacitated for work, and ancillary services such as transport to 
treatment. Although these cost statistics do not account for severity, with 95% of TBI in New 
Zealand being mild it is likely that a large proportion of the total cost represents recovery from 
mTBI. Indeed in a study of the cost of TBI in New Zealand from a societal perspective, Te Ao 
and colleagues (2014) estimated the one year cost of mTBI in 2010 to be US $3395 (NZ $4719) 
per case, and the lifetime cost per case as US $4636 (NZ $6444). While the per case cost for 
mild injury was considerably lower than the cost per moderate/severe case, the substantially 
higher incidence of mild cases meant that the total cost of mTBI was approximately three 
times higher than moderate and severe TBI. 
 
1 ACC is a state-sector organisation providing no-fault accident insurance and injury prevention 
initiatives. It is funded by levies on income tax, business, fuel, vehicle licencing, and government 




 Diagnostic criteria. The two most widely used classification systems in the field of 
psychology are the DSM and the International Classification of Diseases (ICD). Both of these 
systems provide diagnostic labels for ongoing symptoms after mTBI and the different iterations 
of each system list different criteria. The DSM-5 (American Psychiatric Association [APA], 2013) 
label for such ongoing symptoms is ‘mild neurocognitive disorder due to traumatic brain injury’ 
and criteria include:  
• Evidence of modest cognitive decline compared to premorbid function in one or more 
cognitive domains. This may be based on the concern of the injured individual, the 
clinician, or a knowledgeable third party. The impairment must be documented by an 
appropriate quantified clinical assessment.  
• Cognitive deficits do not prevent the individual from completing instrumental activities 
of daily living, though compensatory strategies or extra effort may be necessary. 
• The symptoms do not occur solely during an episode of delirium and are not better 
attributed to another mental disorder.  
• There must be evidence of TBI such as loss of consciousness, post-traumatic amnesia, 
disorientation and confusion, or neurological signs.  
• The problems present immediately after injury, or upon regaining consciousness, and 
“persists past the acute post-injury period” (APA, 2013, p. 624).  
While criteria for the duration of LoC and PTA, as well as a GCS score of 13-15 are outlined as 
necessary for evidencing a mTBI, the DSM-5 does not provide guidelines for the duration of the 
acute post-injury period, other than a rather vague statement that mTBI usually resolves 
within a few weeks to months (APA, 2013).  
 The DSM-5 criteria represent a change from the DSM-IV-TR research criteria for 
postconcussional disorder. The DSM-IV-TR criteria focused on assessment of attention and 
memory rather than other cognitive domains, and required the individual to be experiencing 
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three or more symptoms such as: becoming fatigued easily; disordered sleep; headache; 
vertigo or dizziness; irritability or aggression on little or no provocation; anxiety, depression, or 
affective lability; apathy or lack of spontaneity; and other changes in personality. These 
symptoms must have developed following a head trauma of sufficient severity to cause 
significant concussion, be present for more than three months, and if pre-existing symptoms 
were present, they must have been significantly worsened by the trauma. Contrary to the 
DMS-5’s neurocognitive disorder, the symptoms of postconcussional disorder must lead to a 
significant impairment in social or occupational functioning (APA, 2000).   
 In line with changes to the DSM, the ICD criteria evolved from a ‘postconcussional 
syndrome’ to a ‘mild neurocognitive disorder’ when moving to the latest version. The ICD 10 
postconcussional syndrome simply required the presence of three or more symptoms similar 
to those from the DSM-IV-TR postconcussional disorder criteria, and stated that depression or 
anxiety may be present, attributing this to loss of self-esteem and fear of permanent brain 
injury (World Health Organisation [WHO], 2004) thereby highlighting the psycho-social aspects 
of PCS while to some extent discounting the possible neuro-chemical causes of mood 
dysfunction. Like the DSM-5, neither the ICD-10 or -11 provides guidance for the timeframe of 
symptoms or recovery. Mild neurocognitive disorder in the ICD-11, as with the DSM-5 disorder 
of the same name, requires a subjective decline from the previous level of functioning and 
objective evidence of such a decline in one or more cognitive domains that does not 
significantly interfere with activities of daily living. While this can be specified as due to 
concussion, no limits are placed on the severity of the initial injury (WHO, 2019). 
 The lack of consensus in the diagnostic criteria both reflects and perpetuates 
disparities in the PCS literature. High quality research is required to inform diagnostic criteria, 
and standardised criteria are necessary for comparing conclusions between studies and 
collecting valid epidemiological data. It is not yet clear when the acute phase of mTBI ends and 
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PCS begins, nor what degree of dysfunction the sufferer must experience in order to qualify for 
diagnosis.  
 Prevalence and cost. Diagnostic criteria chosen may have serious repercussions on 
prevalence rates, cost to the health system, and compensation claims. In a study comparing 
the ICD-10 and DSM-IV-TR criteria for postconcussional syndrome (PCS) and postconcussional 
disorder (PCD) at 6 months post-injury, it was found that 14.4% of the participants met PCD 
criteria, and 44.6% met criteria for PCS (McCauley et al., 2008). Additionally, higher 
proportions of participants who had the potential to access compensation for their injury 
through workplace compensation schemes or litigation met criteria for each disorder. Of those 
who had the potential to access compensation, 28.3% met criteria for PCD and 60.9 % met 
criteria for PCS, compared with 7.8% and 37.8% respectively for those who did not have the 
potential for compensation. While the effect sizes of these findings were considered small, the 
costs to healthcare systems could potentially be large.  
 In the 2015 calendar year, ACC received 1168 claims for PCS, which included diagnoses 
termed ‘postconcussional syndrome’ and ‘post-traumatic brain syndrome’ (ACC, 2016). The 
1927 active (requiring some form of payment from ACC) claims for these diagnoses during 
2015 cost $31,159,993 (ACC, 2016). Individuals initially covered for TBI may have their 
diagnosis changed (or added to) and therefore their injury costs initially attributed to TBI then 
later covered under PCS, thus the PCS cost differs from the TBI costs discussed previously. It 
may be that if PCD criteria were required for cover, the above figure would be considerably 
lower.  
 Post concussion syndrome as a diagnostic entity. Post-concussion syndrome is a 
contentious issue. According to several studies (e.g., Heitger et al., 2009; Barker-Collo, et al., 
2015) the symptoms of mTBI usually abate within days or weeks post-injury, however 20-30% 
of sufferers develop ongoing symptoms that can persist for many months, or even years. 
Several researchers (e.g., Levin & Diaz-Arrastia, 2015; Meares et al., 2011; Mounce et al., 2012; 
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Rathbone et al., 2015) argue that residual symptoms such as fatigue and headaches are non-
specific, occur frequently in the general population, and may be misattributed to mTBI. Levin 
and Diaz-Arrastia (2015) state that the evidence for persisting cognitive deficits is weak, as 
there are few prospective longitudinal studies longer than six months. Many authors however, 
seem to consider chronic symptoms to be those that persist for longer than one to three 
months (Carroll et al., 2014). This is sometimes stated explicitly, but is more often implicit in 
the assertion that symptoms usually remit within this time for the majority of individuals.  
In a three month prospective study of 62 adults with mTBI and 58 non-brain trauma 
controls, Meares et al. (2011) found that mTBI did not predict PCS using the ICD-10 criteria; 
PCS rates and symptoms did not differ between groups. Pain however, was associated with 
PCS and the authors posited this may be due to the increased attention given to physical 
sensations when people experience chronic pain, leading to greater endorsement of PCS like 
symtoms. In contrast, Webb and colleagues’ (2015) study of US airmen with mTBI compared to 
those with other injuries, reported hazard ratios for cognitive disorder NOS (not otherwise 
specified) and memory loss at 180 days or longer since injury as 10.75 and 4 respectively. This 
study excluded individuals who had suffered mTBI in the two years prior to the study entry, or 
mTBI during the study period, indicating that a single mTBI event can have ongoing effects. 
Oldenburg, Lundin, Edman, Nygren-De Boussard, and Bartfai (2016) compared a PCS 
group, recovered mTBI group and a community control group on measures of post-concussion 
symptoms and various cognitive domains. The PCS group was defined as those who endorsed 
three or more symptoms of the Rivermead Postconcussion Symptoms Questionnaire (RPQ) at 
three months post-injury, thus meeting the ICD-10 criteria for PCS, while the recovered mTBI 
group had fewer or no symptoms three months post injury. There was limited evidence of the 
PCS group performing lower on cognitive measures than the recovered group, and the authors 
attributed the slight variation to the pre-morbid characteristics of the PCS group as they were 
found to have a lower ‘cognitive reserve’ based on IQ, education and occupation information. 
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There was however, a small but significant difference between the combined PCS and 
recovered group when compared with the community control group on the total recall, 
consistent long-term recall, and cued recall trials of the Selective Reminding Test (SRT). This 
led the authors to conclude that PCS sufferers are not a subgroup of individuals who have 
suffered mTBI, but that mTBI is associated with ongoing subtle executive memory deficits. In 
this study 23.5% of the recovered group (15.6% of the total sample) were experiencing one or 
two ongoing symptoms from the RPQ. Had the DSM-5 criteria requiring only evidence of 
modest cognitive decline in one domain been employed, the PCS group may have been 
substantially larger and between group results may have differed. This study highlights not 
only the problems of inconsistent diagnostic criteria, but also a common question within mTBI 
research: Should PCS be a diagnostic entity?     
 Most researchers agree that a small percentage of individuals do suffer ongoing 
symptoms after mTBI, however some such as Oldenburg and colleagues (2016) believe that 
many of those suffering mTBI experience ongoing but very subtle effects rather than a clinical 
syndrome or disorder. Similarly, in a 12 month prospective cohort study of adult mTBI 
sufferers, Booker, Sinha, Choudhari, Dawson, and Singh (2019) considered ‘persistent post-
concussion symptoms’ (PPCS) rather than a specific diagnosis due to the lack of consensus on 
PCS as a diagnosis.  
Because participants in Study One may have been given various diagnoses for similar 
symptoms, and such different labels may lead to confusion within both academic and patient 
literature, the review will consider the experience of symptoms after mTBI rather than specific 
diagnoses from this point forward.    
Injury Processes 
 Initial Injury. As the mechanisms of injury that lead to mTBI are varied, different areas 
of the brain may be affected depending on the site of the force to the head. Frontal and 
temporal areas are most frequently injured (Broshek, De Marco, & Freeman, 2015; Mathias, 
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Beall, & Bigler, 2004). These injuries are usually diffuse, though focal symptoms and space 
occupying lesions may occur in a minority of cases (Borgaro, Prigatano, Kwasnica, & Rexer, 
2003).  
 Secondary neuronal injury. Secondary to the initial mechanical trauma, a complex 
cascade of reactions occurs in the damaged area of the brain. Membrane disruption and 
stretching leads to a loss of Na+/K+/Ca2+ flux, neural membrane depolarisation, and 
indiscriminate release of excitatory neurotransmitters (MacFarlane & Glenn, 2015). These 
neurotransmitters bind to N-methyl-D-aspartate (NMDA) receptors, leading to further 
neuronal depolarisation and contributing to the excitotoxicity (Giza & Hovda, 2001). In an 
effort to restore chemical balance to the damaged area of the brain, sodium/potassium pumps 
work excessively, a process which requires a large amount of energy, or adenosine 
triphosphate (ATP); this hyper-metabolic state occurs during a time of reduced cerebral blood 
flow, resulting in a disparity between energy supply and demand, and thus leads to energy 
crisis (Barkhoudarian, Hovda, & Giza, 2011). The influx of calcium during the excitotoxicity 
phase can further damage axonal structures and exacerbate the energy crisis (Barret, 
McBurney & Ciappo, 2014); as the brain attempts to provide more ATP during a time of 
decreased oxidative metabolism, it increases rates of glycolysis, leading to the production of 
lactate, which due to the decreased rate of oxidative metabolism cannot be metabolised 
effectively. Lactate accumulation may lead to neuron dysfunction by way of acidosis, 
membrane damage, altered blood brain barrier permeability, and oedema (Giza & Hovda, 
2001). ATP stores become diminished after the period of hyper-metabolism, leading to a hypo-
metabolic state where insufficient supplies of energy are available; this may last days to weeks 
(MacFarlane & Glenn, 2015).  
 Secondary glial involvement. Damaged neural cells signal the activation of microglia. 
This is initially a protective factor but may become a positive feedback loop where an 
overactive inflammatory response can damage neuron cell membranes further (Barret et al., 
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2014). Inflammation and other brain injury phenomena are frequently studied in animals, to 
allow for controlled injury and treatment conditions as well as close study of the brain post-
mortem. A study of diffuse mTBI in pigs observed neuroinflammation 6 hours post injury 
(Lafrenaye, Todani, Walker, & Povlishock, 2015). It found pervasive microglial activation in 
thalamic areas of injured pigs, the degree of which was correlated with the amount of 
observed diffuse axonal injury (DAI). Activated microglial processes exhibited increased 
contact with neurons positive for amyloid precursor protein (APP) – a marker of the axon 
damage that occurs due to the initial injury, exacerbated by the resultant excitotoxicity and 
oxidative stress (Barrett et al., 2014) – when compared with microglial process contact with 
myelinated axons in sham injured animals. The majority of contacts in injured animals were 
bulbous end processes, rather than the passing by/crossing over of microglial processes and 
axons in sham pigs, who were operated on but not injured. The authors speculate that the 
influx of calcium that occurs in neural injury may alter the extracellular calcium concentration, 
signalling the observed convergence of microglial processes. Activated microglia perform a 
number of functions that may be helpful or harmful in the injured brain, such as phagocytosis, 
cytokine secretion and/or neutrophil secretion, thus this study was among the first to show 
the relationship between DAI and acute neuroinflammation (Lafrenaye et al., 2015).    
In a rat study using closed head injury as an mTBI model, Singh, Trivedi, Devi, Tripathi, 
and Khushu (2016) discovered evidence of an inflammatory cascade. This began with increases 
in the pro-inflammatory cytokine TNF-α four hours post-injury, proceeding to increases in the 
anti-inflammatory cytokine IL-10 one day post-injury, and at three- and five-days post-injury 
increased amounts of hypertrophied astrocytes and glial fibrillary acidic proteins (GFAP) were 
found. GFAP is a brain specific protein expressed predominantly by astroglia and has been 
found to differentiate mTBI sufferers from others (Singh et al., 2016).   
Injury cascades occur in both neurons and glia after the initial mechanical insult to the 
brain. These processes lead to energy crisis, inflammation, and impaired neurotransmission, 
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which in turn lead to the experience of symptoms such as fatigue, headache, and cognitive 
difficulties that characterise mTBI (MacFarlane & Glenn, 2015); acute and ongoing symptoms 
are discussed further in the following sections. See Figure 1.1 below for a pictographic 
representation of the neurochemical processes that occur after mTBI. This provides a 
background for the possible points of intervention by n-3 PUFA, which will be discussed in 
depth in the following chapter.  
Figure 1.1. The neurochemical cascade of concussion. Adapted from ‘ω-3 fatty acid 
supplementation as a potential therapeutic aid for the recovery from mild traumatic brain 
injury/concussion’ by E. Barret, M. McBurney and E. Ciappio, 2014, Advances in Nutrition: An 
International Review Journal, 5, p. 269.  
Symptoms 
 Acute symptoms. Upon regaining consciousness or recovering from post-traumatic 
amnesia, most individuals who have sustained mTBI experience symptoms, though the 
duration of the symptoms varies widely (Karr, Areshenkoff, & Garcia-Barrera, 2014). Nausea, 





























(2010) states wear off within days to weeks, as the cellular physiology heals.  However, 
according to Donovan, Cancelliere, & Cassidy (2014), self-reported symptoms of fatigue, 
dizziness, and headache are the most common reasons for seeking treatment after mTBI.  
  With regard to cognitive symptoms, Kay, Newman, Cavallo, Ezrachi and Resnick (1992) 
found that speed and ease of processing were the primary cognitive deficits after mTBI. Using 
the Rey Auditory Verbal Learning Test (RAVLT), they found that what appeared to be difficulty 
with memory related more to the encoding and registration of new information, rather than a 
deficit in retrieval. Similarly, Shanmukhi and Panigrahi (2003) found significant differences in 
learning and remembering a non-verbal pattern when comparing 40 sufferers of mTBI 
approximately two weeks post-injury with 40 uninjured controls. This was considered a deficit 
in procedural learning.  
 A common criticism of research into the symptoms of mTBI is the comparison to 
uninjured control groups, as the pain of the injury and shock of the injury event may confound 
findings. To combat this, Landre, Poppe, Davis, Schmaus, and Hobbs (2006) administered the 
adult vigilance and distractibility subtests of the Gordon Diagnostic System, the Wechsler 
Memory Scales logical memory 1 and 2 subtests, the Trail Making Test A and B, as well as 
measures of body pain, mental health, and post-concussive symptoms to 37 hospitalised 
patients with mTBI and 39 patients hospitalised for other traumas, approximately 5 days after 
injury. The mTBI patients scored significantly lower on all the cognitive measures with 
moderate to large effect sizes, and scores on these measures were not related to pain or 
stress. Interestingly, no differences were found in self-reported post-concussive symptoms, as 
measured by a modified version of the Postconcussive Symptom Checklist, between groups. It 
may be that such checklists measure symptoms common to multiple traumas, while the 
cognitive tests are more specific to mTBI. 
 In a retrospective cohort study using electronic data for active duty US Air Force 
airmen, Webb and colleagues compared mTBI, other injured, and non-injured groups at less 
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than 30, 31-179, and 180 days or longer post-injury. In accordance with Landre and colleagues 
(2006), many cognitive symptoms were more prevalent in the mTBI group. In the ‘acute 
period’ (<30 days post-injury) hazard ratios for the mTBI group compared to the other-injured 
group were 55.88 for memory loss/amnesia and 85.17 for ‘cognitive disorder NOS’. However, 
the risk of seizures, headaches, migraines, pain, dizziness, and sleep disorders were also 
significantly higher in the mTBI group, compared with both the other-injured group and the full 
cohort for the acute injury period. Results were adjusted for post-traumatic stress disorder 
(PTSD) and depression, thus the symptoms reported are likely to be accounted for by the brain 
injury.  
 The research presented above provides evidence of both cognitive and physical 
symptoms occurring within the first week to first month of injury. Donovan and colleagues 
(2014) formed the International Collaboration on mTBI prognosis (ICoMP) to update the WHO 
task-force meta analytic results from 2004 and stated that substantial evidence exists for the 
presence of cognitive deficits in the first two weeks after injury. However, according to both 
the ICoMP authors and Karr et al. (2014) the cognitive deficits reported are very 
heterogeneous, and effect sizes range greatly between studies. Less evidence exists for 
ongoing cognitive difficulties following mTBI. 
 Ongoing Symptoms. As Carroll and colleagues (2014) and Levin and Diaz-Arrastia 
(2015) point out, longitudinal studies of cognitive deficits following mTBI with a follow up 
period greater than six months are lacking. The few that have been published yield varied 
results and contain methodological biases that make generalisation questionable.  
 In a prospective cohort study, Røe, Sveen, Alvsåker, and Bautz-Holter (2009) followed 
up with 52 adult mTBI sufferers at 3, 6, and 12 months post-injury. More than half (55.8%) of 
the sample met the ICD-10 criteria for PCS at 3 months post injury, and 42.3% met criteria at 6- 
and 12-months post-injury. Cognitive symptoms were more prominent at each time point than 
physical or behavioural symptoms. Two participants who met criteria at 6 months no longer 
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met criteria at 12 months; interestingly, two participants developed PCS between the 6 and 12 
month follow up. The authors did not theorise the reasoning for this, however they did 
highlight the high degree of between participant variability in the progression of symptoms. 
The authors analysed results for differences between males and females in the development 
of PCS; no sex differences were found. However, this study included a range of ICD-10 
diagnostic codes covering diagnoses including coma; haemorrhage; focal, diffuse, and 
unspecified injury. While participants were required to have a GCS of 13-15, they were 
recruited after being admitted to hospital care up to 48 hours post-injury, so at least some of 
the injuries suffered may have been on the moderate to severe end of the TBI scale. In 
addition, individuals who dropped out of the study tended to report fewer symptoms than 
those who completed all follow ups, and the sample size of 52 participants completing all 
follow ups was small.  
In a Swedish population based three year follow up study, it was found that 50% of 
females and 30% of males who had presented to an emergency department after mTBI met 
the ICD-10 criteria for PCS according to their RPQ scores (Styrke et al., 2013). In contrast to Røe 
et al. (2009), these results represented a significant difference between sexes. In this study 
almost all RPQ symptoms, with the exception of double vision in females, were significantly 
higher in the mTBI population than the control group of blood donors. The Rivermead Head 
Injury Follow Up Questionnaire (RHFUQ) assessed disability, finding 52% of females and 37% of 
males experienced some level of disability after mTBI. The most frequently endorsed items 
were tiredness at work, difficulty sustaining previous workload, and difficulty in ability to enjoy 
previous leisure activities. Unsurprisingly, endorsement of a high frequency of symptoms on 
the RPQ predicted disability in both sexes (Styrke et al., 2013). This study may represent a 
higher injury severity than other research on mTBI, as although each individual in the mTBI 
group had a GCS of 13-15 upon presentation to the ED, it included any degree of LOC or 
disorientation, PTA, nausea, vomiting, severe headache, & neurological deficit. It may also 
34 
 
have been subject to non-response bias; while alcohol intoxication at the time of the injury – 
which has the potential to lower GCS scores – was more common among individuals who 
declined to participate in the study, loss of consciousness was more prevalent among 
respondents. This may indicate that those who responded to the postal survey were more 
severely injured. 
In a six month prospective cohort study Roy et al. (2019) found that injury severity 
factors predicted PCS at both one and six months post-injury. A combination of loss of 
consciousness and altered mental state (feeling dazed, confused, or disoriented) within 24 
hours of mTBI predicted both depression and PCS symptoms, as per the RPQ, one and six 
months later. Similarly, a six month Dutch cohort study found a higher injury severity scores on 
the Injury Severity Scale (ISS) and Abbreviated Injury Scale – Head (AISH) were associated with 
PCS six months post mTBI (Voormolen et al., 2019). Additionally, Voormolen and colleagues 
found that female sex, lower education, assault as the injury mechanism, hospitalisation and a 
higher RPQ score predicted lower health-related quality of life on the SF-36 health survey. The 
participants meeting PCS criteria had on average a 20% lower health-related quality of life 
compared with mTBI sufferers who were not experiencing three or more PCS symptoms, and 
had lower scores on all SF-36 domains (physical functioning, bodily pain, role limitations due to 
physical health problems, role limitations due to personal or emotional problems, emotional 
well-being, social functioning, energy/fatigue, and general health perceptions) than the Dutch 
population norm. In line with Voormolen and colleagues, a 12 month English adult mTBI cohort 
study found female sex, assault as the injury mechanism, and injury severity factors (GCS of 
less than 15) as well as psychiatric illness history and alcohol intoxication at the time of injury 
was associated with poorer outcomes on the RPQ and RHFUQ (Booker et al., 2019). While 
these studies found similar causes of poor outcomes including injury severity, they all 
represent samples collected from hospital emergency departments and thus likely more 
‘severe’ mTBI.  
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 In contrast to the previously discussed studies, Barker-Collo and colleagues (2015) 
recruited participants from numerous settings including self-referrals (participants responded 
to advertisements), and utilised cognitive testing rather than solely self-report measures for a 
12 month follow up study. They found that symptoms endorsed on the RPQ declined steadily 
over the 12 months. At baseline, the majority of participants performed within the average 
ranges of the CNS Vital Signs neurocognitive assessment, but a substantial proportion of 
individuals performed in the very low range for executive ability (21.5%), complex attention 
(26.0%) and cognitive flexibility (27.4%). In addition, over 20% of the sample produced below 
average scores across indices of processing speed, executive ability, psychomotor speed, 
reaction time and cognitive flexibility. The mean performance on all cognitive domains except 
for memory improved from baseline to 12 months, with the majority of this improvement 
from baseline to six months; improvements from six to 12 months were non-significant for all 
domains except for processing speed – one of the most common deficits following mTBI 
(Barker-Collo et al., 2015; Borgaro et al., 2003; Diwakar et al., 2015; Killgore et al., 2016). At 12 
months follow up 16.3% of participants remained in the very low range on the test of complex 
attention, where only 0.13% of the general population would be expected to score (Barker-
Collo et al., 2015). Additionally, over 20% of participants continued to have some level of 
difficulty with complex attention and memory at the 12 month follow up period.  
 While a substantial subset of Barker-Collo and colleagues’ participants experienced 
ongoing symptoms, the authors noted that a high proportion of participants scored in the 
above average ranges on tests of visual memory and executive ability from one-month follow-
up onwards, and on cognitive flexibility and complex attention at six- and 12-months follow 
up. Much like Oldenburg and colleagues (2016) these authors theorise that this may be due to 
the relatively high education level of their sample, as those with higher education tend to have 
a larger cognitive reserve and may be less prone to difficulties after mild brain injury (Satz et 
al., 1993; Stern, 2002).   
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It seems that regardless of whether or not PCS is diagnosed, a proportion of individuals 
who have suffered a mTBI may benefit from treatment of cognitive symptoms, and the 
assessment of some factors, such as cognitive reserve and injury severity features, may help to 
prospectively identify who will fall into this group. 
 Aetiology of ongoing symptoms. As mentioned earlier, post-concussion symptoms are 
a complex problem of unclear aetiology. The differing classification systems used to diagnose 
PCS and PCD allude to divergence in the literature regarding the cause of ongoing symptoms. 
The ICD-10 (WHO, 2004) states that PCS aetiology is unclear and includes both neurological 
and psychological factors, but seems to consider the ongoing symptoms from a psychosocial 
standpoint with its assertion that the depression and anxiety commonly found in PCS sufferers 
is due to fear of permanent disability and an injury to self-esteem, rather than the physical 
injury (McCauley et al., 2008). Some sufferers may become hypochondriacal, search for 
diagnosis and cure, and adopt a permanent sick role (WHO, 2004). The DSM-5 (APA, 2013) 
acknowledges both psychological and biological factors. Traditionally, initial symptoms such as 
headache and dizziness have been attributed to biological processes, while ongoing symptoms 
have been attributed to psychosocial problems. Psychosocial issues typically include anxiety 
and depression that develop following injury, as well as pre-injury morbidity and personality 
styles. There is however, a growing body of evidence highlighting potential physiological 
causes of persisting symptoms after mTBI.   
  Psychogenic symptoms. Acute symptoms usually remit within days or weeks, however 
for some individuals psychological symptoms evolve during this time and complicate the 
clinical picture. According to Kay et al. (1992) persisting cognitive symptoms may alter an 
individual’s sense of self, leading to anxiety and low mood which exacerbate cognitive 
symptoms, causing further frustration and distress, maintaining the disorder. In this positive 
feedback loop psychological sequelae may become more disabling than the initial injury. There 
are many factors that may contribute to emotional upset following mTBI, for example, a 
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distressing injury event such as an assault, or cognitive difficulties preventing normal 
functioning. 
 Mickeviciene et al. (2002) found few differences between mTBI sufferers and age and 
sex matched controls in their postal survey 22-35 months post-injury. The only significant 
differences between groups were sensitivity to alcohol, worry about brain injury, and feelings 
of depression which were higher in the mTBI group. Symptoms may have remitted by the time 
of follow up. McCauley et al (2008) found an increased incidence of major depressive episodes 
and post-traumatic stress disorder six months post-injury.  
 Rather than post-injury psychological symptoms, Meares’ and colleagues’ (2011) found 
that pre-injury psychological symptoms predicted PCS. Their study of acute PCS symptoms in 
mTBI and other trauma patients found that pre-injury depression or anxiety and pre-injury 
post-traumatic stress disorder increased the odds of developing PCS after both brain and non-
brain injury (OR for depression or anxiety: 2.99, OR for PTSD: 1.05).  
 Pre-injury psychological difficulties and personality traits may also affect the duration 
of symptoms. Hou et al. (2012) conducted a prospective cohort study with 107 adult mTBI 
sufferers recruited from a hospital. After phone-based follow ups three and six months post 
injury, they discovered that 22% of participants met the ICD-10 criteria for PCS at three 
months, and 21% met this criteria at 6 months. Regression analyses showed that all-or-nothing 
behaviour, as measured by the Behavioural Response to Illness Questionnaire (BRIQ), was the 
only significant predictor of PCS at three months post-injury, and head injury perceptions as 
measured by the Brief Illness Perception Questionnaire (BIPQ) were the only significant 
predictor of PCS six months post-injury, with all-or-nothing behaviour trending towards 
significance (Hou et al., 2012). Maladaptive cognitive responses to injury were present early in 
the recovery process and may have been reinforced over time, as individuals attempted too 
much and experienced cognitive and physical failures. The authors suggest early mTBI 
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intervention targeting coping processes as a way to prevent the development or lessen the 
severity of PCS.  
Like Mickeviciene et al. (2002), Styrke and colleagues (2013) discovered a higher rate 
of depression three years post-injury. However, Barker-Collo and colleagues (2015) found that 
the incidence of depression declined over their 12-month study period, while anxiety 
increased until 6 months post-injury, then declined until the 12-month end point.  
 Similar to Hou et al. (2012) Snell, Hay-Smith, Surgenor & Siegert (2013) interviewed 
147 mTBI sufferers within 3 months of their injuries, then again 6 months later, and found that 
participants with stronger injury identity beliefs, expectations of lasting severe consequences, 
and distress at the initial meeting had higher odds of poor outcomes at the second meeting. 
The authors applied Leventhal’s Common Sense Model, whereby individuals construct their 
own representations of a health condition to help make sense of the symptoms experienced 
and provide a basis for coping. In a 2015 cluster analysis study Snell and colleagues found that 
participants could be grouped into high, medium, and low adaptation clusters based on injury 
beliefs. This presents a possibility for identifying individuals who may be at risk of developing 
PCS, and thus may benefit from higher intensity intervention to prevent the development or 
shorten the course of the syndrome.  
 In a study of 171 individuals with TBI of all severities, Lee, Jayasinghe, Swenson, and 
Dams-O’Connor (2019) found that the personality trait of dispositional optimism was positively 
correlated with cognitive function at least one year post-injury. This association was significant 
after controlling for age, race, positive and negative affect, health status, and injury severity. 
The authors state that optimism is a teachable skill and recommend further research into its 
utility as a TBI symptom reduction tool.  
 Considering the above studies, it seems that psychological symptoms may be both a 
risk factor for, as well as an outcome of, mTBI. Pre-existing psychological difficulties and 
maladaptive injury related beliefs may affect the development and duration of other mTBI 
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symptoms, and psychological symptoms may develop after mTBI complicating recovery from 
cognitive symptoms.  
 Neurogenic symptoms. Broshek and colleagues (2015) suggest that emotional 
difficulties experienced after mTBI may be due to the initial structural and secondary 
metabolic injury, noting that injury often involves frontal-temporal damage or diffuse axonal 
injury (DAI) to cortical areas connecting to the limbic system. Indeed in a neuroimaging study 
of 56 young male athletes, Chen, Johnston, Petrides, and Ptito (2008) found that athletes 
suffering both PCS and depressive symptoms exhibited altered neural responses during a 
working memory task. There were no significant differences in performance on the task 
between the four groups which consisted of: three groups of concussed athletes with PCS 
symptoms five to seven months post-injury – without depression, with mild depression, or 
with moderate depression as measured by the BDI-II; and a healthy control group. The PCS 
with depression groups showed reduced activation in the prefrontal cortex and striatum, less 
task related reduction in activity in several other brain regions, and reduced grey matter 
volume in the medial frontal and temporal cortical regions when compared to healthy controls 
and concussed athletes without depressive symptoms. As these athletes were young and had 
no history of mood disorders, the authors reason that it is unlikely that the lower grey matter 
volumes were premorbid and acted as a diathesis for the development of depression, but were 
probably due to injury processes.  
 Heitger and colleagues (2009) compared 36 PCS sufferers to matched controls who 
had recovered well after mTBI, on measures of eye movements and cognition. Eye movement 
control relates closely to the functional integrity of the brain, as it requires the coordination of 
neural circuitry in both cortical and subcortical structures, as well as the cerebellum; several 
parameters of eye movements are beyond cognitive control (Cifu et al., 2015; Heitger et al., 
2009). The PCS group in the Heitger et al. (2009) study performed lower than controls on anti 
and self-paced saccades, memory guided sequences, and smooth pursuit eye movements, 
40 
 
suggesting problems in response inhibition, short-term spatial memory, motor-sequence 
programming, visuospatial processing, and visual attention. The PCS group also performed 
lower on neuropsychological measures of memory, complex attention, and executive function, 
however the oculomotor measures were more strongly related to symptom load as measured 
by the RPQ. The control group in this study were found to have a higher predicted IQ 
determined by the Wechsler Test of Adult Reading (WTAR), which affected some of the 
neuropsychological measures; the oculomotor deficits however, were unrelated to depression, 
intellectual functioning, or malingering, indicating ongoing cerebral impairment in the PCS 
group. 
 Su et al. (2014) examined the C-reactive protein (CRP) levels of 213 patients with mTBI 
in a three month follow up study. CRP is a biomarker of systemic inflammation that is sensitive, 
but not specific, to trauma. Thus, participants who had suffered other injuries, recent 
infection, previous head trauma, were cognitively impaired or had psychiatric diagnoses were 
excluded from the study. Su and colleagues (2014) found that higher CRP levels at baseline 
were associated with persistent post-concussion symptoms, psychological problems (anxiety 
and depression), and cognitive impairment, with odds ratios of 2.72, 1.54, and 1.69 
respectively. This indicates that systemic inflammation, as well as neuro inflammation, may 
play a role in post concussive symptoms. 
 A small Diffusion Tensor Imaging (DTI) study of 15 mild to moderate TBI sufferers and 
15 matched controls found that alterations in the microstructural integrity of white matter was 
associated with poor balance and cognitive symptoms after injury (Kim et al., 2019). This 
suggests glial involvement in ongoing symptoms as well as the systemic, neural, and 
psychological involvement found in other studies.  
 There is consistent evidence of acute cognitive symptoms such as memory, attention, 
and processing speed deficits, after mTBI. There also exists some evidence for ongoing 
symptoms, however methodological issues as well as the heterogeneity of both symptoms 
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experienced as well as their progression, prevent a consensus being reached regarding the 
typical course of symptoms and the utility of diagnosis. Both psychological and physiological 
processes underlie symptoms, though more research is needed to delineate their respective 
contributions and interactions. Understanding the mechanisms behind post-mTBI symptoms 
helps to inform intervention. As will be discussed in later chapters, n-3 PUFA may exert effects 
on symptoms via physiological pathways, while information provision affects psychological 
processes.   
Assessment of Post-Concussion Symptoms  
The assessment of PCS depends on the diagnostic criteria used. The vast majority of 
studies employ the ICD-10 criteria and rely on self-report symptom measures such as the RPQ , 
and the Post-Concussion Symptom Checklist. As with all self-report measures this introduces 
the possibility of several biases. One bias particularly common with post-concussion symptom 
reporting is the ‘good old days’ bias. After suffering mTBI many individuals under-report 
premorbid symptoms, misperceiving their premorbid functioning to be better than the 
average person (Iverson, Lange, Brooks, & Ashton Rennison, 2010; Lange, Iverson, & Rose, 
2010; Yang et al., 2014). Unsurprisingly, Iverson and colleagues (2010) found that this effect 
was more pronounced in participants who failed an effort test. Those who failed the Test of 
Memory Malingering (TOMM) under reported premorbid symptoms, and reported more 
current symptoms, than both mTBI participants who passed the TOMM, and healthy controls 
(Iverson et al, 2010).  
 As outlined in above sections, various neuropsychological tests are used to evaluate 
cognitive symptoms following mTBI. Tests of memory, attention, processing speed and 
executive function are common. According to Heitger and colleagues’ (2009) study however, 
oculomotor testing had a stronger correlation than the neuropsychological measures with 
post-concussion symptom load and problems with activities of daily living. Both Heitger et al. 
(2009) and Cifu et al. (2015) propose eye movement tracking as an effective measure to 
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distinguish PCS sufferers from healthy or recovered controls, however the required equipment 
is not yet commonly possessed by concussion clinics and more research may be necessary 
before this method can be considered for standard practice.   
Treatment of Post-Concussion Symptoms 
Current treatment for symptoms after mTBI includes rest and information regarding 
the course of injury, with more specialist treatment such as occupational therapy or 
psychological therapy offered for individuals who are identified by the concussion service as 
requiring further input (The New Zealand Guidelines group, 2006; ACC, 2019). For treatment of 
ongoing symptoms after mTBI, the New Zealand Guidelines Group (2006) recommend 
symptom-based approach to minor problems, and offering the injured individual reassurance 
and information regarding symptom management and strategies. For clinically significant TBI, 
which may encompass PCS, the New Zealand Guidelines Group (2006) posit that rehabilitation 
should be functionally oriented, provide information and support to family/whānau/carers of 
the injured individual, and provide access to psychological assessment and intervention when 
required. 
 A Canadian paper by Marshall and colleagues (2015) recommended a similar 
symptom-based approach. Their paper updating clinical practice guidelines for the treatment 
of persisting symptoms following mTBI recommended: initiating rehabilitation of any cognitive 
impairments found during formal cognitive assessment, or if learning compensatory strategies 
would facilitate the individual returning to work or other functional activity; including both 
compensatory and remediation approaches to cognitive rehabilitation; and where possible, 
informing employers or teachers of potential temporary alternative duties or working hours in 
order to avoid anxiety related to cognitive difficulties and experiencing repeated errors or 
setbacks in work or school. They also recommended Cognitive Behavioural Therapy (CBT) for 
ongoing mood, anxiety and/or sleep difficulties, gradual return to sport/exercise and leisure 
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activity as symptoms allow, physiotherapy and/or neurology for peripheral and vestibular 
problems, and pharmacotherapy for headache.  
 MTBI and PCS are heterogeneous conditions; every case involves a unique 
combination of forces acting on an individual’s unique anatomy (Taber & Hurley, 2013) and is 
likely moderated by his or her unique personality, beliefs, and coping styles. Thus, there is no 
‘one size fits all’ solution to intervention and as the New Zealand Guidelines Group (2006) 
recommend, a multi-disciplinary approach is favourable.   
 ACC manage the rehabilitation of head injuries caused by accidents in New Zealand, 
and employ a ‘concussion service’ for claimants who have suffered mild or moderate TBI. 
These concussion services are non-governmental organisations (NGOs) that apply to ACC to 
provide services for a contracted price. The concussion service is offered from a 
biopsychosocial perspective, and each service provider must include a minimum of a medical 
specialist with qualification in neurology, or internal medicine with a focus on brain injury; a 
clinical neuropsychologist; and an occupational therapist (ACC, 2019). Each service provider 
must also have access to other professionals such as optometrists, various types of 
counsellors, cultural advisors, and advocacy services. Individuals are referred to the concussion 
service via primary health care professionals (e.g., a general practitioner [GP], or a medical or 
allied health professional from a district health board [DHB] if the individual presented to a 
hospital) or by an ACC case manager. ACC (2019) stress the individual nature of injury, and as 
such each individual’s pathway through the service is dependent on recommendations made 
after a comprehensive assessment. The organisation also places emphasis on educating clients 
about mTBI in order to prevent PCS, though explicitly states within the services operational 
guidelines that clients should not be provided such education if the diagnosis has not yet been 
confirmed. If treatment within the service is indicated, this may include medical consultation, 
psychological counselling, and/or allied health and vocational services specific to the 




Mild traumatic brain injury (mTBI) is caused by mechanical forces to the head which 
disrupt normal brain function. Traditionally mTBI has been referred to as concussion, a term 
that continues to be used in some services and by some researchers though is frequently 
considered to be at the ‘milder’ end of the mTBI spectrum and heal within weeks. Regardless 
of terminology, the injury involves primary and secondary components, as complex injury 
cascades begin in the acute period and continue into the post-acute period. Many individuals 
suffer from physical, cognitive, and affective symptoms in the acute period, but recovery is 
usually rapid, occurring within days or weeks for most individuals. A small percentage of mTBI 
sufferers however, experience symptoms that persist beyond this time. Chronic symptoms 
tend to include fatigue, headache, and difficulties with memory and attention.  
There is debate around the classification and cause of ongoing symptoms. While 
chronic symptoms have traditionally been attributed to psychological causes, recent research 
has outlined physiological deficits and processes that contribute to symptoms and suggest 
ongoing cerebral impairment. A biopsychosocial approach to treatment is usually taken, and in 
New Zealand multidisciplinary teams are engaged to provide intervention. Interventions 
include education, reassurance, and psychotherapy when necessary, as well as allied health 
input depending on the individual’s circumstances. This approach adheres to guidelines for 
individualised treatment, however given the significant minority who suffer ongoing symptoms 
and an increasing understanding of the mechanisms and aetiology of symptoms, there is scope 
for adjunct intervention. One possible adjunct intervention is omega-3 polyunsaturated fatty 




Chapter Two: Omega-3 Polyunsaturated Fatty Acids 
 Omega-3 polyunsaturated fatty acids (n-3 PUFAs) are a class of nutrients essential to 
the human body. Fats perform many functions in the body: they provide the most energy per 
gram (37kJ/g) of all the macronutrients; provide a means of storing energy; insulate the body 
and its organs; form part of cell membranes, hormones, and other chemical messengers; and 
aid the absorption of fat soluble vitamins (Whitney, Rolfes, Crowe, Cameron-Smith, & Walsh, 
2011). Fatty acids consist of a hydrocarbon chain with a carboxyl group at one end (named the 
alpha end) and a methyl group at the other (named the omega end); different types of fats 
have different saturation levels – the saturated fats contain the maximum number of hydrogen 
atoms as can be attached to the carbon chain (the carbon chain is ‘saturated’ with hydrogen 
atoms), the unsaturated fats contain at least one carbon that is not saturated with hydrogen, 
and at this point a double bond exists with the next carbon in the chain (Whitney et al., 2011).  
The present research focuses on the long chain n-3 PUFAs (LC n-3 PUFAs) 
eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) as these have shown promise in 
various arenas of health research, including cognitive health. These fatty acids consist of 
hydrocarbon chains 20 (EPA) and 22 (DHA) carbon atoms in length. Each has a carbon to 
carbon double bond three carbons from the omega end of the chain, hence the term ‘omega-
3’ and contains further double bonds – or points of unsaturation – hence the term 





Figure 2.1. The chemical structure of EPA and DHA. Each line represents the bond between 
carbon atoms; double lines represent double bonds. This illustrates the polyunsaturated 
nature of these fatty acids. Adapted from Whitney et al., (2011). 
While most fats can be synthesised in the human body, alpha linolenic acid (ALA) – the 
precursor to both EPA and DHA – and linoleic acid (LA) cannot; these are termed essential fatty 
acids as they must be obtained from the diet (Whitney et al., 2011). Although EPA and DHA 
can be synthesised from ALA, the rate of synthesis is very low and may not meet an 
individual’s requirements, making them ‘conditionally essential’ nutrients – it is essential to 
obtain them from the diet when synthesis is inadequate (Whitney et al., 2011). Estimates of 
the amount of ALA converted to DHA in the body range from less than one percent, to up to 
nine percent (Arterburn, Hall, & Oken, 2006). A limiting factor in the conversion of the n-3 
PUFAs is competition for the enzymes necessary for this process.  
The omega-6 (n-6) fatty acids, present in many foods such as nuts, grains, and 
vegetable oils, use the same enzymes for similar conversion processes, thus the presence of 
these fats can impede EPA and DHA synthesis, particularly when the ratio of n-6 to n-3 is high 
(Whitney et al., 2011). The optimal ratio of n-6 to n-3 fats is approximately 1-2:1, however the 
typical ‘western diet’ has a widely varied but largely out of proportion ratio of 10-25:1 (Lewis, 
2016). In addition, males convert less ALA to EPA and DHA than females (Arterburn et al., 
2006), and individual differences in stress hormones, genes, vitamin and mineral deficiency, 
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and alcohol consumption can also limit the synthesis of EPA and DHA in the body (Uauy & 
Valenzuela, 2000). Due to these limitations, dietary sources of EPA and DHA are recommended 
(Lunn & Theobald, 2006). The richest sources of these fatty acids are oily fish such as salmon, 
tuna, and mackerel (Whitney et al., 2011), as well as algae sources (Lunn & Theobald, 2006; 
Weiser, Butt, & Mohajeri, 2016).  
 The remainder of this chapter will focus on the role of the LC n-3 PUFAs in the body – 
particularly the brain. Information regarding the relationship between a high LC n-3 PUFA diet 
and mortality and morbidity, n-3 PUFA consumption in New Zealand and abroad, and studies 
using EPA and DHA supplements in human populations will be reviewed.  The chapter 
concludes with a specific focus on EPA and DHA supplements for mTBI.  
A Brief History of Dietary Omega-3. Diet plays an essential role in health and 
development through the lifespan and may have played a central role in human evolution. A 
high quality diet was both necessary for, and a consequence of the evolution of the large 
human brain (Kyriacou, Parkington, Marais, & Braun, 2014). A key dietary factor for the 
development of the large brain in the human species was fish and/or shellfish due to their 
concentration of iodine, iron, and DHA (Cunnane, 2005; Cunnane, Plourde, Stewart, & 
Crawford, 2007). Indeed, excavation of stone age sites have unearthed evidence of abundant 
and intentional fish and shellfish intake by both humans and Neanderthals (Cunnane et al., 
2007; Kyriacou et al., 2014; Stringer et al., 2008). Given that the nutrients present in these 
foods, particularly DHA, are essential for the development of brain structure and function, the 
exploitation of such marine resources may have played an essential role in making humans 
what we are today. 
 Omega-3 Fatty Acids and Brain Structure and Function.  The brain is a fat-rich organ; 
DHA represents over 90% of its n-3 PUFA, and 10-20% of its total lipids (Weiser et al., 2016). 
While EPA exerts acute actions in the brain and is absorbed in approximately equal 
proportions to DHA, very little EPA exists in brain tissue as it is rapidly oxidised and removed, 
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or converted into other fatty acids (Weiser et al., 2016). Therefore, n-3 PUFAs’ effects on brain 
structure and function are considered to be significantly dependent on DHA. 
 DHA begins to accumulate in neural tissues at a high rate from the third trimester of 
gestation, continuing at this rate to the end of the second year of life (Lauritzen et al., 2016; 
McCann & Ames, 2005). High levels are then maintained throughout the lifespan. Individual 
differences exist in DHA accretion, with an important factor being dietary consumption. For 
infants, this includes consumption via maternal DHA stores, which are transferred through the 
placenta and breast milk (Innis, 2007). Later in life, DHA must be consumed in its complete 
form, or synthesised following the consumption of other n-3 PUFAs, though as outlined 
previously the synthesis process is inefficient. Brain DHA has an estimated half-life of 2.5 years, 
as it is metabolised at a rate of approximately 4mg per day (Barceló-Coblijn & Murphy, 2009; 
Weiser et al., 2016). As DHA is mainly synthesised in the liver and the rate of synthesis in the 
brain is very low, brain DHA levels are maintained through delivery via the circulating blood 
(Chen et al., 2015). 
 DHA is concentrated in the cerebral grey matter, and stored primarily in membrane 
phospholipids (Brenna & Diau, 2007). It cycles in and out of the membrane from phospholipids 
to the intracellular free fatty acid pool, providing a mechanism to help meet the energy 
demands of rapid growth and other cellular challenges (Chen, Green, Orr, & Bazinet, 2008; 
Weiser et al., 2016). DHA can influence membrane fluidity, lipid raft function, neurotransmitter 
release, transmembrane receptor function, gene expression, signal transduction, myelination, 
neuroinflammation, and neuronal growth and differentiation (Innis, 2007).  Thus it plays 
several important roles in the structure and function of the brain throughout the lifespan. DHA 
deficiency has been associated with alterations in normal neurodevelopment, neural 
inflammation, and increased mortality and morbidity (Muldoon et al., 2010). 
49 
 
Dietary Omega-3 Fatty Acids and Mortality and Morbidity 
 The Mediterranean Diet. Dietary patterns high in LC n-3 PUFA have shown an 
association with health and longevity. Possibly the most well known and most widely 
researched of these is the Mediterranean diet. This dietary pattern includes large amounts of 
fruit, vegetables and wholegrains; moderate consumption of nuts, seeds, legumes, olives/olive 
oil, alcohol (mainly red wine with meals) and fish/shellfish; and limited meat, dairy and sweets 
(Serra-Majem & Medina, 2015). Such a diet provides substantial micronutrients, adequate 
macronutrients and dietary fibre, and a favourable profile of lipids, including DHA (Buckland & 
Agudo, 2014). 
 Numerous prospective cohort studies have found an inverse association between the 
Mediterranean diet and all-cause mortality. In a study of middle aged Spanish university 
alumni, the highest level of adherence to a Mediterranean diet, which was characterised by 
high vegetable, fish and seafood, fruit, and virgin olive oil intake, was associated with a 47% 
decreased risk of mortality from all causes when compared with the lowest level of adherence 
(Martínez-González et al., 2015). Similarly, a 38% reduction in all-cause mortality was noted 
with high adherence to the Mediterranean diet pattern in a 20 year cohort study of 40-74 year 
old Italians (Prinelli et al., 2015). This reduced to a 21% lower risk for those who had a medium 
level of adherence to the Mediterranean diet. In a United States cohort, a 20% and 21% 
reduction in all-cause mortality was found for women and men adhering to the Mediterranean 
diet respectively (Mitrou et al., 2007). Danish and Swedish cohorts also showed a reduction in 
mortality with higher adherence to a Mediterranean dietary pattern, however these were 
more modest results, with a reduction of 7% in both studies (Tognon, Lissner, Saebye, Walker, 
& Heitmann, 2013; Tognon et al., 2011). Taken together, this shows a pattern of decreased all-
cause mortality in several cultures. Some studies suggest a dose-response relationship, with a 
4%-5% (Prinelli et al., 2015; Vormund et al., 2015) decrease in all-cause mortality with every 
point on a scale of adherence to the diet, and a meta-analysis (Sofi, Macchi, Abbate, Gensini, & 
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Casini, 2013) found an 8% decrease in all-cause mortality, 10% decrease in cardiovascular 
mortality, and 4% decrease in cancer mortality for each 2 points on an adherence scale.  
 The Mediterranean diet has consistently been associated with a lower risk of 
cardiovascular disease and stroke (Estruch et al., 2013; Reedy et al., 2014; Sofi et al., 2013) 
however its association with cognitive function is still under frequent investigation. In a 
systematic review of the Mediterranean diet’s association with cognitive function and 
dementia, Lourida et al. (2013) found a consistent inverse association between adherence to 
the diet, cognitive decline, and risk of dementia. However, the relationships for Mild Cognitive 
Impairment (MCI) – a possible dementia prodrome – were inconsistent. Using the Mini Mental 
Status Exam (MMSE), Trichopoulou et al. (2015) found an inverse relationship between 
Mediterranean diet adherence and cognitive decline in a 7 year follow up study with a Greek 
cohort.  
Which aspect of the diet accounts for the reduction in the risk of cognitive decline is 
not clear. In Trichopulou and colleagues’ (2015) study, only vegetable intake had a significant 
relationship with cognitive performance. Galbete et al. (2015) however, observed a significant 
relationship only with the monounsaturated to saturated fatty acid ratio in their study of a 
Spanish cohort. In this study, those with low or moderate adherence to the Mediterranean 
diet at baseline exhibited higher levels of cognitive decline when followed up with the 
Telephone Interview of Cognitive Status – Modified, 6-8 years later. The authors noted that the 
differences between adherence groups were small in magnitude, however it appears that fatty 
acids played an important part in explaining the relationship seen.  
 While no statistically significant relationship between fish consumption and mortality 
was found in single dietary component analyses from the aforementioned studies, Féart et al. 
(2011) found that adherence to the Mediterranean diet was positively correlated with plasma 
DHA, the EPA+DHA index, and total n-3 PUFA. This indicates that the diet provides the 
necessary elements for maintaining DHA levels in the blood, and consequently the brain. 
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 Fish Consumption. In a 1999 study of fish consumption and mortality data from 36 
countries, Zhang, Sasaki, Amano, and Kesteloot found significant inverse correlations between 
fish consumption, all-cause mortality, and mortality from ischaemic heart disease and stroke. 
Wang et al. (2011) also found that fish consumption was inversely related to all-cause 
mortality as well as ischaemic heart disease, stroke, and cancer mortality in a Chinese case-
control study, though suggest further longitudinal study be conducted to support the 
relationship seen. Villegas, Takata, Murff, and Blot (2015) found differences in cooking 
methods altered relationships between fish and all-cause mortality, and this also varied 
between ethnicities. Total fish consumption, fried fish, and baked/grilled fish were associated 
with decreased all-cause mortality over the total sample, though only baked/grilled fish and 
total fish was associated with mortality in black participants. These results suggests that fish 
consumption may be associated with decreased mortality and morbidity, but preparation 
methods could be a mediating factor for some populations, thus should be taken into account 
when analysing data and setting recommendations.  
 Studies of fish consumption and cognitive performance have yielded mixed results. A 
French study discovered a positive relationship between fish consumption and cognitive 
performance in older adults (Kesse-Guyot et al., 2011), though after adjusting for psychological 
health and education the observed relationships only just reached statistical significance. A 
large study of Swedish adolescents Kim et al. (2010) found a dose-response relationship 
between fish consumption and academic performance, which remained after adjustment for 
parental education. At the other end of the age span Del Brutto, Mera, Gillman, Zambrano, 
and Ha, (2016) found a positive dose-response relationship between oily fish consumption and 
cognitive performance as assessed by the Montreal Cognitive Assessment (MoCA) in 
community dwelling older adults in rural Ecuador. In contrast, Danthiir et al. (2014) found that 
higher levels of current and childhood fish consumption both predicted lower performance on 
measures of cognitive speed and reaction time.  
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The differences in results between studies may stem from the differences in the 
measures used, populations studied, type of fish consumed, and its typical method of 
preparation. This highlights the difficulty of comparing populations, and recommending a 
whole food group for health benefits without considering the local food supply and customs.  
Omega-3 intake in New Zealand 
Dietary recommendations. An adequate Intake (AI) of n-3 PUFA for New Zealand and 
Australian adults has been set as 160mg/d for males, and 90mg/d for females (National Health 
and Medical Research Council [NHMRC], 2006). These values are based on observed median 
intakes for groups of apparently healthy Australian adults, and are assumed to be adequate for 
both Australian and New Zealand populations (NHMRC, 2006), but may not represent optimal 
intake. The AI relates to n-3 PUFA in the form of ALA only; no separate value for DHA or EPA 
has been set. The NHMRC (2006) also propose a combined suggested dietary target (SDT) for 
DHA, EPA, and DPA (another LC n-3 PUFA) of 610 mg/d for males and 430 mg/d for females; 
this value is suggested for lowering risk of chronic disease. The NHMRC have also set an upper 
level (UL) reference value for the LC n-3 PUFAs (DHA, EPA, and DPA) of 3000mg per day, which 
is based on the United States’ Food and Drug Administration’s recommendations for levels 
generally considered safe for US adults.  
New Zealand population intake. Findings from the 2008/09 New Zealand Adult 
Nutrition Survey showed that on average adult New Zealand males consume 13.5g/d all PUFAs 
and females 10g/d, with 5.2% of this coming from fish and other seafood sources (Ministry of 
Health [MOH], 2011). No data is available for the n-3 PUFAs or the type of fish/seafood 
consumed, thus it is unclear whether New Zealanders are meeting the dietary targets for more 
specific types of fat. This lack of information, as well as the individual differences in the 
conversion of other PUFAs to DHA, mean it is difficult to infer whether the NZ population are 
meeting the n-3 PUFA or DHA dietary requirements. One study, however, has labelled NZ LC n-
3 PUFA status ‘marginal’ (Stonehouse et al., 2011). 
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Supplemental intake. Recent years have seen a worldwide increase in supplement use 
for a wide variety of ailments (Millen, Dodd, & Subar, 2004; Ritchie, 2007). The 2008/09 New 
Zealand Adult Nutrition Survey found that oil supplements – which included both n-3 and n-6 
PUFAs – were the most commonly used (MOH, 2011). There were differences in use by 
ethnicity, with 4.6% males and 4.5% females of Pacific Island descent using oil supplements, 
7.7% males and 8% females of Māori descent using such supplements, and 14.7% males and 
20.8% females of New Zealand European/other descent using oil supplements. There also 
appeared to be a social gradient to supplementation, with 19.4% of male and 24.6% of female 
oil supplement users living in the least deprived areas, while only 10.6% of male and 9.6% of 
female oil supplement users lived in the most deprived areas according to the NZDep2006 
index of deprivation quintiles (MOH, 2011; Salmond, Crampton, & Atkinson, 2007). This may 
be indicative of a cost barrier to obtaining supplements.  
A more recent cross-sectional study of fish oil supplement use in New Zealand found 
that 21.9% of the 334 respondents were regular fish oil consumers (Mengelberg, Leathem, & 
Podd, 2018). These self-identified consumers were more likely to also be regular consumers of 
oily fish, thus less likely to be deficient in n-3 PUFA intake. This sample of survey respondents 
were mainly female, under 40 years of age, and highly educated, therefore not representative 
of the wider New Zealand population, nor a population particularly susceptible to mTBI. In 
addition, the fish oil users were more likely to earn over $150,000 per annum, adding further 
support to the notion of a cost barrier for the general population obtaining such supplements. 
Interestingly, just 26% of this consumer group were taking a dose that would meet the daily 
recommendations of DHA+EPA.  
Due to the lack of information regarding New Zealander’s intake of n-3 PUFAs from 
both food and supplementary sources, it cannot be determined whether the NZ population is 
consuming this important nutrient in adequate amounts. However like most Western 
countries, it is likely that they are not (Hibbeln, Blasbalg, & Riggs, 2006). It appears that those 
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of lower socioeconomic status may be less likely to consume adequate DHA and EPA, possibly 
due to the high cost of both supplements and LC n-3 PUFA rich seafood. It is also possible that 
deficiency is more common in non-coastal areas, where fishing and gathering shellfish is not an 
option. This is a line of inquiry that needs further investigation. 
Supplemental Omega-3 PUFA Intervention Studies in Human populations 
 Several randomised controlled trials have been conducted to assess both cognitive 
function and mood after LC n-3 PUFA supplementation. Results have been mixed, and do not 
always support observational evidence. Please see Table 2.1 for a summary of these studies. 
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Table 2.1  
Randomised Placebo Controlled Trials of the Cognitive and Mood Effects of LC n-3 PUFA Supplementation 
Title Authors Year Population  Duration  Treatment 
and dose 
Placebo n-3 PUFA status Mood outcomes Cognitive outcomes 
Randomised double-
blind placebo-
controlled trial of fish 
oil in the treatment 
of depression 






12 weeks 8g/day tuna 
oil – 2.4g 
DHA + 0.6g 
EPA 
Olive oil Circulating RBC 
levels of DHA and 
EPA more than 
doubled from 
baseline to 
completion in the 
treatment group. 













Kotani et al. 2006 39 amnestic 
adults from 
Japan, aged 
45+ - 21 
with MCI, 10 
with organic 
brain injury, 
and 8 with 
early stage 
Alzheimer’s 
90 days 240mg 
arachidonic 
acid (ARA) + 
240mg 
DHA/day 
Olive oil N/A N/A Immediate memory 
improved in MCI 
and organic injury 
groups, delayed 
memory improved 
in the organic 
injury group, and 
attention improved 
in the MCI group. 
All domains 
measured using a 
Japanese version of 
the RBANS. 





cognitive function in 
older people: a 
randomized, double-
blind, controlled trial 
Dangour et 
al. 
2010 748 70-79 
y/o healthy 
adults 
2 years 500mg DHA 
+ 200mg 
EPA/day 













subjects with mild 
cognitive impairment 









1 year 1.3g DHA + 
45mg 
EPA/day 
Corn oil Serum EPA and 
DHA significantly 
increased after 12 
months for the 
treatment group 







delayed recall as 
measured by Visual 
Reproduction I 
from WMS-R, Digit 
Span backwards, 
and the RAVLT.  
Effects of n-3 fatty 
acids, EPA v. DHA, on 
depressive 
symptoms, quality of 
life, memory and 
executive function in 





Sinn et al. 2012 40 adults 
aged 65+, 
with MCI 
6 months 1.67g EPA + 
.16g 
DHA/day, or 





RBC EPA and DHA 
ranged from .95 
to 4.75% total 
fatty acids. This 
increased 
significantly after 
6 months in both 
treatment 
groups. 





with the control 
group. Within-
group changes on 
GDS scores only 
significant for the 





physical function.  
Verbal fluency, 
measured by a 
letter fluency test, 
improved in the 
DHA-rich treatment 
group. 
No effect of 12 
weeks’ 
supplementation 
with 1g DHA-rich or 
EPA-rich fish oil on 
Jackson et 
al. 





12 weeks 450mg DHA 
+ 90 mg 
EPA/day, or 
300mg EPA + 
Olive oil Serum 
concentrations of 
DHA significantly 




as measured by 
visual analogue 
scales the DASS. 
DHA rich group 






cognitive function or 
mood in healthy 






names and faces in 
a recall test. EPA 
rich group reported 
significantly lower 












memory and reaction 
time in healthy 





2013 176 healthy 
18-45 y/o 
adults 












significantly in the 
treatment group 




time of episodic 
memory in both 
sexes, reaction 
time of working 





with DHA and the 
psychological 
functioning of young 
adults 






50 days 400mg 
DHA/day 
Soya oil N/A No change in 
visual analogue 
scales relating to 
the last week. 
Treatment 
participants forgot 
more than control 
on a word list recall 
task.  
The effects of long-




Pase et al. 2015 160 healthy 
50-70 y/o 
16 weeks 480mg DHA 







Baseline RBC n-3 
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Jackson et 
al. 























EPA and DHA 
ranged from .93-
2.85% total fatty 
acids. Percentage 
of whole-blood 












Demand Battery, or 
mental fatigue 








cognitive function in 
the Chinese elderly 





Bo et al. 2017 86 Chinese 
adults with 
MCI, mean 
age 71 y/o 
6 months 480mg DHA 
+ 720 mg 
EPA/day 





after 6 months. 
Mean baseline 
EPA and DHA 
ranged from .8-
1.62% total fatty 
acids. 
N/A Total Basic 
Cognitive Aptitude 
Test, perceptual 
speed, and space 
imagery efficiency 
scores improved 
with treatment in 
both sexes, 
working memory 
scores improved in 
males only.  
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with or without 
multimodal 
intervention on 
cognitive function in 




controlled trial  
Andrieu et 
al. 
2017 1680 adults 
70+ y/o in 
France and 
Monaco 
3 years 800 mg DHA 
















Composite Z score 
of 10x MMSE 
orientation items, 
SRT, Digit Symbol 
Substitution Test 
and Category 
Naming Test. Also 
Trail Making Test 
A&B, COWAT. 
Lower rate of 
decline on MMSE 
items in combined 
intervention group 
v placebo. No other 
between group 
differences.  
Notes. RBC, red blood cell; MCI, mild cognitive impairment; BDI-II, Beck Depression Inventory II; HDRS-SF, Hamilton Depression Rating Scale – Short Form; 
RBANS, Repeatable battery for the Assessment of Neuropsychological Status; WMS-R, Wechsler Memory Scales – Revised; RAVLT, Rey Auditory Verbal 




Omega-3 PUFAs and cognitive function. The observational evidence showing positive 
associations between LC n-3 PUFAs and cognitive function is not always supported by 
experimental evidence, which reports a mix of positive, negative, and no associations, as 
outlined in Table 3.1 above. Two trials in healthy young university students and graduates 
reported increased rates of forgetting after DHA supplementation (Benton, Donohoe, Clayton, 
& Long, 2013; Jackson, Deary, Reay, Scholey, & Kennedy, 2012). Jackson and colleagues (2012) 
also reported that their DHA rich supplement group were faster on the Stroop test than the 
EPA rich and placebo groups, indicating increases in attention and/or response inhibition. 
However, due to the small number of statistically significant results compared with large 
number of tests conducted, and the bidirectional nature of the results, the authors concluded 
that there were no cognitive effects with supplementation. In contrast, Stonehouse and 
colleagues’ (2013) six-month trial in healthy 18-45 year olds found that DHA supplementation 
improved the reaction time of episodic memory in both sexes, improved episodic memory in 
females, and improved the reaction time of working memory in males. Participants in this 
study habitually consumed diets low in DHA, and were provided with a higher dose of DHA for 
a longer duration than the negative trials.  
Several supplement trials have been conducted with older adult populations, with 
mixed results. A Japanese study (Kotani et al., 2006) was conducted with 39 amnestic 
participants – 21 with MCI which was split into treatment and control groups, ten with organic 
brain injuries such as haemorrhage or TBI occurring a minimum of five years before the trial, 
and eight in the early stages of Alzheimer’s disease. The treatment groups received equal 
amounts of arachidonic acid (a n-6 fatty acid) and DHA for 90 days. The Alzheimer’s group 
showed no improvements after supplementation, but the organic injury and MCI treatment 
groups improved in delayed memory and attention respectively, and both showed 
improvements in immediate memory.  
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Similarly, a trial in a Malaysian MCI population from low socioeconomic backgrounds 
showed improved short-term and working memory after 12 months of DHA supplementation 
(Lee, Shahar, Chin, & Yusoff, 2012). A 6 month randomised controlled trial of two doses of LC 
n-3 PUFA supplements in older adults with mild cognitive impairment (MCI) found that those 
receiving the supplement with higher DHA levels showed improvement in verbal fluency and 
self-reported physical functioning, though did not exhibit any memory improvements (Sinn et 
al., 2012).  
A recent trial in an elderly Chinese population with MCI also showed improvements 
after supplementation. Perceptual speed and space imagery efficiency improved for both 
sexes, and working memory for males (Bo et al., 2017). However, a trial in older adults with 
subjective memory complaints but not diagnosed with MCI yielded no significant results 
(Jackson et al., 2016) and two further trials in healthy older adult populations have reported no 
effects of treatment on cognitive performance (Dangour et al., 2010; Pase et al., 2015). An 
interesting finding from Pase and colleagues’ study was that although there were no significant 
effects from any level of treatment, an increase in the ratio of n-3 to n-6 was associated with 
faster spatial working memory response times.  
A large three year multicentre randomised placebo controlled trial aimed at 
preventing Alzheimer’s also found no effect with supplemental intervention (Andrieu et al., 
2017). Community dwelling individuals over 70 years (n=1680) who either reported a 
subjective memory complaint, a limitation in one or more instrumental activities of daily living, 
or had a slow gait speed were assigned to one of four groups. The n-3 PUFA supplement 
consisted of 800mg DHA and 225mg EPA per day, one group took this alone while another 
combined this with the multimodal intervention, which included 43 group sessions relating to 
cognitive training, physical activity and nutritional advice as well as three preventive health 
consultations with a physician. The remaining two groups included the multidimensional 
intervention in conjunction with placebo, and placebo alone. Outcome measures included the 
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Selective Reminding Test, Mini Mental State Examination, Digit Symbol Substitution Test, Trail 
Making Test, Controlled Oral Word Association Test, and the Category Naming Test for 
cognitive performance, as well as a physical performance battery, activities of daily living 
prevention instrument, clinical dementia rating, Fried’s frailty criteria, and the GDS. While no 
between group differences were found at the conclusion of the study, the authors conducted 
further analyses using a ‘modified intention to treat’ protocol that included participants with 
some protocol violations (e.g., not attending the end-point session but having some follow-up 
data available) and found that those in the combined intervention group showed less decline 
on the MMSE orientation items than the placebo only group.  
The lack of significant results in the healthy groups indicate that supplementation may 
only be useful for individuals with certain impairments, or perhaps a certain level of 
impairment. However, Pase and colleagues’ finding of improvement with higher n-3 to n-6 
ratios as well as Stonehouse and colleagues’ results with healthy younger adults, suggest that 
LC n-3 PUFA supplementation does have the potential to benefit healthy individuals. Positive 
results may be more likely after higher levels of supplementation for longer durations, or 
perhaps the relationship between supplements and cognitive effects in non-impaired or non-
deficient populations is not as straightforward as simply increasing intakes of certain nutrients. 
Omega-3 PUFAs and mood. Omega 3 fatty acids are also related to anxiety and 
depression. Cross sectional studies have found that DHA levels in adipose tissue are 
significantly inversely related to depression (Sarri, Linardakis, Tzanakis, & Kafatos, 2008), 
dietary DHA intake is inversely related to anxiety (Jacka et al., 2013) and depression (Meyer et 
al, 2013), and serum DHA levels are inversely associated with anxiety in early pregnancy (Verly-
Miguel et al., 2015). A 2009 meta-analysis of randomised controlled trials by Martin speculated 
that EPA rather than DHA was responsible for the efficacy of LC n-3 PUFAs in the treatment of 
depression. This study did however also report a significant inverse association between 
reported efficacy and methodological quality. Both the high DHA and high EPA groups of Sinn 
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and colleagues (2012) six month trial had improved scores on the Geriatric Depression Scale 
from pre- to post- intervention. The authors propose that DHA may be equally if not more 
effective than EPA at improving mood, however, improvements may relate to other factors 
such as lessened physical pain and improved cognitive performance.  
A trial of two different doses of DHA + EPA versus a placebo found no mood 
differences measured by the Depression Anxiety and Stress Scales (DASS) after supplementing 
healthy 18-30 year olds for 12 weeks (Jackson et al., 2012). Similarly, Benton and colleagues’ 
(2012) 50 day trial of daily DHA supplements with young female university students found no 
alterations in mood assessed using visual analogue scales. It is possible that the studies finding 
no effects were too short in duration to produce an effect, or perhaps the doses were 
insufficient. However, the populations studied were young and in good health, so as per Sinn 
and colleagues (2012) suggestion, the lack of mood effects may be due to a lack of alleviation 
of physical pain or discomfort. Or, perhaps as in the case of DHA supplements and cognition, 
effects are only present or measurable when some form of disorder exists. The effects of LC n-
3 PUFA supplementation on mood remain in need of investigation.  
Omega-3 PUFAs after brain injury. As the above review shows, several studies have 
found improvements in various forms of memory (Kotani et al., 2006; Lee et al., 2012; 
Stonehouse et al., 2013; Pase et al., 2015; Bo et al., 2017) attention (Kotani et al., 2006), 
perceptual speed and spatial ability (Bo et al., 2017), and executive functions (Jackson et al., 
2012; Sinn et al., 2012), after n-3 PUFA supplementation. These cognitive domains are 
frequently impaired after mTBI, thus it holds that n-3 PUFA supplements may aid recovery 
from mTBI symptoms.  
Few studies have been conducted with LC n-3 PUFA in people who have suffered brain 
injury and at present no published data exists comparing brain injury outcomes in populations 
with high versus low LC n-3 PUFA diets. Amen, Wu, Taylor, and Willeumier (2011) treated 30 
brain damaged and cognitively impaired retired NFL football players with fish oil, weight loss, a 
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multi-vitamin, and a ‘brain enhancement’ supplement including acetylcholine, antioxidants, 
and blood flow enhancers. Participants showed improvements in attention, memory, 
reasoning, and information processing. Increased perfusion in the prefrontal cortex, parietal 
lobes, anterior cingulate gyrus, and cerebellum was also noted. However, due to the poly-
supplement approach and lack of a control group it is not possible to attribute these effects to 
fish oil.  
Sears, Bailes, and Asselin (2013) presented two case histories of high dose LC n-3 PUFA 
supplementation in severely brain injured individuals. A man with carbon monoxide poisoning 
beginning n-3 therapy 8 days post-injury and a child with anoxic brain injury beginning n-3 
therapy 82 days post-injury both showed substantial improvements in global functioning 
following treatment. Sears and colleagues attribute this to the ability of LC n-3 PUFA to cross 
the blood brain barrier and exert anti-inflammatory effects.  
In summary, the studies in Table 2.1 above show that the outcomes of research into n-
3 PUFA interventions with human populations are varied, with very little of this research 
related directly to TBI. Due to the lack of epidemiological and experimental TBI and n-3 PUFA 
research in human populations, it is important to consider animal research. The following 
section discusses n-3 PUFA supplementation in animal models of brain injury and the insight 
this provides into n-3 PUFA’s potential to aid human brain injury recovery.
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Supplemental Omega-3 PUFA Studies in Animal Models of mTBI 
Several studies have examined the effect of LC n-3 PUFA or DHA supplementation on 
injury outcomes in rat and mouse models of brain injury, and found that LC n-3 PUFA appear 
to exert a neuroprotective effect on the inflammatory aspects of mTBI. The inflammatory 
response following brain injury is caused by several different processes and appears to be both 
detrimental and beneficial. Inflammation contributes to secondary injury, but also enables 
neural repair (Woodcock & Morganti-Kossmann, 2013). Microglia are responsible for much 
post-injury inflammation and are necessary for the removal of the debris left by other 
neurochemical processes, for controlling the inflammatory response, and for cell survival and 
cell death after injury (Harvey et al., 2015). Microglia are known for their plasticity – being able 
to assume different phenotypes in response to local environmental signals and polarise 
towards specific functions (Harvey et al., 2015) such as surveillance, phagocytosis, and both 
pro- and anti- inflammatory extracellular signalling (von Bernhardi, Heredia, Salgado, & Munoz, 
2016). These cells have been the focus of several experimental studies. 
Trépanier, Hopperton, Orr, and Bazinet (2015) reviewed LC n-3 PUFA’s effects on 
animal models of brain inflammation and found consistent anti-neuroinflammatory outcomes 
for stroke, cognitive impairment, Parkinson’s disease, depression, aging, and irradiation. In a 
similar review Barrett et al. (2014) found that both prophylactic and therapeutic 
supplementation with LC n-3 PUFA reduced the degree of axonal and neuronal damage, 
inflammation, and apoptosis in animal models of mTBI. Zendedel and colleagues (2015) 
furthered this by conducting in vitro analyses as part of a study on LC n-3 PUFA and 
neuroinflammation in a rodent model of stroke, finding that the attenuation of 
neuroinflammation was due to LC n-3 PUFA dampening the expression of pro-inflammatory 
cytokines, and preventing the activation of local microglia from the resting to the pro-
apoptotic form. In this study LC n-3 PUFA exerted effects directly on astrocytes, microglia, and 
neurons to significantly lessen both neuroinflammation and behavioural deficits. Similar results 
66 
 
were reported by Harvey and colleagues (2015), who found that DHA administration after TBI 
moderately decreased proinflammatory markers in the brain, and attenuated the conversion 
of microglia to the destructive proinflammatory phenotype while increasing the number of 
microglia taking on a reparative morphology.  
Trojian and Jackson (2011) reviewed two studies using axons positive for beta amyloid 
precursor protein (APP) as a measure of injury severity. APP is a marker of the axon damage 
that occurs due to the initial injury, and is exacerbated by the resultant excitotoxicity and 
oxidative stress (Barrett et al., 2014). One study supplemented with pure DHA for 30 days 
while the other used fish oil (DHA and EPA) supplementation for 30 days, in brain injured rats. 
In both studies, supplemented rats showed significantly lower levels of this neural membrane 
protein compared with injured but un-supplemented rats. APP levels in the supplemented 
animals were near those of the sham injured animals at the end of the 30 day trials. As APP is 
up-regulated following neural injury (Begum et al., 2014), these findings indicate that the 
administration of LC n-3 PUFA attenuated the injury. Similarly, Begum et al. (2014) found that 
administration of DHA following brain injury reduced the expression of APP, as well as other 
proteins which mark stress of the endoplasmic reticulum – a mechanism of chronic neuronal 
damage after TBI (Harvey et al., 2015). In addition, the rats treated with DHA in Begum and 
colleagues’ study showed earlier recovery of sensorimotor function compared to control rats. 
Harvey and colleagues (2015) also reported that DHA administration post-TBI reduced 
neuronal endoplasmic reticulum stress, which prevents injured neurons from committing to 
apoptotic pathways, thereby reducing the associated subsequent activation of local microglia.  
In addition to attenuating inflammation, DHA supplementation after TBI may reduce 
oxidative stress and preserve neural membrane fluidity and synaptic plasticity by normalising 
levels of Brain Derived Neurotropic Factor (BNDF) and related proteins (Wu, Ying, & Gomez-
Pinilla, 2011). BDNF, its related proteins, and their effects on neural cells have been implicated 
in both learning and memory, and as such reductions in BDNF seen following brain injury may 
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account for the commonly experienced cognitive symptoms; rats in Wu and colleagues’ (2011) 
study displayed learning deficits after injury, however this was counteracted by supplementing 
them with a DHA rich diet.   
 Together, these studies suggest that DHA may modulate the conversion of microglia 
from a resting to an activated phenotype, thereby attenuating the inflammatory response 
without eliminating their neuroprotective effects. In addition, it may help to maintain the 
structural integrity of cells and plasticity of synapses by normalising protein levels. Based on 
the studies summarised above, Figure 2.2 shows the potential areas of intervention on the 
neurometabolic cascade of concussion.  
 In those studies that have measured behavioural or cognitive outcomes after injury, 
the effects of DHA in the brain appear to have translated to fewer negative outcomes 
compared with control animals. It is not yet clear how this will translate to human mTBI, 
however the results show promise for the attenuation of symptoms. Giza and Hovda's (2014) 
explanation of the clinical correlates of the physiological perturbations after mTBI suggests 
that attenuating the axonal injury and other cell damage could also reduce cognitive deficits 
such as slowed processing speed and reaction times, and potentially prevent these 
impairments from persisting. 
68 
 
Figure 2.2. Potential points of DHA intervention on the concussion cascade. Intervening at the 
points circled in blue may lead to lower rates of apoptosis and injury symptoms. Adapted from 
‘ω-3 fatty acid supplementation as a potential therapeutic aid for the recovery from mild 
traumatic brain injury/concussion’ by E. Barret, M. McBurney and E. Ciappio, 2014, Advances 
in Nutrition: An International Review Journal, 5, p. 269. 
Summary 
 The research reviewed above has shown that the LC n-3 PUFA are important for 
healthy brain development and function, and that while adequate amounts can be obtained 
from the diet, this is frequently not the case. Overall levels of both dietary and supplemental 
intake in New Zealand are unclear and while one study suggested approximately one fifth of 
the population used supplements, this was not a representative sample. In line with other 
Western nations, New Zealand’s overall LC n-3 PUFA consumption is likely to be low. 
Observational research has outlined positive relationships between LC n-3 PUFA and health 
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and longevity, including cognitive and psychological health. Supplementation with high levels 
of LC n-3 PUFA over a minimum of 90 days has shown benefit in some populations, mainly 
those with amnestic conditions and those with habitually low intakes of n-3 PUFA. Groups who 
have responded well to supplementation have shown improvements in processing speed and 
working memory – both of which are commonly impaired after mTBI. Animal studies have 
shown that LC n-3 PUFA supplementation may assist recovery from brain injury by reducing 
inflammation and several forms of cell damage, which prevents or mitigates cognitive and 
behavioural symptoms. Little research has been conducted into LC n-3 PUFA supplementation 
in human brain injury, however the aforementioned studies provide compelling pre-clinical 
evidence of LC n-3 PUFA’s potential to reduce mTBI symptoms in humans, and rationale for 
conducting a randomised controlled trial with New Zealand adults who have suffered mTBI. 




Chapter Three: Study One Methodology 
This chapter provides a description of the design for Study One, followed by discussion 
of the justification of the research, detail regarding participants, materials, procedures, and 
planning around analyses and dissemination of results. 
The main objective of this study was to investigate the effects of dietary 
supplementation with fish oil on cognitive function after mTBI. Further aims included; 
investigating the effects of fish oil supplementation on mood after mTBI and whether there 
were any interactions between mood and cognitive effects, examining whether injury beliefs 
were associated with cognitive or mood outcomes, and whether supplementation affected 
post-injury disability ratings. A key consideration and point of difference from other cognitive 
research was the decision to conduct the majority of the study – all aspects involving 
participants, aside from recruitment – via telephone. The rationale for conducting the research 
via telephone related to both cost and time for the researcher and participants, and is 
discussed in more detail in the design, measures and procedures sections below.  
Hypotheses  
 It was hypothesised that n-3 PUFA supplementation post-mTBI would exert a main 
effect of decreasing the duration and severity of cognitive symptoms compared to a placebo 
control group. In addition, supplementation would decrease the duration and severity of mood 
symptoms. An interaction effect was hypothesised between supplementation, mood, and 
cognitive outcomes. It was also hypothesised that post-injury disability ratings would be lower 
after supplementation, and participants with negative injury beliefs would experience poorer 
cognitive and mood outcomes.  
Design 
The study was a two-arm randomised, double-blind, placebo-controlled, superiority 
trial. The efficacy of a fish oil supplement as an adjunct to treatment as usual was to be 
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analysed for superiority over standard treatment within the New Zealand Concussion Services. 
The active treatment was a high DHA fish oil supplement, while the placebo was a supplement 
containing sunflower oil. 
Due to the emphasis on effectiveness, this study best fits within the phase two 
category of standard clinical trial phasing models. As fish oil is widely available over-the-
counter and considered safe under a level of 3000mg/day (NHMRC, 2006) a phase one trial 
was not deemed necessary. A phase three trial, which assesses efficacy against other 
treatments or non-treatment with a large sample, was outside the scope of the researcher’s 
qualification timeframe. However, in order to help control for the effects of time on mTBI 
recovery it was necessary to include the placebo control within the phase two study design.  
Participants were recruited from four Concussion Services in different regions of New 
Zealand, with the assistance of the Services’ clinicians. As outlined in Chapter One, the 
Concussion Services are NGOs holding contracts with ACC to deliver their services for a set 
price. Due to the multi-centre nature of the trial and the placement and classroom 
requirements of the researcher’s programme of study, all testing and contact after 
recruitment was conducted over the telephone, by the lead researcher. This allowed the study 
to be conducted from any location. Baseline measures were obtained pre-treatment 
(baseline), and outcome measures were to be collected three months after beginning 
treatment, and six months after beginning treatment (conclusion).   
Participants 
 Power analysis. A power analysis was conducted using G*Power 3.1.9.2 (Faul, 
Erdfelder, Lang, & Buchner, 2007) to calculate the minimum sample size needed. To detect an 
effect size of partial ƞ²=.02 and provide a statistical power equal to 0.8 at an α level of .05, a 
minimum sample size of 82 participants was required. This would detect a ‘small’ (Cohen, 
1988) effect of n-3 PUFA supplementation on the duration and severity of post-mTBI cognitive 
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symptoms using a two way mixed ANOVA. In order to utilise the full amount of available 
supplement and provide a buffer in case of attrition, the study aimed to recruit 96 participants.  
 Eligibility criteria. Individuals aged 16 years and older who had suffered mTBI and 
were experiencing one or more cognitive symptoms were eligible to participate in the study. 
Participants needed to be engaged with a Concussion Service and have a claim with ACC, 
which meant they were less than 12 months post-injury and symptomatic at the time of 
recruitment.  
While technically considered a food under section two of the Food Act (1981), the fish 
oil supplement was to be trialled for therapeutic purposes in the context of health care 
provision. As such, it was treated as a medicine for the purposes of informed consent. Under 
section 36 the Care of Children Act (2004) individuals of or over 16 years of age may consent to 
medical treatment. In addition, adolescents represent an at-risk population, thus could 
potentially benefit from the trial; in acknowledgement of this vulnerability, parental consent 
was also to be sought for adolescents under 18 years of age.  
Additional requirements included fluency in English, access to a telephone, and a 
distraction-free environment for the testing sessions. 
 Exclusion criteria. Individuals were excluded from the trial if they were already taking 
a fish oil supplement, had taken such a supplement on a regular basis within the previous six 
months, or consumed more than three servings of oily fish per week. The rationale for this was 
that the human brain retains DHA well, and those who consume adequate amounts on a 
regular basis may not benefit from further supplementation (Stonehouse, 2014). 
 Individuals who were taking any medications known to affect cognitive function (e.g., 
nootropics, antipsychotics), or had any mental or neurological disorders that significantly 




 Additional exclusion criteria included any allergy or opposition to seafood or beef 
gelatine, difficulty swallowing capsules, pregnancy, lactation, or non-fluency in the English 
language. 
Measures  
 When selecting measures for the study several considerations were necessary. As the 
research was conducted via telephone, measures had to be presented verbally in a clear 
fashion. Measures designed for verbal presentation, and those that could be explained and 
administered verbally with minimal confusion or repetitiveness, were considered for inclusion. 
As the participants would have various difficulties with concentration, motivation, and 
fatigue as well as headaches, it was important to keep the assessment time to a minimum and 
the instructions clear. Accordingly, time requirements and ease of instruction were taken into 
account for each measure considered, and the entire assessment package kept to a maximum 
of one hour – a shorter time than required for Concussion Service neuropsychological testing.  
Participants were to be tested three times for the study, and some underwent 
repeated cognitive testing as part of treatment as usual within the Concussion Services. 
Concussion Service assessments could not be used for the study because not all Concussion 
Service clients undertake cognitive testing, and cognitive assessment measures are chosen by 
the individual clinicians thus varying between services. In order to minimise overlap between 
settings, measures not used in the Concussion Services, and those with minimal practice 
effects and/or alternative forms were chosen. 
Perhaps most importantly, to maximise the sensitivity of testing it was essential to 
assess the domains of functioning most commonly impaired after mTBI. Particular attention 
was given to memory and executive function as studies have found that speed and ease of 
processing (Kay et al., 1992), learning and remembering (Shanmukhi & Panigrahi, 2003), 
executive ability, complex attention, cognitive flexibility and memory (Barker-Collo et al., 2015) 
may be affected in the first 12 months post-injury.  
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Studies evaluating the validity of telephone-based cognitive measures primarily assess 
brief screening tools not suitable for detecting the more subtle cognitive deficits important to 
this study. Such tools do show good reliability and validity however, and the British 
Psychological Society (2020) state “the validity of telephone-based administration of many 
auditory measures… appear relatively consistent with face-to-face and video-based 
administration.” So while validity data for the chosen measures does not relate to the same 
mode of delivery, it is reasonable to expect a similar level of validity to that reported, when  
administered via telephone.  
In addition, depression, anxiety, and stress are frequent mood-related post-injury 
difficulties (Barker-Collo et al., 2015; Bay, Sikorskii, & Gao, 2009; Chen et al., 2008; Styrke et 
al., 2013) that may benefit from fish oil supplementation (Jacka et al., 2012; Meyer et al., 2013; 
Sarri, Linardakis, Tzanakis, & Kafatos, 2008) thus mood measures were included in the test 
collection. 
 Questionnaires. 
 The Depression Anxiety Stress Scale 21 item version (DASS-21). The DASS-21 
(Lovibond & Lovibond, 1995) is a 21 item self-report measure of the experience of depression, 
anxiety, and stress related symptoms. Participants are asked to rate on a scale of zero to ten 
how much each of 21 statements applied to him/her in the past week. The DASS-21 was 
chosen for its briefness and inclusion of three mood states common in mTBI. It is a reliable and 
valid measure for assessing depression, anxiety, and stress (Antony, Bieling, Cox, Enns, & 
Swinson, 1998), and had a Cronbach’s alpha of .95 when assessing anxiety and depression in a 
sample of brain injured clients (Dahm, Wong, & Ponsford, 2013). 
 The Brief Injury Perceptions Questionnaire (Brief IPQ). The Brief IPQ is an eight item 
questionnaire relating to beliefs about various aspects of injury. It asks participants to rate 
eight statements on a scale of one to ten. This was adapted with permission (E. Broadbent, 
personal communication, August 16 2016) from the Brief Illness Perceptions Questionnaire 
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(Broadbent, Petrie, Main, & Weinman, 2006) by changing the word ‘illness’ to ‘injury’. In 
addition, the free response item requiring participants to rank order the three main causes of 
illness was removed, as this information is not required. A meta-analysis found that the brief 
IPQ has good psychometric properties and has been used with numerous populations and 
disorders (Broadbent et al., 2015).  
 The Rivermead Post Concussion Symptoms Questionnaire (RPQ). The RPQ (King, 
Crawford, Wenden, Moss, & Wade, 1995) is a 16 item self-report questionnaire. Participants 
rate the extent to which they suffer  symptoms on a scale of zero to four. The RPQ assesses 
physical, cognitive, and mood symptoms, and was used to measure change in self-reported 
symptoms and symptom severity over time. The questionnaire was designed for use in a mild 
to moderate TBI population. It was found that the first three items of the questionnaire related 
to a separate construct to the other 13 items, however when scored separately the two scales 
have good reliability and adequate external construct validity (Eyres, Carey, Gilworth, 
Neumann, & Tennant, 2005). 
 The Rivermead Head Injury Follow Up Questionnaire (RHFUQ). The RHFUQ is a 10 
item self-report questionnaire relating to changes in everyday activities and relationships from 
pre- to post-injury, thus ‘following up’ with patients post injury (Crawford, Wenden, & Wade, 
1996). Rather than rating symptoms as per the RPQ, participants rate the change in their 
abilities and relationships on a scale of zero to four. The measure has adequate reliability and 
validity, and is a brief, simple measure of disability after mild to moderate head injury 
(Crawford et al., 1996). The RHFUQ was to be used to measure self-reported outcomes post-
intervention.  
 Cognitive tests. The cognitive domains assessed were those most frequently affected 
by mTBI; memory (Landre et al., 2006; Macleod 2010; Barker-Collo et al., 2015), attention 
(Landre et al., 2006; Macleod, 2010), executive function (Barker-Collo et al., 2015) and 
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processing speed (Kay et al., 1992). See Table 3.1 below for the measures associated with each 
domain and the order in which the cognitive assessments were administered.  
Table 3.1. 
Test Selection and Associated Cognitive Domains in Order of Administration 
Measure  Cognitive Domain Assessed 
Logical Memory 1 Immediate verbal memory 
Digit Span forward Attention 
Digit Span backward Working memory 
Verbal Fluency letter condition Executive function (phonemic fluency) 
Verbal Fluency category condition Executive function (semantic fluency) 
Verbal Fluency switch condition Executive function (cognitive flexibility) 
30 Seconds and Counting Information processing speed 
Paced Auditory Serial Addition Test Information processing speed 
Logical Memory 2 Delayed verbal memory 
 Logical Memory. Logical memory, a subtest from the Wechsler Memory Scales fourth 
edition (WMS-IV; Wechsler, 2009), requires participants to recall a short story immediately 
after its verbal presentation by the examiner, and again 20-30 minutes later. Test-retest 
reliability coefficients are reported as .74 for the immediate condition and .71 for the delayed 
condition. Logical memory tests have been found to differentiate mTBI sufferers from matched 
controls (Guilmette & Rasile, 1995) up to two years post-injury (Dikmen, Machamer, Temkin, & 
McLean, 1990).  
 Logical Memory was chosen for inclusion as the Concussion Service initially consulted 
did not use this measure, using the Rey Auditory Verbal Learning Test (RAVLT) instead. There 
was concern that using similar word list style measures would result in practice or interference 
effects that may affect assessment for treatment as usual, as well as the study results.  
 A literature search revealed two alternative forms for the Logical Memory task, both 
were used, allowing a different set of stories to be used for each testing time, thus eliminating 
the chance of participants recalling the story from their previous testing.  All stories have 25 
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score-able items. One alternative form was created for New Zealand testees (Schnabel, 2012) 
thus did not require modification, however the Morris Revision-fourth edition (MR-IV) was 
created for American testees (Morris et al., 2014) and as such underwent revision to ensure its 
suitability for the study population. Revisions were designed to fit the New Zealand context 
while retaining the same number of syllables and similar meaning to the original terms. See 
Table 3.2 for the revisions made. 
Table 3.2 
List of Replacement Terms Used in the MR-IV 
Original wording Revision 
St Louis Mt Albert 
Quarterback Number 10 
Savannah Balclutha 
Wolves Stags 
Football team Rugby team 
 
 Digit Span Forwards and Backwards. Digit span forwards is a test of attention and 
immediate verbal recall from the Wechsler Adult Intelligence Scale fourth edition (WAIS-IV; 
Wechsler, 2008). Participants must recall increasingly long strings of digits after verbal 
presentation by the examiner. Wechsler (2008) reports a test-retest reliability coefficient of 
.77 for this subtest.  
 Digit span backwards is a subtest of the WAIS-IV that measures working memory. After 
verbal presentation of a string of digits, participants must repeat the digits in reverse order; 
the digit strings increase in length with each trial until a participant provides an incorrect 
response. Test-retest reliability has been reported as .71 (Wechsler, 2008). 
 In a study involving 20 administrations of several memory measures over four to five 
weeks, digit span forwards showed the least practice effect, while digit span backwards 
showed minimal practice effects and differentiated brain injured clients from healthy controls 
(Wilson, Watson, Baddeley, Emslie, & Evans, 2000). 
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 Verbal Fluency. Verbal fluency is a subtest from the Delis Kaplan Executive Function 
System (D-KEFS; Delis, Kaplan, & Kramer, 2001). It requires participants to search for and 
produce words while following certain rules (e.g., not using proper nouns or repeating words). 
The letter fluency test asks participants to name as many words beginning with a particular 
letter within 60 seconds, and the category fluency test to name as many items in a particular 
category (e.g., animals) as possible within 60 seconds. The category switch condition requires 
participants to name items from two categories for 60 seconds, alternating between the 
categories. These tests show good test-retest stability at .79 to .8 (Delis et al., 2001).  
 Similar tests of semantic and phonemic fluency have shown that mTBI sufferers 
produce fewer words and made more errors than non-injured controls, but utilised similar 
clustering strategies (Raskin & Rearick, 1996). Verbal fluency tests were not routinely 
administered by the Concussion Service that was consulted, thus it was deemed an 
appropriate measure of executive ability for the present study.  
 The D-KEFS contains two forms of the Verbal Fluency test, but three testing sessions 
were to be held. Several alternate versions of the phonemic and semantic fluency tasks are 
available, however their equivalence to other versions has been questioned (Barry, Bates, & 
Labouvie, 2008). No alternate version of the switching task could be sourced. Due to this, the 
standard version of the D-KEFS verbal fluency task was to be used for times one and three, and 
the alternate form for time two. A study of repeated neuropsychological testing at different 
intervals over one year found that similar fluency tasks were resistant to, or showed minimal, 
practice effects (Bartels, Wegrzyn, Wiedl, Ackermann, & Ehrenreich, 2010) 
 Paced Auditory Serial Addition Test (PASAT). The PASAT is a measure of information 
processing speed and attention that was created for use with TBI patients. Participants are 
presented with a string of numbers, every number presented at a pre-set interval, and asked 
to add together the most recent two numbers heard. It has shown utility with sufferers of both 
acute and chronic mTBI symptoms (Tombaugh, 2006). As it is somewhat aversive (Wills & 
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Leathem, 2004), only one trial was to be presented and was the second to last test in the 
assessment. The majority of information processing tests require visual presentation; the 
PASAT was chosen due to its verbal presentation mode and absence from the Concussion 
Service’s assessment.  
 Thirty Seconds and Counting. This task was taken from the Brief Test of Adult 
Cognition by Telephone (BTACT) and measures speed of self-generated processing. 
Participants are given 30 seconds to count backwards from 100 as fast as possible. Errors are 
noted, however the primary measure is the speed of backward counting. A pilot study showed 
good test-retest reliability of r=.87 with a six month testing interval (Tun & Lachman, 2005). 
This test was included as an adjunct measure of information processing speed that relies little 
on arithmetic ability. 
 Scoring. Although all measures were to be analysed separately, it was important to 
also assess whether the treatment had an effect on overall cognitive function. To do this, a 
composite score of all of the cognitive measures was created by taking the sum of the z-scores 
for each individual. 
Materials 
 Both the fish oil and sunflower oil were contained in 15 mm length, oblong shaped 
soft-gel capsules. Each fish oil capsule contained 497 mg of DHA and 117 mg of EPA and each 
sunflower oil capsule contained 1000 mg of sunflower oil. The two types of capsules were 
identical in size, colour and shape. Both capsules contained an orange oil flavouring which 
helped to mask the taste of the fish oil. The capsules were dispensed in white opaque plastic 
bottles, each bottle containing 200 capsules. Each bottle was labelled with the participant’s 
code number, the required dose and directions.  
 Participants took four capsules each day, equating to a dose of 1.99 grams of DHA and 
.47 grams of EPA per day. Plasma DHA is considered a useful biomarker for brain DHA (Kuratko 
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& Salem, 2009) and has a dose-dependent relationship with dietary DHA (Arterburn et al., 
2006). Dietary DHA supplementation results in a sharp increase of plasma DHA within the first 
month, and concentrations peak within 180 days (Katan, Deslypere, van Birgelen, Penders, & 
Zegwaard, 1997). A dose of approximately 2g DHA per day results in an near maximal plasma 
response (Arterburn et al., 2006), thus in order to achieve the highest concentration of DHA 
with the fewest capsules, a regime of 4 capsules per day for six months was selected. 
 Participants were provided with an A5 sized paper diary to record their fish 
consumption, missed supplement doses, and any other information they deemed relevant, 
e.g., side effects, changes in eating or exercising habits. 
 A toll free telephone number was available to allow participants and those considering 
participation to call the researcher with any queries. This was linked to the researcher’s 
university computer account, so was accessible from any computer, allowing the researcher to 
accept and conduct calls from any office, and utilise a private space to conduct testing calls. 
Localities 
 The study was conducted with the assistance of four Concussion Services. Locations 
covered included the greater Waikato, Bay of Plenty, Taranaki and Wellington/Kāpiti regions of 
New Zealand; (two of these services served the Waikato region). 
Procedure  
 Randomisation. A research assistant used a random number generator (random.org) 
to assign study numbers to the fish oil and placebo capsules, create four groups of 
supplements (one group for each participating service) and create a randomised list to 
determine the order of distribution.  
 Two columns of random numbers, representing participant code numbers, were 
generated; one column assigned to the treatment, and the other to placebo. This list was 
placed in a sealed envelope and stored until the trial’s completion. Four bottles of either the 
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treatment or the placebo were allocated to each number as determined by the randomised 
list. The assistant then divided the supplements into four groups with equal numbers of each 
type of capsule, and used the random number generator to randomise the list of numbers in 
each group. This became the order of distribution for each Concussion Service. The capsules 
were set aside in a cool, dark space to await transport to each clinic. 
 Recruitment. Participants were identified by the health professionals within the 
Concussion Services. They informed clients about the trial, administered an initial 
questionnaire to determine eligibility, and provided the information and consent forms. 
Participants returned their signed forms to the service, where they were assigned to the next 
study number on the service’s random list and collected their supplements with instructions 
for administration and storage, and the weekly diary. Signed consent forms and participant 
information were scanned and emailed to the researcher in a password protected document. 
See Figure 3.1 for an outline of the process undertaken by the Concussion Services. 
 
Figure 3.1. Recruitment process undertaken by the Concussion Services. 
Presenting client met 
inclusion criteria (mTBI, 
age 16+, cognitive 
symptoms), were 
informed about the study.
Client was interested, 
screening questionnaire 
administered.
Client met eligibility criteria, 




form, supplement packs 
were dispensed and 
client information sent 
to researcher. 
Client did not consent, 
any study information 
collected was disposed 
of by the Concussion 
Service and not passed 
on to the researcher.
Client not eligible, screening 
questionnaire disposed of and no 
information passed on to the 
researcher.
Client not interested, 




 Testing and Communications. Upon receipt of the signed consent form and contact 
details, participants were phoned by the lead researcher to discuss the trial, answer any 
questions, and organise a time for baseline testing. As all testing occurred via telephone, 
participants were asked to ensure that if using a mobile phone it was fully charged, they had a 
distraction free environment, and that they were not to use a pen and paper for any part of 
the tests. For a diagram of participants’ intended flow through the study, see Figure 3.2. 
 
Figure 3.2. Individual Participants’ Flow through the Study. In between the three testing 
sessions, participants were contacted each month to discuss any queries or concerns, and 
check whether the treatment was being adhered to. 
 For each testing session the researcher phoned participants from a distraction-free 
space using a headset to allow for ease of test administration and recording. Testing occurred 
at a mutually agreed time, and the researcher ensured that this time was still suitable when 
the phone call was made. Testing was to occur at baseline, three months, and six months after 
the supplements were begun. 
 Participants began the supplement regime after baseline testing. All information was 
provided in written form with the capsules, and reiterated over the phone. Participants were 
advised to store the capsules in the refrigerator, and take four each morning with breakfast 
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and water. They were asked to record their fish consumption and any missed doses in the 
diary. 
 Participants were contacted via telephone on a monthly basis to discuss their 
tolerance to the supplements, adherence to the treatment regime, and any questions or 
concerns they may have had.  
 At the conclusion of the study participants were asked to return any leftover capsules 
to the Massey University Psychology Clinic in Wellington, or dispose of them after counting 
and informing the researcher of the amount left over.  
Ethics 
The research proposal was approved by the Northern A Health and Disability Ethics 
Committee (reference: 16/NTA/206) and registered with the Australia New Zealand Clinical 
Trial Registry under the registration number ACTRN12617000040369. 
The study was conducted in accordance with the Declaration of Helsinki (World 
Medical Association [WMA], 2013). The reporting of the methodology, results, and discussion 
was guided by the CONSORT statement guidelines for reporting parallel group randomised 
trials (Schulz, Altman, & Moher, 2011). 
Statistical Analyses 
 Data was to be analysed using the latest available IBM SPSS software. Independent 
samples T-tests were to test for equivalence between groups on all dependent measures at 
baseline. Two way mixed between-within analysis of variance (ANOVA) tests were to analyse 
the outcome variables. The between subjects factor for this model was the group at two levels: 
treatment and control. The within subjects factor was the outcome measures at baseline, time 
two, and time three. The primary outcome was the between group comparison of a composite 
score on the cognitive measures, created by calculating then summing the z scores for each 
subtest. Secondary outcomes were between group comparisons of mood measures and post-
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intervention disability data, and correlation of injury beliefs and cognitive outcomes at 
completion.  
Dissemination of Results to Participants 
 Participants were offered the opportunity to receive a summary report of the study 
once it was completed. These were to be disseminated via email and post depending on 
participants’ preferences.  Individuals who requested personalised feedback were to receive a 




Chapter Four: Study One Cessation 
Due to unforeseen difficulties with recruitment, Study one was deemed unfeasible and 
terminated prior to the project’s planned completion time. This chapter outlines the processes 
that were followed in attempt to conduct a feasible study, provides explanation for why the 
trial was cancelled, and discusses both limitations of the approach taken and 
recommendations for future research.  
Study One Processes 
Who was involved in recruitment. As the study was to be carried out by an individual 
researcher rather than a team, it was decided that recruitment would begin slowly, initially 
involving two services before expanding to others. This aimed to allow time for the researcher 
to undertake participant screening and testing, service provider liaison, clinical placements and 
other academic activities required of the Doctor of Clinical Psychology programme. Overall, 
seven Concussion Services were consulted, four of which agreed to participate and completed 
the locality approval process with the Health and Disability Ethics Committee (HDEC). As noted 
in Chapter Three, the four services involved covered the Wellington/Kāpiti, Waikato, Bay of 
Plenty, and Taranaki regions of New Zealand and included over twenty consulting health 
professionals. Table 4.1 below provides information about the services consulted and involved 
in recruitment, as well as their comments regarding the barriers to recruitment. Appendix A 




Table 4.1.  





















1 Few potential participants identified 
Advised neurologist to local concussion service frequently prescribed fish oil 
supplements 
Waikato/ 






8 March 2017 3 Mobile service with no physical office 
Difficult to fit information into standard session times 
Many therapists felt clients were too unwell to be given information or make a 
decision 








2 Several further potential participants identified, who upon discussion with 












5 Several further potential participants identified, who upon discussion with 
researcher opted to purchase fish oil rather than participate 







n/a n/a Did not participate due to service’s already high research load 




n/a n/a Prepared to participate if required. Not utilised due to difficulty recruiting, 
geographical distance from researcher, and changes to the study 






n/a n/a Although initial response was enthusiastic, no further responses to requests 
for consideration were received  
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Alterations to Recruitment Processes 
Due to the diverse nature of the participating services, some processes were altered in 
attempts to assist the recruiting clinicians and increase participant numbers. For example, to 
ensure that client privacy was upheld within each service; the researcher did not receive any 
client information prior to receiving a signed consent form unless the prospective participant 
chose to contact the researcher via the designated toll-free phone line. In such cases, the 
individual’s eligibility, symptoms and queries or concerns were discussed but no official health 
information (e.g., the National Health Index number, clinician recorded LoC or GCS) was 
collected.  
After several clinicians in the Waikato/Bay of Plenty service advised they struggled to 
make time to discuss the research and administer the eligibility questionnaire during client 
consults, a self-report eligibility questionnaire was created for participants to complete in their 
own time and return to their Concussion Service clinician along with their signed consent form 
at their next consult. This occurred in June 2017 and while clinicians advised they appreciated 
the change, recruitment continued to prove difficult. See Appendix B for the questionnaire.  
The Taranaki based service stated they were better placed than the local Concussion 
Service physio- and occupational therapists to recruit participants, however they identified few 
eligible individuals. In order to increase recruitment in this region, in June 2017 a staff member 
reviewed recent cases and phoned to discuss the trial with those who were potentially eligible. 
Those interested were posted an information pack, including the self-report eligibility 
questionnaire and a consent form with a pre-paid envelope to return to the local service. Four 
information packs were sent, and two received back, however one of these individuals was 
ineligible due to allergy and the other initially consented but withdrew prior to baseline 
testing. As this service provided the neuropsychological consults to a local Taranaki concussion 
service and the Waikato/Bay of Plenty service already engaged with the trial, there was 
significant overlap in the information received from these teams. As the Waikato/Bay of Plenty 
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service saw clients prior to neuropsychological consult, the Taranaki team were asked to focus 
solely on Taranaki when contacting potential participants.  
In November 2017 it was clear that it would not be possible to recruit enough 
participants to conduct the trial as initially planned. As there were several participants actively 
taking the supplements it was decided that a pilot study of fish oil versus no supplements 
could be conducted using these participants and any who consented in the coming months. 
The placebo was to be removed in order to prevent the possibility of a high number of 
participants taking the placebo compared with the active treatment.  
Flow of Participants Through the Study 
A total of 12 participants consented to take part in the study, please see Figure 4.1 
below for a flow chart of participants’ progress through the study. Several more individuals 
expressed interest to their care providers and/or the researcher, but for various reasons 
decided not to take part. Frequent reasons for declining were: upon further discussion they 
were ineligible due to current or recent fish oil supplementation, high fish consumption, 
vegetarianism, shellfish allergies, or attempting to conceive; the time commitment was too 
great; the study felt too cumbersome to deal with when feeling unwell; and most frequently 
the individual decided that she/he wanted to take fish oil and was not willing to risk being part 
of the placebo group. Those who during conversation with the researcher decided to purchase 
their own fish oil were advised to look for a supplement containing a high level of DHA and to 
take enough to reach one to two grams of DHA per day depending on their tolerance of the 





Figure 4.1. Flow of participants through the study.  
Of the 12 consenting participants three dropped out prior to baseline testing with one 
citing stress and communication difficulties as the reasons (this participant did not have mobile 
reception at home and was struggling with returning to work) and the other two citing a lack 
of time and feeling much better as their reasons for not continuing. Two participants withdrew 
after baseline testing and prior to the proposed study changes, one experienced severe 
gastrointestinal side effects and the other stated she had forgotten to take the supplements 
“too many times” and could not be contacted to discuss this situation further. After the 
proposed changes to the study all participants were advised of the planned change and 
whether they were taking the active treatment or the placebo. They were offered the 
opportunity to cease the trial and keep or receive the fish oil supplements for their own 
benefit as a token of gratitude for their time, or if taking the fish oil from the beginning, to 
continue as per the initial agreement. Those taking the placebo were also offered the 
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opportunity to cease taking the capsules but remain in the trial as control participants, who at 
the end of the trial would receive a supermarket voucher as a token of gratitude. Only one 
participant, who was taking the placebo, decided to drop out of the study, one decided to stop 
taking the (placebo) supplements and become a control participant, and two elected to receive 
the fish oil and continue – one of these participants had recently completed the baseline 
testing and the other had yet to complete the baseline tests. However, several participants 
could not be reached by phone or by email to conduct this discussion. These participants were 
then advised of the changes to the study via email and their continued lack of response was 
deemed withdrawal of consent to participate.   
Justification of Cancellation 
 Because the supplements expired in September 2018 the deadline for recruitment was 
six months prior to this - early March 2018. By the end of February 2018, no new participants 
had been recruited and those still active within the study could not be reached via telephone 
or email despite several attempts at making contact. This meant there were no participants 
remaining and too little existing data to conduct a feasible study, thus the trial was ceased. 
Limitations  
 As briefly outlined above, the Concussion Service clinicians noted several barriers to 
successful participation and recruitment. These included being too busy both during 
consultations and with the resultant paperwork, clients being too unwell to focus on both the 
standard session content and the study information, having high caseloads so not taking 
further referrals, and high numbers of clients simply not being eligible. The majority of this 
feedback came from the Waikato/Bay of Plenty service, which was structured differently to 
those with a head office and a physical clinic for seeing clients. The other services provided few 
comments on barriers to effective recruitment when asked.  
 According to clinicians and several participants and potential participants, taking part 
in the study required too much effort. Participants were being asked to complete their 
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standard rehabilitation, continue with everyday life which often involved beginning their 
return to work while still suffering various effects of mTBI, and liaise with ACC regarding 
compensation and rehabilitation issues. Several individuals commented that it was difficult to 
keep track of their appointments, and that they felt very tired by the end of the baseline 
testing, indicating they were struggling with the very symptoms that the trial was aiming to 
treat.  
Given the added burden during a time of difficulty, it may be that the study lacked 
adequate reward to justify the extra effort. The uncertainty about whether the supplements 
were active treatment or placebo, as well as the lack of tangible incentive to complete the 
trial, may have meant that it became low on individuals’ list of priorities leading to eventual 
attrition.  
 Conducting the trial by telephone as a separate activity to standard rehabilitation may 
also have contributed to the high rate of attrition. As well as adding to the individual’s mental 
load, the lack of face to face contact also served to add a sense of distance from the trial 
making it easier to decline, neglect, or drop out from. Where providers of standard treatment 
must report to ACC and can remind clients of the consequences of not attending 
appointments, there was no social or compensatory disadvantage to declining or dropping out 
from the study.  
Recommendations  
 Given the barriers to participation expressed by both professionals and potential 
participants, several alterations to the nature and process of any future trial research into n-3 
PUFA as a treatment for mTBI are suggested.  
In order to increase participant eligibility, it is recommended that vegan supplements 
are manufactured for future trials. Vegan n-3 PUFA supplements are sourced from marine 
algae and use vegetable alternatives to gelatine encapsulating agents. This would prevent 
participants declining due to dietary choices and fish/shellfish allergies.  
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To decrease the number of appointments and the amount of testing for participants, 
future research could be carried out in closer alignment with the concussion services. This may 
mean employing concussion service psychologists to complete the testing, which would 
eliminate test crossover between the research and concussion services, eliminate the need for 
test selection to consider telephone administrability and thus enable more user-friendly tests 
of processing speed and executive function to be used, and enable the concussion service 
practitioners to use the data for their own practice with the client. This would likely require 
liaison with ACC, as concussion service psychologists tend to see clients only once due to ACC’s 
concussion service contract allocating a set number of hours and a set dollar figure for 
neuropsychological consultation, and could theoretically involve using “their” data. In addition, 
for a meaningful trial to be conducted with the general population in this manner, sufficient 
time and funding must be available.  
 Prior to extending a future trial to the general population, research could be 
conducted in alliance with high level sports organisations, such as the New Zealand Rugby 
Union. Improving concussion outcomes, as well as experiencing the other beneficial effects of 
n-3 PUFA, is likely to be beneficial for players and organisations alike, and players with actively 
managed diets may be more likely to adhere to the treatment and attend testing sessions. 
Such a population is, however, less likely to be deficient in dietary DHA and more likely to 
recover from injury in a timely manner. As such, the likelihood of positive results may be lower 
than the general population who do not have ready access to dietary advice and management, 
and results may not be generalisable.  
 Removing the placebo control, as per the proposed changes to the present trial, may 
increase participation. This would however come at the expense of the scientific “gold 
standard” and preclude concluding that the n-3 PUFA supplements had had an effect over and 




 Numerous difficulties with participant recruitment and retention prevented this study 
from obtaining a sample large enough to conduct a meaningful trial, or any meaningful data 
from those who did participate. Due to this, as well as the time constraints associated with 
both the researcher’s qualification framework and the supplements’ shelf life, the trial was 
ceased. Future recommendations include conducting a larger scale trial with greater time and 
financial resources, in closer alliance with both ACC and the Concussion Service clinicians, as 
well as using a vegan product to increase client eligibility.  
 For the researcher, the difficulties encountered during this study provided many 
valuable lessons. It highlighted the disparity between research goals and researcher ambitions, 
and the reality of participants’ everyday lives. It also underscored the lack of incentive for 
research participation and how this can affect motivation for both potential participants and 
those who have agreed to take part. Researcher reflections are discussed in more depth in 
Chapter Nine.  
This concludes the n-3 PUFA portion of the present research. The following chapters 
present Study Two, focusing on healthcare practitioners’ provision of information to 
individuals who have suffered mTBI.  
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Chapter Five: Information Provision after Mild Traumatic brain Injury 
There has been substantial research focused on treating mTBI symptoms after they 
have arisen, including the consideration of n-3 PUFA supplementation as reported earlier. 
Anecdotal evidence from Study One participants and potential participants suggested that 
some mTBI patients did not receive adequate or understandable information, and this lack of 
information was distressing. Indeed, the importance of information to patient wellbeing is 
supported by literature. Providing patients and the people who support them with appropriate 
information after mTBI is important for safety, anxiety reduction, and symptom management 
(Morris, 2001; Ponsford et al., 2002). Several studies have shown that information provision 
upon discharge from acute settings can reduce an individual’s overall health service use, may 
help to prevent ongoing symptoms, and can be as effective as more intensive treatment for 
many mTBI sufferers (Borg et al., 2004; Matuseviciene, Borg, Stalnacke, Ulfarsson & de 
Boussard, 2013; Paniak, Toller-Lobe, Durand, & Nagy, 1998; Paniak, Toller-Lobe, Reynolds, 
Melnyk & Nagy, 2000; Ponsford et al., 2002). This chapter reviews international and New 
Zealand based research on the benefits of providing information to mTBI sufferers, guidelines 
for providing information, and issues regarding the quality of information provided.  
Information Provision as Treatment for MTBI 
Information provision for adults. Borg and colleagues (2004) from the WHO 
Collaborating Centre Task Force on Mild Traumatic Brain Injury conducted a systematic 
literature review on non-surgical intervention for mTBI. They found evidence that early 
educational intervention can reduce long term complaints and that this intervention need not 
be intensive.  The key studies contributing to Borg and colleagues’ conclusion are summarised 
below along with more recent studies of the effectiveness of educational intervention for 
mTBI.  
Paniak and colleagues (1998) compared an education-oriented single session 
treatment with a more extensive assessment in addition to “treatment-as-needed” 
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intervention for 111 adults with mTBI . The participants were recruited after admission to a 
hospital emergency ward and were randomised into the two treatment groups; treatment was 
begun no later than three weeks post-injury. The single session treatment involved reading a 
brochure on “Minor Head Injury” and discussing any concerns with the study investigator. The 
aims of treatment in this group included legitimising participants’ experiences, education 
about common post-mTBI complaints, advice on dealing with common complaints with a 
particular focus on rest as needed and gradual reintegration into activities, and reassurance of 
a positive outcome. Participants in this group were advised no further input would be provided 
by the study but were encouraged to seek treatment from their GP for any further concerns.  
Those in the treatment-as-needed group received the same intervention as the single 
session group, with the addition of a three to four hour neuropsychological and personality 
assessment, feedback session, physical therapist consult, and ongoing treatment as needed for 
any identified mTBI related complaints.  
Results on the Problem Checklist (PCL) and Short Form-36 (SF-36) health survey three 
to four months after injury showed significant improvement with time, but no difference 
between treatment groups. In addition, vocation related analyses such as occupational status 
and days before return to full-time pre-injury vocational activity, did not differ between 
groups. Results on the Community Integration Questionnaire (CIQ) were not significant, 
indicating no change with time (from pre-injury to follow up), group, or time and group 
interaction. The groups did not differ on the average number of treatment sessions sought 
outside of the study protocol, and neither did they differ on their ratings of satisfaction with 
treatment. Follow up data from 105 of these participants showed that the results did not 
significantly differ between the groups 12 months post-injury (Paniak et al., 2000). As such, the 
authors concluded that when applied within three weeks of sustaining a mTBI, a brief 
educational and reassurance related intervention is as effective as a more intensive 
assessment and treatment model.  
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Matuseviciene et al., (2013) like Paniak and colleagues, showed that the provision of 
information can be just as effective as more intensive treatment, even for those at higher risk 
of ongoing difficulties. The 80 participants deemed to be at high risk of experiencing enduring 
symptoms were randomised into an ‘early intervention visit’ group who were seen by a 
specialist rehabilitation medicine physician two to three weeks post-injury, and a treatment as 
usual group who were treated according to local routines and received written information 
about common mTBI symptoms and outcomes. No between group differences in the rate of 
overall or specific symptom amelioration were found on the RPQ, and no differences were 
found on the Hospital Anxiety and Depression Scales (HADS).  
Rather than comparing two treatment groups, Ponsford and colleagues (2002) 
compared an intervention with a non-intervention group. They recruited 202 adult mTBI 
patients from two hospital emergency departments. The 79 individuals assigned to the 
intervention group were seen five to seven days post-injury, at which time they completed a 
detailed history and neuropsychological assessment before receiving an information booklet 
about mTBI symptoms, their likely time course, and suggested coping strategies. No specific 
feedback regarding assessment results was provided. The non-intervention group did not 
participate in assessment until the three month follow up period, nor did they receive the 
information booklet, however all participants were provided with standard emergency 
department care including advice to contact their family doctor with any further concerns.  
At three months post-injury those in the non-intervention group were more likely to 
report symptoms on the Post-concussion Syndrome Checklist (PCSL), particularly difficulty 
sleeping and anxiety, and had higher scores on the Symptom Checklist 90-R global severity 
index, particularly the paranoia and hostility subscales. The groups performed similarly on the 
neuropsychological measures. The authors concluded that the provision of an information 
booklet reduces anxiety and reporting of ongoing symptoms after mTBI, however this does not 
consider a possible effect of the initial consultation and testing at the baseline assessment 
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period which may have provided additional reassurance for the intervention group as they had 
been seen and heard by a professional who was likely obliged to act on any issues had they 
been identified.  
In a New Zealand based qualitative study by Snell, Martin, Surgenor, Siegert, and Hay-
Smith, (2016) adult former mTBI patients also identified information as a necessary element of 
their treatment. Regardless of whether they had fully recovered by the time of their interview 
for the study, participants identified having a coherent understanding of their injury and 
recovery as important to their wellbeing. This coherent understanding included social support, 
validation and reassurance, and credible evidence-based information. They described feeling 
distressed when they weren’t provided with information regarding what to expect with their 
recovery and what constituted a reasonable recovery timeline, or when the information 
provided was contradictory. Participants reported varied advice and levels of validation from 
their treatment providers, which served to either reassure them or magnify their distress and 
confusion. One participant described a health provider explaining how the experienced 
symptoms ‘lined up’ with the injury to a particular part of the head, which facilitated the 
individual’s understanding of the experience. Up until this point, the participant had been 
“terrified”.  This study was conducted with various health and recovery professionals and 
shows that there may be a lack of coherence in the treatment of mTBI, including the 
information provided to patients by consulting professionals, in New Zealand. 
Both quantitative and qualitative research has shown that timely information provision 
after mTBI is important for adult populations. Relevant information may be as effective as 
more intensive intervention for preventing the development of ongoing symptoms, as well as 
alleviating stress and anxiety, thus reducing service use.   
Information provision for young persons. The majority of studies on information 
provision, and indeed treatment, for mTBI have focused on adults; few have considered 
adolescence as a unique developmental stage requiring different approaches to standard adult 
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or paediatric practices. Gagnon, Swaine, Champagne, and Lefebvre, (2008) considered 
adolescent and parent perspectives regarding adolescents’ mTBI related service needs in a 
qualitative study. They interviewed individuals with varied levels of service use in the 12 
months since injury and covered the impact of mTBI on different areas of the adolescent’s life, 
their needs following injury, quality of services received, and any services they wish had been 
available to assist recovery. All adolescents and parents interviewed spoke of the need for 
information falling into the three broad categories of “what happened?... what to expect… and 
what can I/my teen do now?” (Gagnon et al., 2008, p. 165) and the expectation that healthcare 
providers should address the adolescents directly, rather than speaking only to their parents. 
All parents expressed a need to know about the injury and what to expect, and if these were 
not answered by the treatment providers they did not hesitate to look elsewhere for 
information, including to less reputable sources such as the internet or their friends. The 
adolescents expressed a need for timely service and professionals who are caring and 
acknowledge their differences from younger children, while many parents and some 
adolescents spoke about needing better communication between the health and school 
systems in order to assist the return to academic activity. Those with more severe or multiple 
injuries, and those experiencing ongoing symptoms, also wanted information regarding the 
prevention of future injury.  
A related study also considered service provider perspectives using an eight person 
multidisciplinary focus group and validation survey of 33 further professionals (Swaine et al., 
2008). Providers agreed that adolescents are a unique group but expressed that they often 
found them challenging. They spoke of risk taking behaviours such as fighting and taking drugs, 
as well as the strong desire to perform well in school and sporting endeavours which is often 
driven by parents, making it difficult to get them to take breaks or pace themselves in times of 
illness or injury. They agreed that information was the most important element of service 
provision but expressed wariness of providing too much information out of concern for 
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encouraging symptom malingering. The authors however, found no evidence of a relationship 
between the amount of information received and persisting symptoms following mTBI. A study 
with mTBI sufferers aged six to 15 years provided with an information booklet reported fewer 
symptoms and less stress three months post-injury than those who did not receive the booklet 
(Ponsford et al., 2001). This booklet included symptom information and coping strategies, was 
given to the parents/guardians of the participants, but was written with simple language and 
cartoon illustrations, and directly addressed the child.  
A Chicago based longitudinal cohort study found that adolescents who had suffered 
mTBI experienced significantly greater levels of aggressive behaviour, delinquency and anxiety 
and depression symptoms compared with non-mTBI sufferers two to three years after injury, 
even after controlling for previous psychopathology (Connolly & McCormick, 2019). Together 
these studies suggest a need for information in the adolescent population, and perhaps a 
degree of disconnection between patient needs and service provision, potentially owing to 
value judgements from some practitioners acting as a barrier to providing best-practice care. 
Taken together, these studies show that the timely provision of detailed information 
and reassurance may reduce ongoing symptoms and related service use, as well as patient 
distress, post-mTBI. Relevant information and reassurance is important and effective for 
adults, young persons and  caregivers. It is also evident that the information routinely provided 
is not always timely and/or detailed enough to have these effects.  
Recommendations for Information Provision 
The United Kingdom based National Institute for Health and Care excellence (NICE) 
and Scottish Intercollegiate Guidelines Network (SIGN) have created guidelines for healthcare 
professionals providing information to mTBI sufferers and/or their caregivers. Both 
organisations recommend giving both verbal and printed discharge advice to patients – and 
their families or carers – with mTBI upon discharge. They both provide examples of 
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appropriate leaflets, though rather than being specific to mTBI these are for adults who have 
sustained any degree of ‘head injury’.   
According to NICE (2014), printed information should be age appropriate and inclusive 
of both acute care and ongoing recovery related details. For the acute period they recommend 
including details of the nature and severity of the injury, risk factors signalling a need to return 
to the emergency department (e.g., lack of full consciousness, prolonged drowsiness during 
normal wake times, confusion, focal signs, vomiting, seizures, bleeding from the ears, fluid 
discharge from ears or nose), and a specification that a responsible adult should stay with the 
patient for the first 24 hours after their injury. Ongoing care information should include: 
details about the recovery process, including the fact that some patients may appear to make 
a quick recovery but later experience symptoms; some may experience ongoing symptoms; 
contact details of community and hospital services in case of delayed or ongoing 
complications; information about return to everyday activities, including school, work, sports 
and driving; and details of support organisations. For those who presented with drug or 
alcohol intoxication, information and advice on alcohol or drug misuse is also recommended.  
Some of the advice on the suggested information sheet is ambiguous, for example the 
advice regarding driving, operating machinery, and returning to work or school states that 
patients should not return to these activities until they feel that they have “fully recovered”. 
However it may be difficult for an individual suffering cognitive difficulties to know when they 
are ‘fully recovered’ or it may not be feasible to completely abstain from such activities for the 
time required for all symptoms to fully remit. Also, regarding the use of sedatives, tranquilisers 
or sleeping pills the leaflet states these shouldn’t be taken “unless given by a doctor” which 
some patients may take to mean they can safely continue taking such medications if they were 
prescribed pre-injury. 
While the NICE example discharge advice card provides the details listed above for 
patients discharged after any degree of head injury, SIGN (2009) provide a similar, though 
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slightly less detailed, information sheet for patients “allowed home from the ED” indicating it 
may be targeted toward more mild injuries as they have not required hospital admission. The 
SIGN example leaflet provides brief information regarding common symptoms and recovery. It 
advises that people can feel unwell with symptoms such as slight headache, dizziness, memory 
problems, poor concentration, irritability or being easily annoyed, tiredness, and/or poor 
sleep, even after discharge. It states that symptoms should clear up without any treatment, 
but if they persist for two weeks the patient should see their doctor. It also provides some 
extra advice to aid recovery such as resting and avoiding stressful and noisy situations; 
abstaining from alcohol, non-prescribed drugs, sleeping pills, sedatives and tranquillisers; and 
avoiding contact sport for at least three weeks unless cleared by a doctor. Unlike the NICE 
guidelines, SIGN do not advise on symptoms that warrant a return to the emergency 
department. 
The Centres for Disease Control and Prevention (CDC) produced a ‘patient take-home 
instructions’ information sheet for sufferers of ‘concussion’, based on mTBI policy published by 
Jagoda et al. (2009). This sheet provides space for personalised instructions from the 
healthcare provider and tick boxes for whether or not the patient underwent CT scanning and 
the reassurance of no injury findings if yes, or rationale if no. They provide a list of reasons to 
return to the emergency department (repeated vomiting, worsening headache, loss of or 
waning consciousness, confusion or agitation, seizure, difficulty with walking or balance, 
weakness or numbness, vision problems, and any symptom that concerns the patient or their 
family or friends) along with the explanation that serious problems sometimes develop after a 
head injury. This sheet goes on to provide information and advice via a question and answer 
section, making it stylistically quite different to the NICE and SIGN leaflets. The Q&A section 
explains what a concussion is and that most people recover quickly and fully, lists common 
symptoms grouped into four domains (thinking/remembering, physical, emotional/mood, and 
sleep), and provides advice on rest, alcohol consumption, discussing the injury with work for 
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compensation purposes if the injury was work related, when to seek a doctor’s advice (e.g., 
before return to driving, sport and recreational activities, or not improving after a week) and 
avoiding concussion in future.  
Like both NICE and SIGN, the New Zealand Guidelines Group (NZGG, 2006) 
recommendations for post-injury information are often in the context of TBI of any severity 
rather than specific to mTBI. Unlike the other groups discussed above, the NZGG did not 
produce a sample information sheet, however they did recommend that all patients with 
suspected or confirmed TBI receive both verbal and written advice upon discharge. They 
advise that patient information should cover symptoms and signs which may indicate a need 
for further investigation, including what action the patient or their caregiver should take if they 
experience any of these (such as, go to a general practitioner or Emergency Department); 
reassurance about common symptoms and signs that need not be cause for concern (e.g., 
headache, nausea, dizziness, blurred vision, confusion, fatigue, poor concentration, memory 
problems, sleep difficulties, irritability and noise intolerance), including the expected progress 
and resolution of such after-effects of the injury. The NZGG acknowledge that early, relevant 
information about common symptoms of mild TBI, emphasising high rates of recovery, can 
positively influence the rate of later persistent symptoms.  
Regarding longer term difficulties or disability, NZGG state that all people with head 
injury of any severity, and their carers, should be made aware of the possibility of long-term 
symptoms and disabilities from a TBI, as well as the existence of services that they could 
contact should they experience long-term problems. Details of support services should be 
included on written discharge advice and patients should also be advised to contact their 
doctors about these problems. Advice about safety and self-care, including minimising the risk 
of re-injury and caution with use of drugs and alcohol, information and advice on alcohol or 
drug misuse for people who initially presented with drug or alcohol intoxication, and 
information about community resources should also be provided.  
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The NZGG also stipulate the manner in which information should be provided. They 
advise that information about possible long-term effects should be given in a practical and 
reassuring manner, and efforts should be made to alleviate concerns. They state that this is 
particularly important for people who appear more anxious and thus may attribute unrelated 
symptoms to the TBI, after the TBI sequelae have resolved. The details of this written 
information should be discussed with the patient and their carer and if necessary, other 
formats (such as other languages, pictures, tapes or videos) should be used to communicate. 
Written information should be offered proactively rather than upon request and when being 
given the material, patients and support persons should be given the opportunity to ask 
questions and express concerns, with the practitioner available to provide reassurance and 
advice.  
All of the above guidelines recommend providing similar information, with variation 
relating to how detailed discharge forms should be and the timing of further consultation for 
ongoing issues or returning to activities. The NZGG may recommend the most detailed 
discharge information, however this advice relates to TBI of any severity and is spread across 
several chapters of their guideline document. They have not provided a template for patient 
information sheets; doing so could assist professionals to adhere to the guidelines and ensure 
patients receive the recommended timely and detailed advice. The NZGG also add valuable 
advice for practitioners regarding the manner of providing information, as well as formats that 
should be available.  
Issues with Information Provided Following MTBI 
International studies have shown substantial variability in the written information 
provided to patients after a mTBI in terms of both content and accessibility of the information 
(Baker et al., 2015; Kempe et al., 2014; Macdonald et al., 2010; Peachey et al., 2011). This is 
perhaps unsurprising given the variation in guidelines and examples provided by prominent 
groups such as NICE, SIGN, CDC and NZGG.   
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Macdonald and colleagues (2010) compared 45 head injury related leaflets from the 
30 Emergency Departments in Scotland with the SIGN recommendations on early 
management of head injuries. They scored each leaflet one point for each guideline included, 
then calculated the total as a percentage of the SIGN guidelines. Twenty-four of the leaflets 
provided less than half of the information recommended by SIGN, and none provided all of the 
recommended information. In addition, readability was assessed using the Simplified Measure 
of Gobbeldygook (SMOG) and the Flesch Reading Ease (FRE) scale, while legibility was assessed 
against the Royal National Institute for the Blind (RNIB) clear print guidelines. No leaflets met 
the recommendation for a 5th grade or lower reading level with all written at the 8th grade level 
or above, the mean FRE score was in the ‘fairly difficult’ range which is able to be understood 
by approximately 40% of the population, and mean compliance with RNIB guidelines was 78%, 
with many leaflets neglecting the font size and text justification criteria thereby making them 
difficult to read.  
A study by Peachy and colleagues (2011) also found issues with the content of written 
discharge information for mTBI sufferers. The authors created a comprehensive leaflet based 
on the NICE and SIGN guidelines and used this as a template against which to evaluate leaflets 
received from the 35 Emergency Departments in the Republic of Ireland. The authors reported 
that all EDs discharged patients with written information, but there was substantial variability 
in the amount and quality. Most sheets included information on symptoms that should trigger 
a return to the ED, though this was varied, particularly the advice regarding vomiting. Many 
information leaflets lacked important information regarding post-concussion symptoms and 
how to aid recovery. In addition, only 46% of EDs used separate information sheets for 
children, with only one providing a specialised sheet for infants and toddlers; 54% provided 
information for carers, with two EDs not providing information for the patient him/herself. 
One ED offered their leaflet in large print, and none provided leaflets in braille, audio-format, 
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or languages other than English, thus the vast majority of information available was accessible 
only to  English speakers with adequate visual ability. 
Kempe and colleagues (2014) assessed written information provided to mTBI sufferers 
by four hospitals in South-East Queensland, Australia, as well as publications available from 
reputable sources (e.g., government departments) on the internet. These authors also found 
highly varied information and accessibility, showing that some publications met most of the 
NICE and SIGN guidelines while others did not. On average, the publications covered 
approximately two thirds of the recommended content with the most common omissions 
relating to post-injury symptoms (e.g., what symptoms to expect and how long they may last) 
and recovery advice. Eighty percent of the assessed publications had an FRE score less than 70, 
indicating some were considered ‘standard’ while others were more difficult, and therefore 
the information was inaccessible to much of the population.  
Another Australian study focused on advice regarding fitness to drive after mTBI. Baker 
and colleagues (2015) surveyed EDs across Australia and found only 36% of responding EDs 
recommended a period of no driving following mTBI, and the advice regarding when to return 
to driving was varied. Many clinicians reportedly expressed a need for a review of fitness to 
drive guidelines. As noted previously the driving advice recommended by NICE is somewhat 
ambiguous and possibly difficult for a patient to gauge, particularly when not provided with 
sufficient information regarding ongoing symptoms and how to manage these. The CDC 
recommend asking a healthcare professional for advice before returning to driving, and when 
discussing the present study Baker et al. (2015) posit that occupational therapists are well 
positioned to be those healthcare professionals. It may be unlikely however, that most mTBI 
sufferers are able to consult an occupational therapist prior to returning to driving. 
These international studies show considerable variability in the content of advice 
provided to mTBI patients and suggest that many did not adhere to published guidelines. In 
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addition, information tended to be available in limited language and format options, 
potentially disadvantaging those with disabilities or diverse cultural backgrounds. 
Information Provision in the New Zealand Context  
A New Zealand study (Moore & Leathem, 2004) found that only 45.9% of the New 
Zealand Emergency Departments and General Practitioners that responded to their postal 
survey, provided written information to patients who had a confirmed or suspected mTBI. 
Considerably more EDs (93.4%) than GPs (42.8%) provided written information. The 
information sheets ranged from one to ten pages in length thus were varied in content and 
quality, though all provided information regarding what symptoms to watch for (e.g., vomiting, 
severe headache, weakness, visual disturbance, and inability to rouse the patient). 
Approximately half of the sheets included information regarding the return to activities such as 
driving (61.7%), sport or exercise (58.3%) and school or work (40%), though the quality of this 
information varied, for example driving advice ranged from many suggesting periods of at least 
24 hours before driving and others leaving it to individual judgement. Forty three percent of 
information sheets identified the likelihood of ongoing symptoms, with only 10% providing 
advice about what to do about any ongoing concerns. Regarding the accessibility of these 
information sheets, just over half of the sheets provided by GPs were considered readable by 
70% of the population, while over 92% of ED information sheets met this criterion (FRE score 
over 61). The majority of information sheets adhered to the National Institute for the Blind 
recommendations to use at least 12 point font, keep the right margin unjustified and to use 
headings and bullet points to guide the reader. Since this study took place, several patient 
leaflets have been produced by the ACC and are based on the NZGG recommendations, but it 
is not known if these are routinely provided to patients by their healthcare providers, or which 
leaflets are most used. These leaflets are brief advice forms aimed at patients being discharged 
after ‘head injury’ or ‘concussion’ and/or their caregivers.   
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Like participants in Snell and colleagues’ (2016) Christchurch based study, individuals 
discussing participation in Study One with the researcher frequently indicated uncertainty 
about what was happening with their health and recovery. They indicated that they did not 
have a clear understanding of which symptoms commonly occurred in the weeks and 
sometimes months after a mTBI and were often surprised to learn that what they were 
experiencing was not uncommon. This may suggest that the ACC and other leaflets are not in 
routine use, however this cannot be gauged by the small sample from study one. In several 
instances, treatment providers had recommended these individuals take dietary supplements 
(as well as prescribed medications), though the individuals concerned were not certain why, 
other than being “good for concussion”. As outlined in the background for Study One there is 
some evidence of dietary supplements such as long chain omega-3 fatty acids (e.g., fish oil) 
having the potential to treat mTBI symptoms, however this does not form part of standard 
treatment guidelines. Patient information guidelines (e.g., the EQIP by Moult, Franck & Brady, 
2004) recommend providing patients with an overview of benefits, risks, and alternatives to 
any prescribed or recommended treatments. It appears that the information provided to mTBI 
sufferers in New Zealand remains highly varied and neither restricted to, nor encompassing all 
of, the guidelines published by reputable organisations such as SIGN, NICE, CDC or the NZGG.  
Summary 
  Taken together the studies reviewed above suggest that the routine provision of 
more intensive treatment may not be necessary in this patient population, and the timely 
provision of information relating to injury symptoms, recovery timeframes, advice on returning 
to premorbid activities, and the expectation of a positive outcome may reduce future 
morbidity and related service use. Patients have expressed the need for such advice, distress 
when it is not forthcoming or is contradictory, and the tendency to seek said advice from less 
than reputable sources when not received by healthcare providers. The guidelines for 
information provision also recommend that health practitioners provide such advice in a 
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timely and reassuring manner while remaining available to address follow up questions and 
concerns. Provision of this information and service to mTBI sufferers however, is inconsistent 
both internationally and nationally in terms of the content of the information provided, the 
manner in which it is provided, and how accessible it is to the general population. In addition, 
previous New Zealand based research on the content and accessibility of patient information is 
out of date, particularly considering the subsequent publication of the NZGG advice and ACC 
leaflets, as well as the increasing tendency of individuals to source information from the 
internet. Study Two aimed to assess the consistency, quality, and accessibility of information 




Chapter Six: Study Two Methodology 
This chapter provides a description of Study Two’s design, including the rationale, 
participants, procedures, analyses and dissemination of results. 
The main objective of this study was to investigate the consistency, quality and 
accessibility of information provided to patients and/or caregivers after mTBI. Only patient 
literature, rather than information accessible on the internet, was considered. The study also 
aimed to determine the frequency with which health practitioners provided information, 
including the ACC leaflets. A key consideration and point of difference from prior research was 
the inclusion of allied health professionals and providers working in post-acute settings (e.g., 
concussion clinics) in addition to  medical and administrative staff from emergency 
departments and general practices, who have been the focus of prior studies.  
The survey also sought to replicate and expand on Moore and Leathem’s 2004 study to 
gain an understanding of contemporary practices for providing information to mTBI patients. It 
assessed provided information using multiple established criteria, and surveyed health 
professionals on the information they impart via other means (e.g., verbally) as well as any 
barriers they face when seeking to provide their patients with information. By surveying 
emergency department, general practice, and concussion service professionals this study also 
aimed to show differences between information provision practices and materials between 
service areas, as well as the potential flow of information patients receive should they require 
ongoing care.  
Design 
 The study was a survey design that utilised systematic and convenience sampling 
methods to select participating practices and individuals respectively.  
Hypotheses 
 It was hypothesised that a majority of healthcare providers would provide both 
written and verbal information, though the content and accessibility of information provided 
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would vary between service areas. In light of ACC publishing their brochures however, it was 
hypothesised that the frequency of information provision would have improved since Moore 
and Leathem’s (2004) study and that the ACC publications would be provided by a majority of 
hospitals and general practices. It was also hypothesised that in line with international 
research (Peachey et al., 2011), the majority of written information available for health 
professionals to provide would be limited to the English language and standard print formats, 
and that both consultation times and the patients’ own symptoms (e.g., difficulty 
concentrating) would be the most frequently reported barriers to providing information. 
Participants 
 Participants were workers from general practices, hospital emergency departments, 
and concussion clinics. The survey was open to any health professional in a patient-facing 
position who interacted with people post mTBI . This included doctors, nurses, 
physiotherapists, occupational therapists, psychologists, other allied health staff and 
administrative staff.  
Measures 
 Similar to the Moore and Leathem (2004) study data was collected via survey, though 
rather than via post, the survey was conducted online. 
Survey questions. Participants were asked to provide general information such as their 
profession, the geographic location of their practice, the type of practice they worked in, and 
the approximate number of mTBI patients they had seen in the last month. This information 
provided an understanding of how representative the sample was and assisted with dividing 
the sample for analyses. See Appendix C for the full survey. 
Participants were also asked to outline the type of information and advice that was 
typically provided to patients, by whom this was provided, and in what form this was provided 
and/or available (e.g., verbal, written, audio, visual). This aimed to assess the type and 
accessibility of information that survey respondents may provide in forms other than pre-
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prepared information sheets, or may have been unable or unwilling to upload to the survey as 
requested. It also partially addressed the NZGG’s advice on the manner in which information 
should be provided to patients.  
Participants were asked about the most frequent symptoms encountered in their 
practice with mTBI patients and to outline the advice they provided for specific symptoms and 
treatments. This served to help assess consistency in advice giving as well as whether 
practitioners were meeting the guidelines for providing information on the risks, benefits, and 
alternatives to recommended treatments – necessary elements for informed choice.  
Perceived barriers to providing information to patients were also queried, and this 
information aimed to identify reasons for the non-provision of information and any gaps in the 
current patient literature (e.g., the need for more Te Reo Māori2 resources).  
Assessment of information sheets. Several criteria have been developed for 
evaluating patient literature both generally and specifically relating to mTBI.  
For assessing the accessibility of patient literature more generally, scales of reading 
ease are frequently used. The Flesch Reading Ease (FRE) scale is perhaps the most widely 
known and assesses the ‘readability’ of English language text based on the average sentence 
length and average word length, which is determined by the number of syllables. Scores range 
from zero (very difficult) to 100 (very easy) and can be used to estimate the reading grade 
level. As Jindal and Macdermid (2017) note, the FRE has several limitations when assessing 
patient literature. It does not account for audience factors (e.g., prior knowledge, health 
literacy, anxiety); document factors (e.g., tables, figures, spacing, grammar, font colour, layout 
or legibility); or writing style (e.g., cultural sensitivity, appropriateness for the audience or 
setting, or comprehensiveness) all of which can alter the accessibility of the information 
contained in a document.  
 
2 Te Reo Māori is an official language of New Zealand. 
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As a means of evaluating the style and usefulness of patient information overlooked by 
the FRE, Moult and colleagues (2004) created the Ensuring Quality Information for Patients 
(EQIP) questionnaire. The EQIP assesses the order of information, language use and tone, 
layout, information about publication (e.g., the publishing date), safety of medications and 
procedures, and further support. This constitutes general quality guidelines for ensuring 
patients receive up-to-date and useful information. Moult and colleagues’ study showed good 
preliminary reliability and validity, and this measure may be a useful adjunct for use with 
readability measures (Jindal & Macdermid, 2017).  
Accessibility also refers to the clarity of the actual print, and guidelines for this are 
often produced by agencies advocating for those with visual impairments. As noted in the 
previous chapter, Moore and Leathem (2004) and Macdonald et al. (2010) used guidelines 
produced by the Royal National Institute for the Blind (RNIB) to assess the information sheets 
received in their respective studies. The Round Table on Information Access for People with 
Print Disabilities (2011) expanded on the RNIB guidelines to create a handbook of guidelines 
for producing clear print for use in Australia and New Zealand. This document includes 
information about clear print, large print, how people with low vision read, font requirements, 
text layout, contrast, page layout, navigational aids, graphics, tables, printing and reformatting.  
Macdonald and colleagues (2010) have combined the above guidelines to form the 
Patient Literature Usefulness Index (PLUI) that allows for the comparison of patient 
information sheets. The PLUI is a weighted composite of scores on four different sets of 
criteria: percentage compliance with content guidelines (e.g., the SIGN leaflet; 45%), average 
readability score from two or more measures (25%), RNIB compliance percentage (20%) and 
standard information compliance (e.g., service contact information, date of 




This research project was evaluated by peer review and judged to be low risk. 
Consequently, review by one of the University’s Human Ethics Committees was not required. 
Ethics approval was sought and granted from several organisations that advised they required 
this process; their correspondence is available in Appendix D. Four of the responding district 
health boards required lengthy ethics application and consultation processes; it was decided 
these would not be pursued due to time constraints.  
The survey was securely hosted on the Qualtrics server and jointly managed by the 
coordinating investigator and the Qualtrics licence holder for the Massey University School of 
Psychology. The survey was closed manually by the lead researcher after 20 weeks. 
 All participants provided informed consent by selecting a ‘yes’ option after reviewing 
the electronic information sheet. For any participants who elected not to consent, the survey 
displayed a thank-you message and did not proceed to the question pages.  
 Hard copy information was stored in a locked file, and all electronic information in 
password protected files on password protected devices accessible only by the coordinating 
investigator. No identifying information was collected.  
Procedure 
 In line with Moore and Leathem (2004) all New Zealand hospital emergency 
departments and every fifth general practice from a public directory were contacted via email 
with a request to participate in the survey. To expand on this study, all concussion clinics 
identified by an internet search using the terms ‘concussion clinic’ and ‘concussion service’ 
were also contacted. The directory consulted for general practices was www.healthpoint.co.nz 
and search terms included ‘general practice’, ‘medical centre’, and ‘medical clinic’. Results 
were sorted into alphabetical order before every fifth practice was contacted. Practices that 
did not list an email address were phoned to introduce the study and request an appropriate 
email contact. Following a poor response rate from general practices, all Primary Health 
114 
 
Organisations were contacted with a request to forward the survey to the general practices 
they oversee, thus theoretically requesting participation from every GP practice in the country.  
A link to the electronic survey was sent with the initial email to the research, 
administration, or management email address of the selected healthcare providers. Also 
included was information about the researcher and the study, and a request to distribute the 
survey among relevant staff. Where required by certain organisations (i.e., some DHBs), ethics 
application procedures were begun on receipt of the appropriate request forms and, once 
approved, organisational procedures were followed for distributing the survey among their 
staff.    
The survey was opened on May 13th, 2019 and closed on September 28th, 2019. Upon 
the close of the survey all information sheets were downloaded for analysis. These were 
assessed using the PLUI modified to use only the FRE as the readability measure rather than an 
average of two, as criteria for other readability measures (such as the number of sentences 
present) were not met. The PLUI was further modified to include the EQIP as the measure of 
‘standard information compliance’.  
Descriptive statistics were used to compare information sheets’ adherence to 
guidelines, compare practitioners other advice and methods of providing advice, and 
determine how this differed across regions, services and professions. Data was analysed using 
version 22 of SPSS for Windows.  
Dissemination of Results to Participants 
 As participation was anonymous, summary reports could not be sent to individuals 
upon completion of the study. Several participating DHBs required a report of results as part of 





Chapter Seven: Study Two Results 
Respondent Characteristics 
Of the 125 valid responses to the survey received3, 56.8% (n=71)  were from hospital 
Emergency Department (ED) staff (52.1% nurses, 46.5% physicians, 1.4% unstated), 17.6% 
(n=22) from Community Medical facilities (77.3% General Practitioners), and 25.6% (n=32) 
from ongoing Rehabilitation providers4 (40.6% occupational therapists). As of June 2019 there 
were 3671 GPs and 319 ED physicians with a current practicing certificate and vocational scope 
in New Zealand (Medical Council of New Zealand, 2019), thus only 10% of ED physicians and 
less than one percent of GPs are represented in the present survey. In addition, it is estimated 
that over 6000 nurses work within relevant settings, so less than one percent of the nursing 
workforce is represented (Nursing Council of New Zealand, 2020). No data were available for 
the number of allied health professionals working within Concussion Services. The majority of 
responses came from the North Island, with 35.4% of these from the Wellington region. Table 
7.1 provides a breakdown of responses by professional group, region and whether rural or 
urban for the three service areas, as well as the frequency of response from each DHB region.    
Most respondents (66.4%) from all groups had seen between one and ten mTBI 
patients in the previous month. ED staff were most likely to have seen more than this (26.8% 
had seen 11-20, 8.4% 21-40, and 1.4% over 50 mTBI patients).  
  
 
3 125 respondents consented and provided some responses; not all questions were answered by all participants. 






Number of Health Professionals and Regional Distributions of Respondents in each Service Area  
Hospital ED5 
N (% total sample) 
Community6 
Medical 
N (% total sample) 
Rehabilitation 
N (% total 
sample) 
Total 
Professional Group  
Administrator  1 (0.8) 2 (1.6) 3 (2.4) 
Nurse 37 (29.6) 2 (1.6)  39 (42.2) 
ED Physician 33 (26.4)   33 (36.4) 
General Practitioner  17 (13.6)  17 (13.6) 
Other Medical Specialist   4 (3.2) 4 (3.2) 
Physiotherapist  1 (0.8) 6 (4.8) 7 (5.5) 
Occupational Therapist   13 (10.4) 13 (10.4) 
Psychologist  1 (0.8) 3 (2.4) 4 (3.2) 
Other Allied Health    4 (3.2) 4 (3.2)  
Regions7     
Wellington/Kāpiti 34 (27.2) 1 (0.8) 5 (4.0) 40 (32) 
Auckland 10 (8.0) 2 (1.6) 5 (4.0) 17 (13.3) 
Waikato 9 (7.2) 1 (0.8) 5 (4.0) 15 (12) 
Whanganui 8 (6.4)   8 (6.4)  
Southern District  7 (5.6) 1 (0.8) 8 (6.4) 
BOP 1 (0.8) 1 (0.8) 3 (2.4) 5 (4.0) 
Lakes 3 (2.4)  2 (1.6) 5 (4.0) 
Waitemata  3 (2.4) 2 (1.6) 5 (4.0) 
Northland 2 (1.6)  2 (1.6) 4 (3.2) 
Taranaki 3 (2.4) 1 (0.8)  4 (3.2) 
Hawkes Bay  1 (0.8) 2 (1.6) 3 (2.0) 
Manawatū/Horowhenua   3 (2.4) 3 (2.0) 
Nelson/Marlborough  2 (1.6)  2 (2.0)  
Counties Manukau   2 (1.6) 2 (2.0)  
Tairāwhiti 1 (0.8)   1 (0.8) 
Wairarapa  1 (0.8)  1 (0.8) 
South Canterbury  1 (0.8)  1 (0.8)  
North Island Total 71 (56.8) 11 (8.8) 31 (24.8) 113 (90.4) 
South Island Total  10 (8) 1 (0.8) 11 (8.8) 
Urban 67 (53.6) 15 (12) 27 (21.6) 109 (87.2) 
Rural 4 (5.6) 7 (31.8) 4 (12.5) 15 (12) 
Note. No responses were received from the Canterbury, West Coast, or Otago regions. 
 
5 One respondent from this group did not state their profession. 
6 This category combined both general practice medical clinics and the one responding accident and medical facility. 
7 One respondent from the Community Medical group did not state their region; one respondent from the 
Rehabilitation group did not state whether urban or rural. 
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Provision of Written Information Sheets 
The vast majority of respondents (92.8%) provided information in some format. 
Written Information was provided by 84.8% (n=106) of respondents (93% ED; 75% 
Rehabilitation and 72.7% Community Medical) usually accompanied by verbal information 
(81%). In 43.2% (n=60)of cases, the written information was personalised (42.3% ED, 18.2% 
Community Medical, 62.5% Rehabilitation). Of the 13.6% (n=17) of respondents (5.6% ED, 
27.3% Community Medical, 21.9% Rehabilitation) who did not provide written information, 
most (n=10) provided verbal information (1.4% ED, 18.2% Community Medical, 15.6% 
Rehabilitation), some (n=4) did not provide information at all (4.2% ED, 3.1% Rehabilitation) 
and others (n=3) did not answer the format of information question (9.1% Community 
Medical, 3.1% Rehabilitation).  
Non ACC information sheets were routinely supplied by 60.8% (n=76) of respondents 
(70.4% ED, 22.7% Community Medical, 65.6% Rehabilitation). ACC information sheets were 
routinely supplied by 48% (n=60) of respondents, including ‘Caring for yourself after a Head 
Injury’ (ACC 572), 42.4% (n=53); ‘Knowing about your Mild Traumatic Brain Injury’ (ACC 4154), 
17.6% (n=22); ‘Returning to activity from Concussion or Mild Traumatic Brain Injury’ leaflet for 
children (ACC 7639), 16.8% (n=21); ‘Caring for your child after their Head Injury’, (ACC 6009), 
2.4% (n=3); and the ‘Going head to head with TBI’ poster (ACC 7953) was cited as an available 
resource by one respondent. Further information about the leaflets provided by the three 
services is shown separately on Figure 7.1 below. 
Most respondents (71.2%) advised that any information sheets provided were handed 




Figure 7.1. Percentage of respondents from each service area providing written information to 
mTBI patients.  
Information specific to children was provided by 44% (n=55) of respondents; for adults 
32.8% (n=41), while few had information specific to infants, adolescents, older adults or 
caregivers. See Figure 7.2 below for population-specific information. 
 
Figure 7.2. Percentage of respondents from each service area providing written information 
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Format of Information 
Most information was provided in English (98.8% of those who responded to this 
question 8, 68% total sample; n=85), and 7.2% respondents (n=9) had information available in 
Te Reo Māori. Four respondents across the three service areas had other languages available, 
(usually to be downloaded as required) one of whom did not provide English language 
information, though downloaded ACC information sheets “as appropriate”.   
Audio (e.g., sound recordings) or visual (e.g., pictures) information was available in a 
few cases (6.4%; n=8) the majority (87.5%; n=7) from the Rehabilitation group and one from 
ED. No respondents provided information in Braille. Approximately one fifth (20.8%) of the 
total sample said they directed patients to mTBI related websites e.g., ACC, Brain Injury 
Association New Zealand, Centres for Disease Control and Prevention (CDC), Ministry of 
Health, and Health Navigator.   
Content and Accessibility of Written Information 
Thirty-eight information sheets were uploaded to the survey by 22 respondents 
(17.6%). Five from the same ED setting were almost identical and yielded identical scores 
across measures; they were all included in the results as they were submitted by five separate 
treatment providers. Two ‘information sheets’ were not analysed because they were not 
patient literature (one was an assessment measure and the other a set of guidelines, both 
made for sports physicians). The remaining 36 forms were assessed on their accessibility using 
the Roundtable Guidelines for Clear Print, their general quality using the EQIP and their 
readability using the FRE.  
 
8 32% survey respondents (n=40) skipped this question. 
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Content was evaluated where applicable 9 against the NICE recommended information sheets 
for adults, (although scoring for those made for children was altered to avoid artificially low 
scores due to lack of advice for avoiding alcohol, driving, sleeping pills and operating 
machinery). Sheets that had scores for all four elements were assessed with the mPLUI, for 
overall usefulness. ACC acute care information sheets were also assessed with these measures 
for comparison.  
As shown on Table 7.2, ED information sheets scored the highest on content, 
readability and overall mPLUI for acute care forms. Interestingly the ACC information sheets, 
which state they are based on the NZGG (2006) recommendations, scored lowest on the 
content measure but highest on the EQIP across all service areas, suggesting they are logical, 
respectfully worded, and easy to follow.  
The forms provided by the Community Medical group rated lowest for readability, 
indicating that the language used was difficult to understand, and highest for clarity, indicating 
that they adhered closely to the Roundtable clear print guidelines. However, this group 
provided only two sheets for evaluation both produced by outside organisations – one a joint 
publication between ACC and the Starship Foundation and the other a poster from New 
Zealand Rugby. Information sheets provided by the Rehabilitation group scored the lowest on 
the EQIP and second lowest on both the clarity and readability measures. These ‘sheets’ 
tended to be longer and contain more in-depth information about specific symptoms and 
rehabilitation targets than those provided by other groups.  
 
9 As the content recommendations from the NICE guidelines related to acute care services, this was not 
analysed for all sheets; the two information sheets provided by Community Medical services and most 
of the sheets provided by Rehabilitation professionals did not meet the acute care criteria. Whether 
an information sheet qualified as ‘acute care’ depended on whether it contained any information 
relating to symptoms requiring immediate medical assessment or reassessment, as this typically 




Of the three service areas, ED information sheets yielded the highest scores for both 
clarity and readability, while Community Medical forms scored highest for general quality of 
layout and wording. Compared with ACC leaflets, ED information sheets were deemed more 
useful for patients, overall.  
Table 7.2 
Mean Content, Clarity, EQIP, FRE and mPLUI Scores for each Service area 
 
Content Clarity EQIP FRE FRE Descriptor mPLUI 
ACC 52.7 (8.5) 75.7 (15.5) 74.0 (3.6) 65.5 (5.0) Standard 62.6 (6.3) 




81.3 (6.2) 68.8 (6.4) 46.8 (1.1) Difficult n/a 
Rehabilitation n/a 74.3 (24.8) 52.5 (18.3) 59.3 (9.6) Fairly Difficult n/a 
 
Notes. Mean scores are presented first, with standard deviations in parentheses. All measures 
have a possible score range of 0-100. EQIP = Ensuring Quality Information for Patients, FRE = 
Flesch Reading Ease, mPLUI = modified Patient Literature Usefulness Index. Content scores 
were not provided for the Community Medical and Rehabilitation service areas as the provided 
forms did not meet ‘acute care’ criteria.  
General Advice Provision 
Specific areas of concern. As shown on Figure 7.3 the three service areas provided 
similar amounts of information on each area queried except for substance use and symptoms 
requiring medical attention. Rehabilitation respondents more frequently advised on substance 
use, while Community Medical and ED respondents more frequently advised on symptoms 
requiring medical attention. This is perhaps unsurprising, given that Rehabilitation providers 
are likely to be consulted after the acute injury phase when patients are less likely to suffer life 
threatening adverse events. Those that did provide this information largely outlined the same 
advice as provided on the standard information sheets, or simply stated “as per leaflet”.  
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Some also stated that certain activities such as driving or returning to sport needed to 
be assessed by the individual’s GP, while others discussed the individual nature of mTBI and 
advised they could not generalise about the information they provide.  
 
 
Figure 7.3. Percentage of respondents in each service area providing information on specific 
areas of concern.  
 
The symptom most frequently reported as most concerning to patients was headache, 
(56% of total respondents) followed by fatigue (10%) and nausea/vomiting (6%). See Figure 7.4 
































Figure 7.4. Symptom reported by patients as most concerning in each service area. ‘Other’ 
included a range of issues such as anger, lack of appetite, word finding difficulties and sexual 
dysfunction. 
Medications & Supplements.  ED and Community Medical respondents were more 
likely to advise on medication (60.6% and 54.5% respectively) than Rehabilitation respondents 
(37.5%). ED and Community Medical respondents most frequently endorsed paracetamol and 
non-steroidal anti-inflammatory drugs (NSAIDS) as the advised medications for mTBI. 
Rehabilitation providers were more likely than the other two service groups to recommend 
dietary supplements (fish oil and magnesium) or ‘other’ medications (most commonly anti-




























Figure 7.5. Medications and supplements advised by each service area.  
Referral to concussion service. ED staff were least likely to refer patients to 
Concussion Services (32.4% did not do so; 19.7% did if symptoms continued for several weeks; 
22.5% made a Concussion Service referral upon a patient’s initial presentation and 25.4% did 
not answer this question). Qualitative information suggested that the acute nature of the ED 
service meant they are not likely to know who will recover without further assistance, patient 
intoxication or other injuries potentially mimicking or masking mTBI, and a lack of 
understanding of the process for making such a referral.  
Of the Community Medical respondents, 59.1% referred patients to the Concussion 
Service if symptoms persisted for several weeks, 9.1% did so upon initial presentation, 4.5% 
did not refer, and 27.3% did not answer this question. As 50% of the Rehabilitation 
respondents already worked for a Concussion Service the question was not applicable for 
them. However, seven others working in the rehab sector made a referral ranging from initial 
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Barriers to Providing Information  
The most frequently reported barrier to providing information for the overall sample 
was time constraints during consultation, (42.4% of respondents) followed by lack of 
appropriate materials and patient concentration difficulties (20.8%), lack of patient interest in 
the materials and patient distress during consultation, (12.8%). Most respondents who 
selected patient distress as a barrier belonged to the Rehabilitation group. Figure 7.6 further 
outlines these barriers faced by healthcare practitioners across the three service areas.   
 
Figure 7.6. Barriers to providing information reported by each service group.  
Further Information 
At the conclusion of the survey respondents were provided with space to make 
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ED respondents who did not refer patients to the concussion service but provided advice upon 
discharge and recommended they follow up with their GP if symptoms persist.  
Some respondents expressed concern over the prevalence of concussion and/or the 
way in which their mTBI patients present, for example  
“…I worry about the amount of people that come in with concussion… I find patients 
are not very knowledgeable with what they are dealing with…”,  
“many of our presentations are students, related to sport and/or alcohol consumption 
– this age group presents challenges of their own in their feeling of invincibility… still 
some pressure on key players to get back [into sport], and hence they can minimize 
symptoms to fit the criteria for doing so”  
“difficult problem to deal with”.  
Others outlined the necessity of correct diagnosis and provision of correct and useful 
information as key for setting recovery expectations. Expressions of need for further 
information and/or resources included  
“I would like to have a better understanding of what is available for those with ongoing 
symptoms”,  
“it would be useful to have more resources available in easy read format…”  
“it would be great to have a system in which we could generate documents with 
information based on the client’s specific symptoms and concerns…”.  
Summary 
 One hundred and twenty-five valid survey responses were received, the majority of 
which came from ED staff, the North Island, and urban areas. Three service groups – Hospital 
ED, Community Medical, and Rehabilitation – were compared. The majority of respondents 
from each group provided both written and verbal information to mTBI patients, the content 
and quality of which varied across groups. Hospital ED and ACC information sheets obtained 
the highest scores on the FRE, achieving a ‘standard’ readability score while the Rehabilitation 
and Community Medical groups scored ‘fairly difficult’ and ‘difficult’, respectively. The ACC 
forms scored highest (74) on the EQIP and the Rehabilitation group scored lowest (52.5); 
clarity scores were similar across groups. Of the acute care forms, the ED group adhered most 
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closely to the NICE guidelines. Of those who responded to the language and formatting 
question, 98.8% provided written information in English, while just 10.2% provided 
information in Te Reo Māori. Time constraints, a lack of appropriate materials, and patient 






Chapter Eight: Information Provision Discussion 
  The majority of respondents gave their mTBI patients both verbal and written 
information, as recommended by the NZGG (2006). According to the written responses 
provided within the survey, most advice was in line with the content guidelines, though some 
was tailored to each individual patient’s symptoms or to specific recovery targets. Like Moore 
and Leathem’s (2004) study, Study Two showed that more hospital EDs than Community 
Medical practices provided written information to mTBI patients, however the information 
provided by both of these services was less varied in both content and length than the 2004 
study; and a considerably higher percentage of Community Medical respondents (72.7%, 
compared with 42.8% in 2004) provided some form of written information.  
Usefulness of Information Provided 
The mPLUI scores for the acute care forms were comparable across the Hospital ED, 
ACC, and all acute care groups. The mean mPLUI for all acute care forms was very similar to 
Kempe and colleagues’ (2014) findings (mean mPLUI scores of 65.93 and 65.86, respectively). 
Because no composite measure similar to the mPLUI was used in Moore and Leathem’s 2004 
study, no comparison of the overall content and accessibility in New Zealand mTBI literature 
over time can be made.  
Content guidelines. The NZGG and NICE both recommend that those with TBI and 
their caregivers should be made aware of the possibility of ongoing symptoms and be provided 
with the details of support services as part of their written discharge advice, as well as being 
informed of the warning signs for medical emergency and common symptoms that need not 
cause concern. Aspects of this recommended information however, were often not included 
with written discharge advice. The content items most frequently missed from acute care 
forms included: the warning signs of loss of balance or problems walking, clear fluid leaking 
from the ear or nose, and bleeding from one or both ears; the common symptoms of a lack of 
appetite and insomnia; and advice to stay within reach of a telephone or medical help, that 
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some symptoms may appear after an initial period of seeming relatively well, and information 
about further support. In addition, the ACC forms tended to miss both nausea as a common 
symptom and advice not to drive or operate machinery until symptoms subside. It was also 
noted that advice specific to driving was highly varied, as per both Moore and Leathem (2004) 
and Baker et al. (2015). Driving advice included set periods of no driving, advice to wait until 
certain symptoms such as dizziness subside, driving only short distances with a responsible 
passenger and/or on quiet roads, and consulting one’s GP prior to returning to driving.  
 Survey responses for advice provided in any format indicated that 62.9% of 
practitioners provided advice about returning to sport or exercise, 59.2% about driving, and 
36% work or study. This was similar to the written information collected by Moore and 
Leathem (2004) in which 58.3% advised about sport/exercise, 61.7% driving, and 40% 
returning to work. While any differences in the specific content of the information provided in 
these domains cannot be determined, it appears that little may have changed regarding how 
frequently patients are advised in these areas.  
Accessibility guidelines. Similar to Moore and Leathem (2004) the present research 
noted a higher proportion of readable information from ED services than Community Medical 
services. However, the accessibility of information did not always meet recommended 
standards. This was indicated by the low mean FRE scores for both the Community Medical 
and Rehabilitation groups. The readability scores for these groups were classified as difficult 
and fairly difficult respectively, suggesting that a considerable proportion of the population 
may struggle to read and understand the materials. Regardless of the quality of the 
information contained in an information sheet, if it cannot be read, it cannot communicate the 
information so is not useful to the patient. While this represents an apparent decrease in 
readable information from Moore and Leathem’s 2004 research, the small Community Medical 
sample in the present study and the provision of the ACC sheets (two out of three of which 
were a ‘standard’ level of readability) prevent meaningful comparison.  
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The EQIP also provides an indication of how understandable patient information is, 
and this was somewhat varied between groups. Frequently missed items on the EQIP included 
information about whether patients or families were consulted, space for patients to take 
notes, and details of other information sources. The rehabilitation group scored lowest on this 
measure, where points were lost for missing the points above as well as for not using everyday 
language, ensuring illustrations and diagrams were relevant and easily understood, or directly 
addressing quality of life issues such as mobility and school/work attendance. Where quality of 
life issues were not addressed by this group, the information tended to discuss symptoms 
(e.g., fatigue) that may impact the patient in numerous ways, but not specifically outline how 
this may affect certain activities of daily living or strategies for dealing with the symptoms in 
specific situations. It is likely that such information would be tailored to individual patients and 
be covered during a consultation, however providing concrete written advice, or a section for 
the patient or practitioner to record advice in written form, is likely to assist with retention and 
adherence and was frequently not included. Given that the Rehabilitation group tend to treat 
patients with ongoing symptoms and thus are likely to have working knowledge of the 
information processing, attention and memory difficulties associated with mTBI, it was 
surprising to see lower levels of clarity and readability from this group.  
Most information sheets across all groups adhered well to the clear print guidelines. 
Like MacDonald and colleagues’ (2010) study, mean compliance was 78% and the most 
commonly overlooked recommendation was for font size to be at least 12 point, with text 
justification recommendations sometimes also neglected. While 91.9% of information sheets 
assessed by Moore and Leathem (2004) adhered to the 12 point font recommendation, just 
25.7% of those assessed in the present study did the same. The same percentage of 
information sheets (74.3%) adhered to the text justification recommendation in 2004 and 
2019. As visual disturbances are common symptoms in both acute and ongoing mTBI, text that 
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is large enough to be easily seen is an important element of ensuring written information is 
accessible and thus useful.  
Advice for Different Populations 
Few practitioners had available information for specific populations aside from adults 
and children, and 20% stated that everyone received the same information. Given the 
potential for symptoms to present differently and the varied needs of other populations, it 
would seem pertinent to have more specific information available. For instance, it is likely 
necessary to provide more information regarding behavioural signs of distress and impairment 
for the caregivers of pre- or minimally verbal infants and toddlers (Gagner, Dégeilh, Bernier, & 
Beauchamp, 2019). As per Gagnon and colleagues’ (2008) participants, information for 
adolescents needs to account for this population’s emerging independence and academic and 
sporting commitments, as well as both the internal and external pressures they face which 
may lead to returning to these pursuits too soon (Swain et al., 2008) and the possibility of 
ongoing emotional and behavioural symptoms (Connolly & McCormick, 2019). Regarding older 
adults, there may be a need to provide more information about the possibility of ongoing 
symptoms, their impact on day to day functioning, and future injury prevention, particularly 
relating to falls (Abdulle & van der Naalt, 2019). 
Less than half of practitioners provided personalised information, though the majority 
stated that information was provided to patients directly by the healthcare practitioner. This 
may allow for discussion of how generic information relates to the specific patient, and as per 
the NZGG’s recommendations, allow time for patients and their support people to consider 
the information and ask questions, however this was not assessed by the current study. Where 
any personalised information is provided verbally, this may be easily forgotten by mTBI 




Similarly, few practitioners had information available in languages other than English. 
Just 7.2% of respondents had information available in te reo Māori, New Zealand’s other 
official written language. Two practitioners stated they downloaded other-language resources 
from the ACC website as necessary, however a search of this website revealed that the te reo 
Māori and other language information available related to more severe TBI and more specific 
sequelae rather than symptoms and advice for mTBI. No respondents had information 
available in Braille, and few could supply information in audio format. This lack of different 
formatting places the onus on visually impaired patients to either supply their own technology 
or support person to record information, or to recall it themselves. During a time of injury in 
which both physical and emotional trauma can impair memory and information processing, 
this may not be feasible. This lack of other language and other format information, perhaps 
more than difficult readability and general quality statistics, points to inequities in our 
healthcare system that disadvantage our indigenous and visually impaired populations and 
goes against recommendations from the NZGG. As information regarding the availability of 
other formats and languages was not collected by Moore and Leathem (2004), it cannot be 
determined whether the present results represent change. 
Barriers to Providing Information 
Time constraints during consultations and a lack of appropriate materials were 
identified as significant barriers to providing information in all three service areas. Together, 
this could mean that information is provided in a format not suited to the patient and there is 
little time to help the individual apply this information to his or her own context, thereby 
making the information less useful for the patient. Considering the patient comments made 
regarding the need for timely, reputable and coherent information in Snell and colleagues’ 
(2016) Christchurch based study, such a situation is likely to lead to confusion and distress, 
which has the potential to exacerbate symptoms. Patient concentration difficulties and 
distress were also endorsed as significant barriers by the rehabilitation group and as several 
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researchers (Paniak et al., 1998; Paniak et al., 2000; Ponsford et al., 2002; Matuseviciene et al., 
2013) have shown, these barriers could potentially be reduced with accurate and 
understandable information earlier in the post-injury period.  
Flow of Patient Information Across Services 
The majority of hospital ED respondents provided verbal and written information and 
the sheets provided for analysis suggest that this is accurate and understandable. However, 
this only holds for populations with an adequate understanding of English who are not visually 
impaired. Many ED respondents stated they referred patients to their GP for any ongoing 
symptoms, for assessment relating to driving, work, school and sport, and for further referral 
to concussion services if necessary. The small sample of GPs that responded to the survey 
outlined similar concerning symptoms, treatments, information available and barriers to 
providing this information as the ED group, indicating similar management of acute mTBI and 
similar information provided to patients throughout this period.  
Sixty-eight percent of the responding community medical staff stated they referred 
mTBI patients to concussion services. The high rate of non-response to this survey question 
(27.3%) prevents inference regarding whether some patients who could benefit from this 
service miss out. Rehabilitation respondents tended to provide more in-depth information 
tailored to patients’ symptoms and social needs. The written elements of this information 
however, tended to be less accessible in terms of readability and general quality than that 
provided by acute care practitioners. While the rehabilitation respondents provided a more 
specialised service, they faced similar barriers to providing information and some of the 
information provided may be difficult for patients to comprehend, thus less likely to assist 
recovery.  
Several rehabilitation providers stated they referred patients back to their GP for 
certain issues such as clearance for driving and medication/supplement advice. While this is 
understandable, it highlights the responsibility placed on GPs to provide care at various points 
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of recovery while not necessarily having a clear understanding of a patient’s full range of 
difficulties. It is evident there is a need for clear communication between services as a means 
to prevent the lack of information or contradictory information that Snell and colleagues’ 
(2016) participants found distressing.  
Conclusion 
 Several authors have noted that the timely provision of useful information is beneficial 
for mTBI sufferers and their caregivers. Written and verbal information relating to symptoms 
indicative of medical emergency, common symptoms that need not cause concern, the 
potential for ongoing symptoms, rehabilitation advice, support services, and reassurance that 
a quick and full recovery is likely is recommended for all mTBI patients upon discharge from 
acute care settings. Although ED staff in the present study tended to provide accurate and 
accessible information for the majority of mTBI patients, there are clear gaps in this service for 
non-English speaking and visually impaired populations, as well as areas of improvement for all 
populations across all service areas (Hospital ED, Community Medical, and Rehabilitation).  
The NZGG recommendations for allowing time during consultation to provide and 
explain written information and answer questions about it, providing written information 
regarding ongoing symptoms and supports, and for providing information in various languages 
and formats are frequently overlooked. This may lead to increased anxiety, distress, and 
service use for patients. The barriers to providing information identified by healthcare 
practitioners included consult time constraints, patient distress and difficulty concentrating, 
and a lack of appropriate materials. This suggests information provision difficulties may be due 
to systemic issues such as the fast paced and high pressured nature of both acute care and 
recovery services, and lack of understanding regarding other services available.  
 The present results indicate that while some elements of information provision may 
have improved since Moore and Leathem’s 2004 study, others have not. Driving and other 
return to activity advice remains varied, as does the length of information sheets and the type 
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of information they include (e.g., acute symptom, ongoing symptom, returning to activity 
advice). The same percentage of information sheets adhered to text justification 
recommendations, but fewer adhered to the 12 point font advice, making these sheets less 
accessible for patients with visual impairments. A similar percentage of ED respondents 
provided written information to mTBI patients, and a larger percentage of Community Medical 
respondents did the same (76.8% in the present study, 42.8% in 2004). Almost a quarter 
(23.2%) of respondents in the present study stated they do not have any ACC information 
sheets available for their patients. While considerable variation still exists between patient 
information forms for mTBI sufferers, the ACC brochures may provide a degree of consistency 
in the information available across services and is an easy, readily available method for 
practitioners to provide sound information.  
Recommendations 
 Given the time constraints healthcare practitioners face and the complex nature of 
mTBI, a wider variety of easily accessible information for mTBI patients seems to be required. 
It is recommended that information sheets outlining the acute and ongoing symptoms of mTBI 
and strategies and support for dealing with these are created in various languages and 
formats, and for different populations. Similarly, as per a suggestion in the free-answer section 
of the survey, a repository of information for specific symptoms and their management 
available for practitioners to compile for individual needs may prove useful and minimally time 
consuming for busy health professionals.  
Limitations 
With 125 responses and slightly more than a quarter of these (27.2%) coming from ED 
staff in the Wellington/Kāpiti region, the survey results are based on a small sample and may 
not be generalisable to the wider mTBI care system in New Zealand. However, many of the 
main centres in the North Island were represented by both ED and rehabilitation staff and 
likely can provide valuable insight. It may be that due to a larger sample and more 
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standardised resources within emergency departments, more can be extrapolated from this 
group’s responses than the other two groups. The rehabilitation group was the most diverse in 
relation to professions and organisational settings represented, and this was evident in the 
responses collected, particularly the qualitative information. As such, while it may be difficult 
to determine whether the responses given by this group represent the information provided 
by rehabilitation professionals more generally, it is likely that the nature of the information – 
in-depth, individualised and geared towards post-acute care – is. A very low response rate 
from general practitioners likely prevents generalisation of the data obtained from the 
Community Medical group, particularly as they may have fewer shared patient resources than 
a typical Emergency Department. However, responses from this group and qualitative remarks 
from the other groups provide insight into both the expectations and limitations of this area of 
the medical workforce. Responses to requests for participation in the study suggested that 
reasons for the low response rate include a high volume of requests for research participation, 
general busyness of healthcare professionals, and particularly for the GP practices, the survey 




Chapter Nine: Overall Discussion 
Terminology 
 Studies One and Two both encountered similar terminology confusion to that 
mentioned in prior research. Terms such as minor/mild head injury, concussion, mild traumatic 
brain injury, minor brain injury, post-concussive disorder, and post-concussion syndrome are 
common throughout the literature. However, the NZGG (2006) recommended ‘head injury’ or 
‘head trauma’ to describe the injury to the head, rather than the brain, prior to a diagnosis of 
traumatic brain injury with a specifier for severity if necessary. The NZGG acknowledged that 
the mild severity specifier may not be agreeable for the injured party, but that it is necessary 
for treatment planning and resource allocation. While most Study One practitioners used both 
concussion and mTBI, the ‘mild’ element of mTBI was at times upsetting to participants 
struggling with their symptoms. Participants tended to use the terms ‘concussion’, ‘ head 
injury’ and ‘head knock’ when referring both to their initial injury and the ongoing effects.  
Responses collected for Study Two reflected varied terms such as head injury, minor 
head injury, traumatic brain injury (TBI), and brain injury as well as concussion and mTBI. Only 
the ACC leaflets explained that a head injury involved trauma to the head which could then 
lead to an injury to the brain, as per the NZGG guidelines these information sheets were based 
on. Several of the materials stated “also known as concussion” to explain the use of other 
terminology, which given the name of the ACC ‘Concussion Service’ is likely a useful 
clarification. Variation may also be present in the verbal information provided to patients, as 
indicated by the qualitative information received through the survey, e.g., “…most are mTBI 
without concussion…” and “I don’t refer patients with very minor head injury/TBI…”.  
Receiving information with multiple differing terms is likely to confuse and distress 




“use of terminology and confusion for clients e.g. Dr advises client they have had a 
concussion, Clinical Psychologist then completes a Neuropsych Screen and advises 
based on DSM criteria that ‘mild traumatic injury’ and now resolved – real dilemma for 
clients hearing this when they are still experiencing significant symptoms. Then the Drs 
start talking about ‘post concussion’…”.  
As such, keeping with the terms mTBI and concussion as well as providing clear and 
understandable explanation of injuries, as per the NZGG guidelines, is recommended.  
Diagnostic Difficulties 
 Peripheral injuries, intoxication and psychological trauma can all cause similar 
symptoms, potentially masking or mimicking mTBI and confounding diagnosis. Several Study 
Two survey respondents outlined that they see patients too soon after injury to know whether 
they will experience concussion symptoms for more than a few days, so may not diagnose 
mTBI at that time. As noted in Chapter One, the WHO and ACRM definition of mTBI requires 
that symptoms not be due to intoxication or other injuries (Carroll et al., 2004), so acute care 
providers may have little choice but to refer such a diagnosis to the individual’s GP, which 
many stated they do. Delaying a diagnosis in this manner may be necessary, however it may 
also lead to a delay in the patient receiving useful information about their injury and delays in 
seeking or obtaining treatment. This was a situation that participants in Study One found 
confusing and frustrating, perhaps indicating a need for more effective communication from 
healthcare providers.  
Flow of Information Through Services 
A lack of diagnosis at the acute stage may lead to frustration for other providers when 
patients experience ongoing symptoms, as indicated by the following Study Two survey remark 
“correct diagnosis an issue. GPs do not seem to be able to determine if someone has had a 
concussion or bump to the head”. Many ED professionals advised they referred patients to 
their GP if symptoms persisted, and the majority provided patients with some form of written 
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information relating to mTBI symptoms which usually reiterated this, but the timeframe varied 
from a few days to two weeks making it likely that some patients do re-present too early for 
accurate diagnosis.  
If diagnosis is not confirmed by a subsequent ED or GP visit, this can preclude access to 
ACC concussion services and necessitate further medical appointments that cost a patient time 
and money, likely causing some degree of stress. The operational guidelines for ACC’s 
Concussion Service (ACC, 2019) state that they require the correct referral form or a referral 
letter with medical notes proving that a medical professional has seen the patient and either 
diagnosed concussion/mTBI or recommended a concussion service referral. However, as 
several survey respondents noted being unsure about referral processes and pathways this 
necessity may not be widely understood. It could be that more detailed note-taking or more 
frequent sharing of notes with ACC and/or patients’ GPs could expediate the referral process. 
This may prevent the frustration, stress and confusion experienced by Study One participants 
and the participants in Snell and colleagues’ (2016) qualitative study. 
In addition, more information about the concussion service may be of use to acute 
care providers, as indicated by comments such as “lack of clarity of what concussion services 
are available in our area” and “I would like a better understanding of what is available for 
those with ongoing symptoms”. Not only would this potentially enhance the referral process, 
but allow healthcare providers to advise patients of the support available to them should they 
require it, something frequently missing from acute care information sheets. Given the 
busyness evident in the concussion services from Study One however, it may not be feasible to 
increase the volume of referrals without further straining the system and increasing wait 
times.  
Treatment 
Due to the cancellation of Study One it remains to be seen whether DHA supplements 
can reduce the severity or shorten the duration of ongoing mTBI symptoms. The unsuccessful 
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trial did, however, produce several lessons to inform future work. These mostly related to the 
time and effort required to be part of the study. For recruiting clinicians, the time required to 
determine eligibility, discuss the study, and complete the requisite paperwork added strain to 
their already full session plans and caseloads. In future trials, it may be necessary to reduce the 
pressure on clinicians’ time. For participants, the time and effort required to complete testing, 
take the supplements and record fish consumption, side effects and missed doses proved too 
much. Future researchers will need to decrease barriers and increase motivation for 
participation. This is discussed further in the following section. 
Despite the lack of empirical data, anecdotal reports suggested a number of 
practitioners recommended DHA and other nutritional supplements for mTBI patients. This 
was not, however, frequently seen from the health professionals surveyed. This may be due to 
practitioners genuinely not recommending nutrition based treatments, or due to a non-
representative sample consisting mainly of acute care practitioners from EDs. One dietician 
responding to the survey expressed a wish for ACC to include dietetic care within the 
Concussion Service to allow the consideration of dietary treatment. Because registered 
healthcare professionals are bound by their disciplines’ scopes of practice and evidence-based 
practice guidelines, rates of DHA supplementation are unlikely to increase without further 
evidence of clinical effectiveness.  
Early educational intervention begins at the first point of contact for most mTBI 
sufferers – the ED or their GP. While the information provided by ED services may be more 
consistent than prior New Zealand based research (Moore & Leathem, 2004) has found, it is 
not clear whether information provided by GPs is of equally high quality, and rehabilitation 
services may benefit from adhering more closely to patient literature accessibility and quality 
guidelines. To assess whether supplementary treatment with DHA could form part of the more 
intensive intervention provided by rehabilitation services for ongoing mTBI symptoms, further 
research is required.  
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Recommendations for Future Research 
 Key recommendations for future research were outlined in Chapter Four. These 
include randomised controlled trials of an algae based DHA supplement with adequate time, 
personnel, and financial resources to allow for an appropriately sized sample to be recruited 
and supported. In order to attract the necessary funding for this, it is likely that beginning with 
a small pilot study and working very closely with, or perhaps even working as part of, a 
concussion service would improve processes and outcomes. Working closely with all 
stakeholders from funders to potential participants and beginning with focus groups and other 
qualitative studies, could lead to the collection of data meaningful to all parties, earlier 
identification of barriers to recruitment and retention, and could inform decisions about 
scaling up the study to multiple centres if feasible. To prevent encountering the same 
recruitment issues as Study One however, a pilot study would need to be funded well enough 
to compensate clinicians for their time, or perhaps be run from a DHB where time issues 
seemed less prevalent.   
With regard to the provision of information, the previous chapter suggested a 
repository of resources be created for diverse populations including different languages and 
accessibility requirements, as well as information regarding treatment for certain symptoms 
able to be compiled according to patient needs. If this was done, a survey of healthcare 
practitioners and patients could assess its uptake and provider satisfaction, while trials of new 
information in comparison with the services’ ‘treatment as usual’ information may ascertain its 
effectiveness at preventing the development of ongoing symptoms and/or further service use. 
If DHA was found to be an effective treatment for ongoing symptoms, it would likely be a 
useful inclusion in acute care patient literature due to being considered generally safe and well 




Over the course of conducting the two presented studies I learned a great deal about 
the world of research. With a keen interest in nutrition and a background in professional 
cookery, I began Study One excited to combine my long standing passion for food and 
nutrition with my burgeoning interest in the human brain. With minimal prior research 
experience I was initially somewhat daunted by the scale of the project, but remained 
enthusiastic and optimistic that I could contribute meaningful research to the field of 
neuropsychology. This was fuelled further by the positive reception from several Concussion 
Services approached for participation. Building relationships with the staff in these services 
and sharing the aspirations for the study was a rewarding element of the research process. It 
was this optimism that led me to persevere with Study One when the initial plan was not 
working. It was perhaps also this optimism, coupled with my inexperience, that initially 
clouded my vision from some of the practical realities of research participation for both 
individual and organisational participants.     
Large organisations such as hospitals and some GP practices receive numerous 
requests to participate in research. Due to this, many require time-consuming application 
processes or simply decline if a high volume of requests has been received, and even when 
initially eager to help may not have time to do so. This applied mostly to Study Two, however 
likewise because most Concussion Services are funded entirely by ACC, who restrict the 
number of hours providers may claim payment for, some Study One services likely did not 
have the time to participate. Perhaps I was naïve to not have realised that time is money in our 
private healthcare services, just as it is in other industries. For both studies, the busyness of 
organisations that agreed to participate meant they could not always provide the assistance 
they initially agreed to, regardless of how enthusiastic they were about the research.  
 I learned to allow plenty of time for organisations to consider requests, and to ensure 
that all important information was presented in a concise and easily accessed manner. Polite 
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follow-up of organisations’ progress with requests was also necessary. It quickly became clear 
that follow up calls and emails provided reminders and encouraged feedback from healthcare 
providers about difficulties with recruitment and participation. For some practitioners 
however, reminders appeared to increase stress. It was important to remember that they were 
assisting out of good will rather than being employed for the study, and those in Study One 
were accountable to ACC for their time. I often felt a slight sense of guilt for adding to an 
already high workload with little to offer in return. Using a friendly tone, conveying 
understanding of their situation and attempting to avoid putting pressure on the individual 
practitioner was important for maintaining valuable collegial relationships. I did sometimes 
wonder though, whether this made me – and consequently the study – easier to brush aside.  
 Individual service users from Study One also tended to be very busy, or significantly 
impaired. In both circumstances they had little time and energy to devote to participating in 
research and declined, withdrew, or struggled to adhere to the protocol because of this. In 
addition, some potential participants were uncomfortable with the possibility of being in the 
control group, opting instead to simply purchase fish oil supplements. I learned the importance 
of ensuring involvement in research is as easy as possible for participants – after all, they gain 
little for their considerable efforts while I stand to gain much. A more personal communication 
style was necessary with these participants, as enquiring in-depth about their wellbeing was 
necessary both for the research and for building and maintaining rapport. For each participant 
and each telephone call I had to find a balance between ‘data-collector’ and ‘counsellor’ to 
allow the timely collection of information while ensuring each individual felt cared for. I had a 
great deal of appreciation for these participants and toiled with feeling like I had let them 
down when the study couldn’t continue – I felt that all their efforts had come to nothing, thus I 
had wasted their precious time and energy.  
 The cessation of Study One was a low point in my doctoral journey. Although I thought 
I had expended as much energy and effort as possible within the project’s constraints, I still felt 
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disappointed in myself. I kept asking myself what I had missed, what I should have done 
differently, and wondering how I could come back from such a setback. It was with the support 
of supervisors, classmates and the Concussion Service practitioners that I was able to look 
forward and find another path. I was reminded to treat myself as I would treat a client – with 
empathy, creativity and openness, and without judgement. I am thankful to have been able to 
use participant experiences to guide me in a new direction, which helped to alleviate negative 
feelings around Study One’s cessation. This was a valuable lesson in observation and flexibility, 
as well as self compassion. After ending Study One wondering whether I was capable of high 
level research, I found renewed vigour through Study Two. It was not without challenges, but I 
felt better able to handle these after my Study One experiences.  
 An overarching lesson from this experience was that clinical research is dynamic, and 
so a researcher must be too. As outlined above, I learned how important adjustments and 
accommodations for different organisations, processes, and individuals are to developing 
research relationships. I learned that as with clinical practice, the relationships built 
throughout the research process are essential to both morale and research outcomes. I 
learned that regardless of how well research is pitched and received, how strong relationships 
are, or how well planned processes are, there is no guarantee of research success. Flexibility in 






Abdulle, A., & van der Naalt, J. (2019). The role of mood, post-traumatic stress, post-
concussive symptoms and coping on outcome after MTBI in elderly patients. 
International Review of Psychiatry. https://doi.org/10.1080/09540261.2019.1664421 




Accident Compensation Corporation. (2019). Concussion service operational guidelines. 
Retrieved from https://www.acc.co.nz/assets/contracts/e748c7033b/concussion-og.pdf 
Amen, D. G., Wu, J. C., Taylor, D., & Willeumier, K. (2011). Reversing brain damage in former 
NFL players : Implications for traumatic brain injury and substance abuse rehabilitation. 
Journal of Psychoactive Drugs, 43(1), 1–5. 
https://doi.org/10.1080/02791072.2011.566489 
American Psychiatric Association. (2000). Diagnostic and statistical manual of mental disorders 
(4th ed., text rev.). Washington, DC: American Psychiatric Association. 
American Psychiatric Association. (2013). Diagnostic and statistical manual of mental disorders 
(5th ed.). Washington, DC: American Psychiatric Association. 
Andrieu, S., Guyonnet, S., Coley, N., Cantet, C., Bonnefoy, M., Bordes, S., … Olivier-Abbal, P. 
(2017). Effect of long-term omega 3 polyunsaturated fatty acid supplementation with or 
without multidomain intervention on cognitive function in elderly adults with memory 
complaints (MAPT): a randomised, placebo-controlled trial. The Lancet Neurology, 16(5), 
377–389. https://doi.org/10.1016/S1474-4422(17)30040-6 
Antony, M. M., Bieling, P. J., Cox, B. J., Enns, M. W., & Swinson, R. P. (1998). Psychometric 
properties of the 42-item and 21-item versions of the Depression Anxiety Stress Scales in 




Arterburn, L. M., Hall, E. B., & Oken, H. (2006). Distribution, interconversion, and dose 
response of n− 3 fatty acids in humans. The American Journal of Cinical Nutrition., 
83(6(S)), 1467S-1476S. Retrieved from 
http://ajcn.nutrition.org/content/83/6/S1467.short 
Baker, A., Unsworth, C. A., & Lannin, N. A. (2015). What information is provided in Australian 
emergency departments about fitness-to-drive after mild traumatic brain injury: a 
national survey. Australian Occupational Therapy Journal, 62(1), 50–55. 
https://doi.org/10.1111/1440-1630.12172 
Barceló-Coblijn, G., & Murphy, E. J. (2009). Alpha-linolenic acid and its conversion to longer 
chain n-3 fatty acids: Benefits for human health and a role in maintaining tissue n-3 fatty 
acid levels. Progress in Lipid Research, 48(6), 355–374. 
https://doi.org/10.1016/j.plipres.2009.07.002 
Barker-Collo, S., Jones, K., Theadom, A., Starkey, N., Dowell, A., McPherson, K., … Feigin, V. 
(2015). Neuropsychological outcome and its correlates in the first year after adult mild 
traumatic brain injury: A population-based New Zealand study. Brain Injury, 29(13–14), 
1604–1616. https://doi.org/10.3109/02699052.2015.1075143 
Barkhoudarian, G., Hovda, D. A., & Giza, C. C. (2011). The molecular pathophysiology of 
concussive brain injury. Clinics in Sports Medicine, Vol. 30, pp. 33–48. 
https://doi.org/10.1016/j.csm.2010.09.001 
Barrett, E., McBurney, M., & Ciappio, E. (2014). Ω-3 fatty acid supplementation as a potential 
therapeutic aid for the recovery from mild traumatic brain injury/concussion. Advances in 
Nutrition: An International Review Journal, (5), 268–277. 
https://doi.org/10.3945/an.113.005280.268 
Barry, D., Bates, M. E., & Labouvie, E. (2008). FAS and CFL forms of verbal fluency differ in 




Bartels, C., Wegrzyn, M., Wiedl, A., Ackermann, V., & Ehrenreich, H. (2010). Practice effects in 
healthy adults: A longitudinal study on frequent repetitive cognitive testing. BMC 
Neuroscience, 11(118). https://doi.org/10.1186/1471-2202-11-118 
Bay, E., Sikorskii, A., & Gao, F. (2009). Functional status, chronic stress, and cortisol response 
after mild-to-moderate traumatic brain injury. Biological Research for Nursing, 10(3), 
213–225. https://doi.org/10.1177/1099800408326453 
Begum, G., Yan, H. Q., Li, L., Singh, A., Dixon, C. E., & Sun, D. (2014). Docosahexaenoic acid 
reduces ER stress and abnormal protein accumulation and improves neuronal function 
following traumatic brain injury. The Journal of Neuroscience, 34(10), 3743–3755. 
https://doi.org/10.1523/JNEUROSCI.2872-13.2014 
Benton, D., Donohoe, R. T., Clayton, D. E., & Long, S. J. (2013). Supplementation with DHA and 
the psychological functioning of young adults. The British Journal of Nutrition, 109(1), 
155–161. https://doi.org/10.1017/S0007114512000566 
Bo, Y., Zhang, X., Wang, Y., You, J., Cui, H., Zhu, Y., … Lu, Q. (2017). The n-3 polyunsaturated 
fatty acids supplementation improved the cognitive function in the chinese elderly with 
mild cognitive impairment: a double-blind randomized controlled trial. Nutrients, 9(1), 
54. https://doi.org/10.3390/nu9010054 
Booker, J., Sinha, S., Choudhari, K., Dawson, J., & Singh, R. (2019). Description of the predictors 
of persistent post-concussion symptoms and disability after mild traumatic brain injury: 
the SHEFBIT cohort. British Journal of Neurosurgery, 33(4), 367–375. 
https://doi.org/10.1080/02688697.2019.1598542 
Borg, J., Holm, L., Peloso, P. M., Cassidy, J. D., Carroll, L. J., Von Holst, H., … Yates, D. (2004). 
Non-surgical intervention and cost for mild traumatic brain injury: Results of the WHO 
Collaborating Centre Task Force on mild traumatic brain injury. Journal of Rehabilitation 
Medicine, 36 (Suppl. 43), 76–83. https://doi.org/10.1080/16501960410023840 
148 
 
Borgaro, S. R., Prigatano, G. P., Kwasnica, C., & Rexer, J. L. (2003). Cognitive and affective 
sequelae in complicated and uncomplicated mild traumatic brain injury. Brain Injury, 
17(3), 189–198. https://doi.org/10.1080/0269905021000013183 
Brenna, J. T., & Diau, G-Y. (2007). The influence of dietary docosahexaenoic acid and 
arachidonic acid on central nervous system polyunsaturated fatty acid composition. 
Prostaglandins, Leukotrienes and Essential Fatty Acids, 77(5–6), 247–250. 
https://doi.org/10.1016/j.plefa.2007.10.016 
British Psychological Society, (2020). Division of Neuropsychology Professional Standards Unit 




Broadbent, E., Petrie, K. J., Main, J., & Weinman, J. (2006). The Brief Illness Perception 
Questionnaire. Journal of Psychosomatic Research, 60(6), 631–637. 
https://doi.org/10.1016/j.jpsychores.2005.10.020 
Broadbent, E., Wilkes, C., Koschwanez, H., Weinman, J., Norton, S., & Petrie, K. J. (2015). A 
systematic review and meta-analysis of the Brief Illness Perception Questionnaire. 
Psychology & Health, 30(11), 1361–1385. 
https://doi.org/10.1080/08870446.2015.1070851 
Broshek, D. K., De Marco, A. P., & Freeman, J. R. (2015). A review of post-concussion syndrome 
and psychological factors associated with concussion. Brain Injury, 29(2), 228–237. 
https://doi.org/10.3109/02699052.2014.974674 
Buckland, G., & Agudo, A. (2014). The Mediterranean diet and mortality. In The Mediterranean 
Diet: An Evidence-Based Approach (pp. 47–60). https://doi.org/10.1016/B978-0-12-
407849-9.00005-1 




Carroll, L. J., Cassidy, J. D., Cancelliere, C., Cote, P., Hincapie, C. A., Kristman, V. L., … 
Hartvigsen, J. (2014). Systematic review of the prognosis after mild traumatic brain injury 
in adults: Cognitive, psychiatric, and mortality outcomes: Results of the international 
collaboration on mild traumatic brain injury prognosis. Archives of Physical Medicine and 
Rehabilitation, 95(Suppl. 3). https://doi.org/10.1016/j.apmr.2013.08.300 
Carroll, L. J., Cassidy, J. D., Holm, L., Kraus, J., & Coronado, V. G. (2004). Methodological issues 
and research recommendations for mild traumatic brain injury: The WHO Collaborating 
Centre Task Force on mild Traumatic Brain Injury. Journal of Rehabilitation Medicine, 36 
(Suppl. 43), 113–125. https://doi.org/10.1080/16501960410023877 
Cassidy, J. D., Carroll, L. J., Peloso, P. M., Borg, J., Von Holst, H., Holm, L., … Coronado, V. G. 
(2004). Incidence, risk factors and prevention of mild traumatic brain injury: Results of 
the WHO Collaborating Centre Task Force on mild traumatic brain injury. Journal of 
Rehabilitation Medicine, 36 (Suppl. 43), 28–60. 
https://doi.org/10.1080/16501960410023732 
Chen, C. T., Green, J. T., Orr, S. K., & Bazinet, R. P. (2008). Regulation of brain polyunsaturated 
fatty acid uptake and turnover. Prostaglandins Leukotrienes and Essential Fatty Acids, 
79(3–5), 85–91. https://doi.org/10.1016/j.plefa.2008.09.003 
Chen, C. T., Kitson, A. P., Hopperton, K. E., Domenichiello, A. F., Trépanier, M-O., Lin, L. E., … 
Bazinet, R. P. (2015). Plasma non-esterified docosahexaenoic acid is the major pool 
supplying the brain. Scientific Reports, 5(15791), 1–12. 
https://doi.org/10.1038/srep15791 
Chen, J-K., Johnston, K. M., Petrides, M., & Ptito, A. (2008). Neural substrates of symptoms of 
depression following concussion in male athletes with persisting postconcussion 




Cifu, D. X., Wares, J. R., Hoke, K. W., Wetzel, P. A., Gitchel, G., & Carne, W. (2015). Differential 
eye movements in mild traumatic brain injury versus normal controls. The Journal of 
Head Trauma Rehabilitation, 30(1), 21–28. 
https://doi.org/10.1097/HTR.0000000000000036 
Cohen, J. (1988). Statistical Power Analysis for the Behavioral Sciences (2nd ed.). Hillsdale, NJ: 
Lawrence Erlbaum Associates 
Connolly, E. J., & McCormick, B. F. (2019). Mild traumatic brain injury and psychopathology in 
adolescence: evidence from the project on human development in chicago 
neighborhoods. Journal of Adolescent Health, 65(1), 79–85. 
https://doi.org/10.1016/j.jadohealth.2018.12.023 
Crawford, S., Wenden, F. J., & Wade, D. T. (1996). The Rivermead head injury follow up 
questionnaire: a study of a new rating scale and other measures to evaluate outcome 
after head injury. Journal of Neurology, Neurosurgery, and Psychiatry, 60(5), 510–514. 
https://doi.org/10.1136/jnnp.60.5.510 
Cunnane, S. C. (2005). Origins and evolution of the Western diet: implications of iodine and 
seafood intake for the human brain. American Journal of Clinical Nutrition, 82(2), 483 
Cunnane, S. C., Plourde, M., Stewart, K., & Crawford, M. A. (2007). Adaptive dimensions of 
health research among indigenous Siberians. American Journal of Human Biology : The 
Official Journal of the Human Biology Council, 19, 578–581. https://doi.org/10.1002/ajhb 
Dahm, J., Wong, D., & Ponsford, J. (2013). Validity of the depression anxiety stress scales in 
assessing depression and anxiety following traumatic brain injury. Journal of Affective 
Disorders, 151(1), 392–396. https://doi.org/10.1016/j.jad.2013.06.011 
Dangour, A. D., Allen, E., Elbourne, D., Fasey, N., Fletcher, A. E., Hardy, P., … Uauy, R. (2010). 
Effect of 2-y n-3 long-chain polyunsaturated fatty acid supplementation on cognitive 
function in older people: a randomized, double-blind, controlled trial. The American 




Danthiir, V., Hosking, D., Burns, N., Wilson, C., Nettelbeck, T., Calvaresi, E., … Wittert, G. (2014). 
Cognitive performance in older adults is inversely associated with fish consumption but 
not erythrocyte membrane n-3 fatty acids. The Journal of Nutrition, 144(3), 311–320. 
https://doi.org/10.3945/jn.113.175695 
Del Brutto, O. H., Mera, R. M., Gillman, J., Zambrano, M., & Ha, J. (2016). Oily fish intake and 
cognitive performance in communitydwelling older adults: the Atahualpa project. Journal 
of Community Health, 41, 82–86. 
Delis, D. C., Kaplan, E., & Kramer, J. H. (2001). Delis-Kaplan Executive Function System (D-KEFS) 
Technical Manual. San Antonio, TX: The Psychological Corporation 
Dikmen, S., Machamer, J., Temkin, N., & McLean, A. (1990). Neuropsychological recovery in 
patients with moderate to severe head injury: 2 year follow-up. Journal of Clinical and 
Experimental Neuropsychology, 12(4), 507-519. 
https://doi.org/10.1080/01688639008400997 
Diwakar, M., Harrington, D. L., Maruta, J., Ghajar, J., El-Gabalawy, F., Muzzatti, L., … Lee, R. R. 
(2015). Filling in the gaps: Anticipatory control of eye movements in chronic mild 
traumatic brain injury. NeuroImage. Clinical, 8, 210–223. 
https://doi.org/10.1016/j.nicl.2015.04.011 
Donovan, J., Cancelliere, C., & Cassidy, J. D. (2014). Summary of the findings of the 
International Collaboration on Mild Traumatic Brain Injury Prognosis. Chiropractic & 
Manual Therapies, 22(38), 1-14. https://doi.org/10.1186/s12998-014-0038-3 
Dyall, S. C. (2015). Long-chain omega-3 fatty acids and the brain: A review of the independent 
and shared effects of EPA, DPA and DHA. Frontiers in Aging Neuroscience, 7(52), 1–15. 
https://doi.org/10.3389/fnagi.2015.00052 
Estruch, R., Ros, E., Salas-Salvadó, J., Covas, M-I., Corella, D., Arós, F., … Martínez-González, M. 
A. (2013). Primary prevention of cardiovascular disease with a mediterranean diet. New 
152 
 
England Journal of Medicine, 368(14), 1279–1290. 
https://doi.org/10.1056/NEJMoa1200303 
Eyres, S., Carey, A., Gilworth, G., Neumann, V., & Tennant, A. (2005). Construct validity and 
reliability of the Rivermead Post-Concussion Symptoms Questionnaire. Clinical 
Rehabilitation, 19(8), 878–887. https://doi.org/10.1191/0269215505cr905oa 
Faul, F., Erdfelder, E., Lang, A-G., & Buchner, A. (2007). G*Power 3: A flexible statistical power 
analysis program for the social, behavioral, and biomedical sciences. Behaviour Research 
Methods, 39(2), 175-191. https://doi.org/10.3758/bf03193146 
Féart, C., Torrès, M. J. M., Samieri, C., Jutand, M-A., Peuchant, E., Simopoulos, A. P., & 
Barberger-Gateau, P. (2011). Adherence to a Mediterranean diet and plasma fatty acids: 
data from the Bordeaux sample of the Three-City study. The British Journal of Nutrition, 
106(1), 149–158. https://doi.org/10.1017/S0007114510005805 
Feigin, V. L., Theadom, A., Barker-Collo, S., Starkey, N. J., McPherson, K., Kahan, M., … 
Ameratunga, S. (2013). Incidence of traumatic brain injury in New Zealand: A population-
based study. The Lancet Neurology, 12(1), 53–64. https://doi.org/10.1016/S1474-
4422(12)70262-4 
Food Act, No 32. (2014). Retrieved from 
http://www.legislation.govt.nz/act/public/2014/0032/latest/DLM2996073.html 
Gagner, C., Dégeilh, F., Bernier, A., & Beauchamp, M. H. (2019). Persistent changes in child 
behavior after early mild traumatic brain injury. Journal of Pediatric Psychology, 45(1), 
50-60. https://doi.org/10.1093/jpepsy/jsz071 
Gagnon, I., Swaine, B., Champagne, F., & Lefebvre, H. (2008). Perspectives of adolescents and 
their parents regarding service needs following a mild traumatic brain injury. Brain Injury, 
22(2), 161–173. https://doi.org/10.1080/02699050701867381 
Galbete, C., Toledo, E., Toledo, J. B., Bes-Rastrollo, M., Buil-Cosiales, P., Marti, A., … Martínez-
González, M. A. (2015). Mediterranean diet and cognitive function: The sun project. 
153 
 
Journal of Nutrition, Health and Aging, 19(3), 305–312. https://doi.org/10.1007/s12603-
015-0441-z 
Giza, C. C., & Hovda, D. A. (2001). The neurometabolic cascade of concussion. Journal of 
Athletic Training, 36(3), 228–235. Retrieved from www.journalofathletictraining.org 
Giza, C. C., & Hovda, D. A. (2014). The new neurometabolic cascade of concussion. 
Neurosurgery, 75(4), S24–S33. https://doi.org/10.1227/NEU.0000000000000505 
Guilmette, T. J., & Rasile, D. (1995) Sensitivity, specificity, and diagnostic accuracy of three 
verbal memory measures in the assessment of mild brain injury. Neuropsychology, 9(3), 
338-344. http://dx.doi.org/10.1037/0894-4105.9.3.338 
Harvey, L. D., Yin, Y., Attarwala, I. Y., Begum, G., Deng, J., Yan, H. Q., … Sun, D. (2015). 
Administration of DHA Reduces Endoplasmic Reticulum Stress-Associated Inflammation 
and Alters Microglial or Macrophage Activation in Traumatic Brain Injury. American 
Society for Neurochemistry, 7(6), 1–15. https://doi.org/10.1177/1759091415618969 
Heitger, M. H., Jones, R. D., MacLeod, A. D., Snell, D. L., Frampton, C. M., & Anderson, T. J. 
(2009). Impaired eye movements in post-concussion syndrome indicate suboptimal brain 
function beyond the influence of depression, malingering or intellectual ability. Brain, 
132(10), 2850–2870. https://doi.org/10.1093/brain/awp181 
Hibbeln, J. R., Blasbalg, T. L., & Riggs, J. A. (2006). Healthy intakes of n Ϫ 3 and n Ϫ 6 fatty 
acids : estimations considering worldwide diversity. American Journal of Clinical Nutrition, 
6(83), 1483-1493. https://doi.org/10.1016/j.plipres.2007.12.004 
Hou, R., Moss-Morris, R., Peveler, R., Mogg, K., Bradley, B. P., & Belli, A. (2012). When a minor 
head injury results in enduring symptoms: A prospective investigation of risk factors for 
postconcussional syndrome after mild traumatic brain injury. J Neurol Neurosurg 
Psychiatry, 83, 217–223. https://doi.org/10.1136/jnnp-2011-300767 




Iverson, G. L., Lange, R. T., Brooks, B. L., & Ashton Rennison, L. V. (2010). “ Good old days ” bias 
following mild traumatic brain injury. The Clinical Neuropsychologist, 24(1), 17–37. 
https://doi.org/10.1080/13854040903190797 
Jacka, F. N., Pasco, J. A., Williams, L. J., Meyer, B. J., Digger, R., & Berk, M. (2012). Dietary 
intake of fish and PUFA, and clinical depressive and anxiety disorders in women. British 
Journal of Nutrition, 109(11), 1–8. https://doi.org/10.1017/S0007114512004102 
Jackson, P. A., Deary, M. E., Reay, J. L., Scholey, A. B., & Kennedy, D. O. (2012). No effect of 12 
weeks’ supplementation with 1 g DHA-rich or EPA-rich fish oil on cognitive function or 
mood in healthy young adults aged 18-35 years. The British Journal of Nutrition, 107(8), 
1232–1243. https://doi.org/10.1017/S000711451100403X 
Jackson, P. A., Forster, J. S., Gordon Bell, J., Dick, J. R., Younger, I., & Kennedy, D. O. (2016). 
DHA supplementation alone or in combination with other nutrients does not modulate 
cerebral hemodynamics or cognitive function in healthy older adults. Nutrients, 8(2). 
https://doi.org/10.3390/nu8020086 
Jagoda, A. A. S., Bazarian, J. J., Bruns, J. J., Cantrill, S. V, Gean, A. D., Howard, P. K., … Whitson, 
R. R. (2009). Clinical policy: Neuroimaging and decisionmaking in adult mild traumatic 
brain injury in the acute setting. Journal of Emergency Nursing, 35, 5–40. 
https://doi.org/10.1016/j.jen.2008.12.010 
Jindal, P., & Macdermid, J. C. (2017). Assessing reading levels of health information: Uses and 
limitations of flesch formula. Education for Health: Change in Learning and Practice, 
30(1), 84–88. https://doi.org/10.4103/1357-6283.210517 
Karr, J. E., Areshenkoff, C. N., & Garcia-Barrera, M. A. (2014). The neuropsychological 
outcomes of concussion: a systematic review of meta-analyses on the cognitive sequelae 
of mild traumatic brain injury. Neuropsychology, 28(3), 321–336. 
https://doi.org/10.1037/neu0000037 
Karr, J. E., Grindstaff, T. R., & Alexander, J. E. (2012). Omega-3 polyunsaturated fatty acids and 
155 
 
cognition in a college-aged population. Experimental and Clinical Psychopharmacology, 
20(3), 236–242. https://doi.org/10.1037/a0026945 
Katan, M., Deslypere, J., van Birgelen, A., Penders, M., & Zegwaard, M. (1997). Kinetics of the 
incorporation of dietary fatty acids into serum cholesteryl esters, erythrocyte 
membranes, and adipose tissue: an 18- month controlled study. J. Lipid Res., 38(10), 
2012–2022. Retrieved from http://www.jlr.org/content/38/10/2012.short 
Kay, T., Newman, B., Cavallo, M., Ezrachi, O., & Resnick, M. (1992). Toward a 
neuropsychological model of functional disability after mild traumatic brain injury. 
Neuropsychology, 6(4), 371–384. https://doi.org/10.1037/0894-4105.6.4.371 
Kempe, C. B., Sullivan, K. A., & Edmed, S. L. (2014). A critical evaluation of written discharge 
advice for people with mild traumatic brain injury: What should we be looking for? Brain 
Injury, 28(12), 1551–1558. https://doi.org/10.3109/02699052.2014.937360 
Kesse-Guyot, E., Péneau, S., Ferry, M., Jeandel, C., Hercberg, S., & Galan, P. (2011). Thirteen-
year prospective study between fish consumption, long-chain n-3 fatty acids intakes and 
cognitive function. The Journal of Nutrition, Health & Aging, 15(2), 115–120. 
https://doi.org/10.1007/s12603-010-0318-0 
Killgore, W. D. S., Singh, P., Kipman, M., Pisner, D., Fridman, A., & Weber, M. (2016). Gray 
matter volume and executive functioning correlate with time since injury following mild 
traumatic brain injury. Neuroscience Letters, 612, 238–244. 
https://doi.org/10.1016/j.neulet.2015.12.033 
Kim, J. L., Winkvist, A., Åberg, M. A. I., Åberg, N., Sundberg, R., Torén, K., & Brisman, J. (2010). 
Fish consumption and school grades in Swedish adolescents: A study of the large general 
population. Acta Paediatrica, International Journal of Paediatrics, 99(1), 72–77. 
https://doi.org/10.1111/j.1651-2227.2009.01545.x 
Kim, E., Seo, H.G., Lee, H.H., Lee, S.H., Choi, S.H., Cho, R-E., … Oh, B-M. (2019). Altered white 
matter integrity after mild to moderate traumatic brain injury. Journal of Clinical 
156 
 
Medicine, 8(9), 1318. https://doi.org/10.3390/jcm8091318 
King, N. S., Crawford, S., Wenden, F. J., Moss, N. E. G., & Wade, D. T. (1995). The Rivermead 
Post Concussion Symptoms Questionnaire: a measure of symptoms commonly 
experienced after head injury and its reliability. Journal of Neurology, 242(9), 587–592. 
https://doi.org/10.1007/BF00868811 
Kotani, S., Sakaguchi, E., Warashina, S., Matsukawa, N., Ishikura, Y., Kiso, Y., … Yamashima, T. 
(2006). Dietary supplementation of arachidonic and docosahexaenoic acids improves 
cognitive dysfunction. Neuroscience Research, 56(2), 159–164. 
https://doi.org/10.1016/j.neures.2006.06.010 
Kuratko, C. N., & Salem, N. (2009). Biomarkers of DHA status. Prostaglandins Leukotrienes and 
Essential Fatty Acids, 81(2–3), 111–118. https://doi.org/10.1016/j.plefa.2009.05.007 
Kyriacou, K., Parkington, J. E., Marais, A. D., & Braun, D. R. (2014). Nutrition, modernity and the 
archaeological record: Coastal resources and nutrition among Middle Stone Age hunter-
gatherers on the Western Cape coast of South Africa. Journal of Human Evolution, 77, 
64–73. https://doi.org/10.1016/j.jhevol.2014.02.024 
Lafrenaye, A. D., Todani, M., Walker, S. A., & Povlishock, J. T. (2015). Microglia processes 
associate with diffusely injured axons following mild traumatic brain injury in the micro 
pig. Journal of Neuroinflammation, 12(1), 186. https://doi.org/10.1186/s12974-015-0405-
6 
Landre, N., Poppe, C. J., Davis, N., Schmaus, B., & Hobbs, S. E. (2006). Cognitive functioning and 
postconcussive symptoms in trauma patients with and without mild TBI. Archives of 
Clinical Neuropsychology, 21(4), 255–273. https://doi.org/10.1016/j.acn.2005.12.007 
Lange, R. T., Iverson, G. L., & Rose, A. (2010). Post-concussion symptom reporting and the 
“good-old-days” bias following mild traumatic brain injury. Archives of Clinical 
Neuropsychology, 25(5), 442–450. https://doi.org/10.1093/arclin/acq031 
Lauritzen, L., Brambilla, P., Mazzocchi, A., Harslof, L. B. S., Ciappolino, V., & Agostoni, C. (2016). 
157 
 
DHA effects in brain development and function. Nutrients, 8(1), 1–17. 
https://doi.org/10.3390/nu8010006 
Lee, E., Jayasinghe, N., Swenson, C., & Dams-O’Connor, K. (2019). Dispositional optimism and 
cognitive functioning following traumatic brain injury. Brain Injury, 33(8), 985–990. 
https://doi.org/10.1080/02699052.2019.1606448 
Lee, L. K., Shahar, S., Chin, A.-V., & Yusoff, N. A. M. (2012). Docosahexaenoic acid-concentrated 
fish oil supplementation in subjects with mild cognitive impairment (MCI): a 12-month 
randomised, double-blind, placebo-controlled trial. Psychopharmacology, 225(3), 605–
612. https://doi.org/10.1007/s00213-012-2848-0 
Levin, H. S., & Diaz-Arrastia, R. R. (2015). Diagnosis, prognosis, and clinical management of mild 
traumatic brain injury. Lancet Neurology, 14(14), 506–517. 
https://doi.org/10.1016/S1474-4422(15)00002-2 
Lewis, M. D. (2016). Concussions, traumatic brain injury, and the innovative use of omega-3s. 
Journal of the American College of Nutrition, 35(5), 469–475. 
https://doi.org/10.1080/07315724.2016.1150796 
Lourida, I., Soni, M., Thompson-Coon, J., Purandare, N., Lang, I. A., Ukoumunne, O. C., & 
Llewellyn, D. J. (2013). Mediterranean diet, cognitive function, and dementia. A 
systematic review. Epidemiology, 24(4), 479–489. 
https://doi.org/10.1097/EDE.0b013e3182944410 
Lovibond, S.H. & Lovibond, P.F. (1995).  Manual for the Depression Anxiety Stress Scales. (2nd 
ed.). Sydney: Psychology Foundation. 
Lunn, J., & Theobald, H. E. (2006). The health effects of dietary unsaturated fatty acids. 
Nutrition Bulletin, 31(3), 178–224. https://doi.org/10.1111/j.1467-3010.2006.00571.x 
Macdonald, S., McMillan, T. M., & Kerr, J. (2010). Readability of information leaflets given to 




MacFarlane, M. P., & Glenn, T. C. (2015). Neurochemical cascade of concussion. Brain Injury, 
29(2), 139–153. https://doi.org/10.3109/02699052.2014.965208 
Macleod, A. D. (2010). Post concussion syndrome: The attraction of the psychological by the 
organic. Medical Hypotheses, 74(6), 1033–1035. 
https://doi.org/10.1016/j.mehy.2010.01.002 
Marshall, S., Bayley, M., McCullagh, S., Velikonja, D., Berrigan, L., Ouchterlony, D., & Weegar, 
K. (2015). Updated clinical practice guidelines for concussion/mild traumatic brain injury 
and persistent symptoms. Brain Injury, 29(6), 688–700. 
https://doi.org/10.3109/02699052.2015.1004755 
Martínez-González, M. A., Zazpe, I., Razquin, C., Sanchez-Tainta, A., Corella, D., Salas-Salvado, 
J., … Estruch, R. (2015). Empirically-derived food patterns and the risk of total mortality 
and cardiovascular events in the PREDIMED study. Clinical Nutrition, 34(5), 859–867. 
Mathias, J. L., Beall, J. A., & Bigler, E. D. (2004). Neuropsychological and information processing 
deficits following mild traumatic brain injury. J Int Neuropsychol Soc, 10(2), 286–297. 
https://doi.org/10.1017/S1355617704102117 
McCann, J. C., & Ames, B. N. (2005). Is docosahexaenoic acid, an n-3 long-chain 
polyunsaturated fatty acid, required for development of normal brain function? An 
overview of evidence from cognitive and behavioral tests in humans and animals. 
Am.J.Clin.Nutr., 82(2), 281–295. 
McCauley, S. R., Boake, C., Pedroza, C., Brown, S. A, Levin, H. S., Goodman, H. S., & Merritt, S. 
G. (2008). Correlates of persistent postconcussional disorder: DSM-IV criteria versus ICD-
10. Journal of Clinical and Experimental Neuropsychology, 30(3), 360–379. 
https://doi.org/10.1080/13803390701416635 
Meares, S., Shores, E. A., Taylor, A. J., Batchelor, J., Bryant, R. A, Baguley, I. J., … Marosszeky, J. 
E. (2011). The prospective course of postconcussion syndrome: the role of mild traumatic 
brain injury. Neuropsychology, 25(4), 454–465. https://doi.org/10.1037/a0022580 
159 
 
Medical Council of New Zealand. (2019). The New Zealand medical workforce in 2018. 
Retrieved from: https://www.mcnz.org.nz/assets/Publications/Workforce-
Survey/434ee633ba/Workforce-Survey-Report-2018.pdf 
Mengelberg, A., Leathem, J., & Podd, J. (2018). Fish oil supplement use in New Zealand: A 
cross-sectional survey. Complementary Therapies in Clinical Practice, 33(April), 118–123. 
https://doi.org/10.1016/j.ctcp.2018.09.005 
Meyer, B. J., Grenyer, B. F. S., Crowe, T., Owen, A. J., Grigonis-Deane, E. M., & Howe, P. R. C. 
(2013). Improvement of major depression is associated with increased erythrocyte DHA. 
Lipids, 48(9), 863–868. https://doi.org/10.1007/s11745-013-3801-7 
Mickeviciene, D., Schrader, H., Nestvold, K., Surkiene, D., Kunickas, R., Stovner, L. J., & Sand, T. 
(2002). A controlled historical cohort study on the post-concussion syndrome. European 
Journal of Neurology, 9(6), 581–587. 
Millen, A. E., Dodd, K. W., & Subar, A. F. (2004). Use of vitamin, mineral, nonvitamin, and 
nonmineral supplements in the United States: The 1987, 1992, and 2000 National Health 
Interview Survey results. Journal of the American Dietetic Association, 104(6), 942–950. 
https://doi.org/10.1016/j.jada.2004.03.022 
Ministry of Health. (2011). A Focus on Nutrition: Key findings of the 2008/09 New Zealand 
Adult Nutrition Survey. Wellington: Ministry of Health. 
Mitrou, P. N., Kipnis, V., M Thiébaut, A. C., Reedy, J., Subar, A. F., Wirfä lt, E., … Schatzkin, A. 
(2007). Mediterranean dietary pattern and prediction of all-cause mortality in a US 
population results from the NIH-AARP diet and health study. Archives of Internal 
Medicine, 167(22), 2461–2468. 
Moore, C., & Leathem, J. (2004). Information provision after mild traumatic brain injury 
(MTBI): a survey of general practitioners and hospitals in New Zealand. New Zealand 
Medical Journal, 117(1201). 
Morris, J., Swier-Vosnos, A., Woodworth, C., Umfleet, L. G., Czipri, S., & Kopald, B. (2014). 
160 
 
Development of alternate paragraphs for the logical memory subtest of the Wechsler 
Memory Scale-IV. Applied Neuropsychology: Adult, 21(2), 143–147. 
https://doi.org/10.1080/09084282.2013.780172 
Morris, K. C. (2001). Psychological distress in carers of head injured individuals: The provision 
of written information. Brain Injury, 15(3), 239–254. 
https://doi.org/10.1080/02699050010004068 
Mounce, L. T. A., Williams, W. H., Jones, J. M., Harris, A., Haslam, S. A., & Jetten, J. (2012). 
Neurogenic and psychogenic acute postconcussion symptoms can be identified after mild 
traumatic brain injury. Journal of Head Trauma Rehabilitation, 28(5), 397-405. 
https://doi.org/10.1097/HTR.0b013e318252dd75 
Mueller, C. P., Reichel, M., Muehle, C., Rhein, C., Gulbins, E., & Komhuber, J. (2015). Brain 
membrane lipids in major depression and anxiety disorders. Biochimica Et Biophysica 
Acta, 1851(8), 1052–1065. https://doi.org/10.1016/j.bbalip.2014.12.014 
Muldoon, M. F., Ryan, C. M., Sheu, L., Yao, J. K., Conklin, S. M., & Manuck, S. B. (2010). Serum 
phospholipid docosahexaenonic acid is associated with cognitive functioning during 
middle adulthood. Journal of Nutrition, 140(4), 848–853. 
https://doi.org/10.3945/jn.109.119578 
National Health and Medical Research Council. (2006). Nutrient reference values for Australia 
and New Zealand including recommended dietary intakes. Retrieved from: 
hmrc.gov.au/about-us/publications/nutrient-reference-values-australia-and-new-
zealand-including-recommended-dietary-intakes 
National Institute for Health and Care Excellence. (2014). Head injury (NICE clinical guideline 
no. 176). Retrieved from: https://www.nice.org.uk/guidance/CG176 





Oldenburg, C., Lundin, A., Edman, G., Nygren-De Boussard, C., & Bartfai, A. (2016). Cognitive 
reserve and persistent post-concussion symptoms—A prospective mild traumatic brain 
injury (mTBI) cohort study. Brain Injury, 30(2), 146–155. 
https://doi.org/10.3109/02699052.2015.1089598 
Otaegui-Arrazola, A., Amiano, P., Elbusto, A., Urdaneta, E., & Martinez-Lage, P. (2014). Diet, 
cognition, and Alzheimer’s disease: Food for thought. European Journal of Nutrition, 
53(1), 1–23. https://doi.org/10.1007/s00394-013-0561-3 
Paniak, C., & Toller-Lobe, G., Reynolds, S., Melnyk, A., & Nagy, J. (2000). A randomized trial of 
two treatments for mild traumatic brain injury: 1 year follow-up. Brain Injury, 14(3), 219–
226. https://doi.org/10.1080/026990500120691 
Paniak, C., Toller-Lobe, G., Durand, A., & Nagy, J. (1998). A randomized trial of two treatments 
for mild traumatic brain injury. Brain Injury, 12(12), 1011–1023. 
https://doi.org/10.1080/026990598121927 
Pase, M. P., Grima, N., Cockerell, R., Stough, C., Scholey, A., Sali, A., & Pipingas, A. (2015). The 
effects of long-chain omega-3 fish oils and multivitamins on cognitive and cardiovascular 
function: A randomized, controlled clinical trial. Journal of the American College of 
Nutrition, 34(October), 21–31. 
https://doi.org/http://dx.doi.org/10.1080/07315724.2014.880660 
Peachey, T., Hawley, C. A., Cooke, M., Mason, L., & Morris, R. (2011). Minor head injury in the 
republic of ireland: Evaluation of written information given at discharge from emergency 
departments. Emergency Medicine Journal, 28(8), 707–708. 
https://doi.org/10.1136/emj.2010.093872 
Ponsford, J, Willmott, C., Rothwell, A., Cameron, P., Kelly, A-M., Nelms, R., & Curran, C. (2002). 
Impact of early intervention on outcome following mild head injury in adults. Journal of 
Neurology Neurosurgery and Psychiatry, 73(3), 330–332. 
Ponsford, Jennie, Willmott, C., Rothwell, A., Cameron, P., Ayton, G., Nelms, R., … Ng, K. (2001). 
162 
 
Impact of early intervention on outcome after mild traumatic brain injury in children. 
Pediatrics, 108(6), 1297–1303. https://doi.org/10.1542/peds.108.6.1297 
Prinelli, F., Yannakoulia, M., Anastasiou, C. A., Adorni, F., Di Santo, S. G., Musicco, M., … Correa 
Leite, M. L. (2015). Mediterranean diet and other lifestyle factors in relation to 20-year 
all-cause mortality: a cohort study in an Italian population. British Journal of Nutrition, 
113, 1003–1011. https://doi.org/10.1017/S0007114515000318 
Raskin, S. A., & Rearick, E. (1996). Verbal fluency in individuals with mild traumatic brain injury. 
Neuropsychology, 10(3), 416–422. https://doi.org/http://dx.doi.org/10.1037/0894-
4105.10.3.416 
Rathbone, A. T. L., Tharmaradinam, S., Jiang, S., Rathbone, M. P., & Kumbhare, D. A. (2015). A 
review of the neuro- and systemic inflammatory responses in post concussion symptoms: 
Introduction of the “post-inflammatory brain syndrome” PIBS. Brain, Behavior, and 
Immunity, 46, 1–16. https://doi.org/10.1016/j.bbi.2015.02.009 
Reedy, J., Krebs-smith, S. M., Miller, P. E., Liese, A. D., Kahle, L. L., Park, Y., & Subar, A. F. 
(2014). Higher diet quality is associated with decreased risk of all-cause, cardiovascular 
disease, and cancer mortality among older adults. The Journal of Nutrition, 881–889. 
https://doi.org/10.3945/jn.113.189407.881 
Reuben, A., Sampson, P., Harris, A. R., Williams, H., & Yates, P. (2014). Postconcussion 
syndrome (PCS) in the emergency department: predicting and pre-empting persistent 
symptoms following a mild traumatic brain injury. Emergency Medicine Journal, 31(1), 
72–77. https://doi.org/10.1136/emermed-2012-201667 
Ritchie, M. R. (2007). Use of herbal supplements and nutritional supplements in the UK: what 
do we know about their pattern of usage? The Proceedings of the Nutrition Society, 66(4), 
479–482. https://doi.org/10.1017/S0029665107005794 
Røe, C., Sveen, U., Alvsåker, K., & Bautz-Holter, E. (2009). Post-concussion symptoms after mild 
traumatic brain injury: Influence of demographic factors and injury severity in a 1-year 
163 
 
cohort study. Disability & Rehabilitation, 31(15), 1235–1243. 
https://doi.org/10.1080/09638280802532720 
Round Table on Information Access for People with Print Disabilities. (2011). Guidelines for 
producing clear print. Retrieved from: http://printdisability.org/wp-
content/uploads/2013/09/round_table_-clear_print_guidelines-PDF.pdf 
Roy, D., Peters, M. E., Everett, A., Leoutsakos, J. M., Yan, H., Rao, V., … Korley, F. (2019). Loss of 
consciousness and altered mental state predicting depressive and post-concussive 
symptoms after mild traumatic brain injury. Brain Injury, 33(8), 1064–1069. 
https://doi.org/10.1080/02699052.2019.1606447 
Salmond, C., Crampton, P., & Atkinson, J. (2007). NZDep2006 Index of Deprivation user’s 
manual. In Department of Public Health. Retrieved from 
http://www.otago.ac.nz/wellington/otago020337.pdf 
Sarri, K. O., Linardakis, M., Tzanakis, N., & Kafatos, A. G. (2008). Adipose DHA inversely 
associated with depression as measured by the Beck Depression Inventory. 
Prostaglandins Leukotrienes and Essential Fatty Acids, 78(2), 117–122. 
https://doi.org/10.1016/j.plefa.2007.12.004 
Satz, P., Benson, D. F., Crinella, F., D ’elia, L., Earnest, K., Evans, G., … Jolyn, L. (1993). Brain 
reserve capacity on symptom onset after brain injury: a formulation and review of 
evidence for threshold theory. Neuropsychology, 7(3), 273–295. 
https://doi.org/10.1037/0894-4105.7.3.273 
Schnabel, R. (2012). Overcoming the challenge of re-assessing logical memory. The Clinical 
Neuropsychologist, 26(1), 102–115. https://doi.org/10.1080/13854046.2011.640642 
Schulz, K. F., Altman, D. G., & Moher, D. (2011). CONSORT 2010 Statement: updated guidelines 
for reporting parallel group randomised trials. International Journal of Surgery, 9, 672–
677. https://doi.org/10.1016/S0140-6736(10)60456-4 
Scottish Intercollegiate Guidelines Network. (2009). Early management of patients with a head 
164 
 
injury (SIGN Guideline no. 110). Retrieved from: https://www.sign.ac.uk/sign-110-early-
management-of-patients-with-a-head-injury 
Sears, B., Bailes, J., & Asselin, B. (2013). Therapeutic uses of high-dose omega-3 fatty acids to 
treat comatose patients with severe brain injury. PharmaNutrition, 1, 86–89. 
https://doi.org/10.1016/j.phanu.2013.04.002 
Serra-Majem, L., & Medina, F. X. (2015). Chapter 4 – The Mediterranean Diet as an Intangible 
and Sustainable Food Culture. In V. R. Preedy & R. R. Watson (Eds.), The Mediterranean 
Diet (pp. 37–46). Academic Press. https://doi.org/10.1016/B978-0-12-407849-9.00004-X 
Shanmukhi, S., & Panigrahi, M. (2003). Serial pattern learning after mild head injury. Neurology 





Singh, K., Trivedi, R., Devi, M. M., Tripathi, R. P., & Khushu, S. (2016). Longitudinal changes in 
the DTI measures, anti-GFAP expression and levels of serum inflammatory cytokines 
following mild traumatic brain injury. Experimental Neurology, 275, 427–435. 
https://doi.org/10.1016/j.expneurol.2015.07.016 
Sinn, N., Milte, C. M., Street, S. J., Buckley, J. D., Coates, A. M., Petkov, J., & Howe, P. R. C. 
(2012). Effects of n-3 fatty acids, EPA v. DHA, on depressive symptoms, quality of life, 
memory and executive function in older adults with mild cognitive impairment: a 6-
month randomised controlled trial. The British Journal of Nutrition, 107(11), 1682–1693. 
https://doi.org/10.1017/S0007114511004788 
Snell, D. L., Hay-Smith, E. J. C., Surgenor, L. J., & Siegert, R. J. (2013). Examination of outcome 
after mild traumatic brain injury: the contribution of injury beliefs and Leventhal’s 




Snell, D. L., Martin, R., Surgenor, L. J., Siegert, R. J., & Hay-Smith, E. J. C. (2016). What’s wrong 
with me? seeking a coherent understanding of recovery after mild traumatic brain injury. 
Disability and Rehabilitation, 39(19), 1–8. 
https://doi.org/10.1080/09638288.2016.1213895 
Sofi, F., Macchi, C., Abbate, R., Gensini, G. F., & Casini, A. (2013). Mediterranean diet and 
health status: an updated meta-analysis and a proposal for a literature-based adherence 
score. Public Health Nutrition, 17(12), 2769–2782. 
https://doi.org/10.1017/S1368980013003169 
Stern, Y. (2002). What is cognitive reserve? Theory and research application of the reserve 
concept. Journal of the International Neuropsychological Society, 8(3), 448–460. 
https://doi.org/10.1017/S1355617702813248 
Stonehouse, W. (2014). Does consumption of LC omega-3 PUFA enhance cognitive 
performance in healthy school-aged children and throughout adulthood? Evidence from 
clinical trials. Nutrients, 6(7), 2730–2758. https://doi.org/10.3390/nu6072730 
Stonehouse, W., Conlon, C. A., Podd, J., Hill, S. R., Minihane, A. M., Haskell, C., & Kennedy, D. 
(2013). DHA supplementation improved both memory and reaction time in healthy young 
adults : a randomized controlled trial. American Journal of Clinical Nutrition, 94, 1134–
1143. http://doi.org/10.3945/ajcn.112.053371.1 
Stonehouse, W., Pauga, M. R., Kruger, R., Thomson, C. D., Wong, M., & Kruger, M. C. (2011). 
Consumption of salmon v. salmon oil capsules: effects on n-3 PUFA and selenium status. 
The British Journal of Nutrition, 106(8), 1231–1239. 
https://doi.org/10.1017/S000711451100153X 
Stringer, C. B., Finlayson, J. C., Barton, R. N. E., Fernández-Jalvo, Y., Cáceres, I., Sabin, R. C., … 
Riquelme-Cantat, J. A. (2008). Neanderthal exploitation of marine mammals in gibraltar. 
Proceedings of the National Academy of Sciences of the United States of America, 
166 
 
105(23), 14319–14324. Retrieved from http://www.jstor.org/stable/25464227 
Styrke, J., Sojka, P., Björnstig, U., Bylund, P-O., & Stålnacke, B-M. (2013). Sex differences in 
symptoms, disability and life satisfaction three years after mild traumatic brain injury: a 
population- based cohort study. Journal of Rehabilitation Medicine, 45(8), 749–757. 
https://doi.org/10.2340/16501977-1215 
Su, S-H., Xu, W., Li, M., Zhang, L., Wu, Y-F., Yu, F., & Hai, J. (2014). Elevated C-reactive protein 
levels may be a predictor of persistent unfavourable symptoms in patients with mild 
traumatic brain injury: a preliminary study. Brain, Behavior, and Immunity, 38, 111–117. 
https://doi.org/10.1016/j.bbi.2014.01.009 
Swaine, B. R., Gagnon, I., Champagne, F., Lefebvre, H., Friedman, D., Atkinson, J., & Feldman, 
D. (2008). Identifying the specific needs of adolescents after a mild traumatic brain injury: 
A service provider perspective. Brain Injury, 22(7–8), 581–588. 
https://doi.org/10.1080/02699050802189701 
Taber, K. H., & Hurley, R. A. (2013). Update on mild traumatic brain injury: Neuropathology and 
structural imaging. The Journal of Neuropsychiatry and Clinical Neurosciences, 25(1), 1–5. 
https://doi.org/10.1176/appi.neuropsych.12120401 
Te Ao, B., Brown, P., Tobias, M., Ameratunga, S., Barker-Collo, S., Theadom, A., … Feigin, V. L. 
(2014). Cost of traumatic brain injury in New Zealand: evidence from a population-based 
study. Neurology, 83(18), 1645–1652. https://doi.org/10.1212/WNL.0000000000000933 
The New Zealand Guidelines Group (2006). Traumatic brain injury: diagnosis, acute 
management, and rehabilitation. Wellington, New Zealand: New Zealand Guidelines 
Group.   
Tognon, G., Lissner, L., Saebye, D., Walker, K. Z., & Heitmann, B. L. (2013). The Mediterranean 
diet in relation to mortality and CVD: a Danish cohort study. British Journal of Nutrition, 
111(1), 151–159. https://doi.org/10.1017/S0007114513001931 
Tognon, G., Rothenberg, E., Eiben, G., Sundh, V., Winkvist, A., & Lissner, L. (2011). Does the 
167 
 
Mediterranean diet predict longevity in the elderly? A Swedish perspective. Age, 33(3), 
439–450. https://doi.org/10.1007/s11357-010-9193-1 
Tombaugh, T. N. (2006). A comprehensive review of the Paced Auditory Serial Addition Test 
(PASAT). Archives of Clinical Neuropsychology, 21(1), 53–76. 
https://doi.org/10.1016/j.acn.2005.07.006 
Trépanier, M-O., Hopperton, K. E., Orr, S. K., & Bazinet, R. P. (2015). N-3 polyunsaturated fatty 
acids in animal models with neuroinflammation: An update. European Journal of 
Pharmacology. https://doi.org/10.1016/j.ejphar.2015.05.045 
Trichopoulou, A., Kyrozis, A., Rossi, M., Katsoulis, M., Trichopoulos, D., La Vecchia, C., & Lagiou, 
P. (2015). Mediterranean diet and cognitive decline over time in an elderly 
Mediterranean population. European Journal of Nutrition, 54, 1311–1321. 
Trojian, T. H., & Jackson, E. (2011). Il-3 polyunsaturated fatty acids and concussions: treatment 
or not? Current Sports Medicine Reports, 10(4), 180–185. 
Tun, P., & Lachman, M. E. (2005). Brief Test of Adult Cognition by Telephone (BTACT). 
Technical report. Neuropsychology (14), 167-177. 
Uauy, R., & Valenzuela, A. (2000). Marine oils: The health benefits of n-3 fatty acids. Nutrition, 
16(7–8), 680–684. https://doi.org/10.1016/S0899-9007(00)00326-9 
Verly-Miguel, M. V. B., Farias, D. R., Pinto, T. de J. P., Lepsch, J., Nardi, A. E., & Kac, G. (2015). 
Serum docosahexaenoic acid (DHA) is inversely associated with anxiety disorders in early 
pregnancy. Journal of Anxiety Disorders, 30, 34–40. 
https://doi.org/10.1016/j.janxdis.2014.12.002 
Villegas, R., Takata, Y., Murff, H., & Blot, W. J. (2015). Fish, omega-3 long-chain fatty acids, and 
all-cause mortality in a low-income US population: Results from the Southern Community 
Cohort Study. Nutrition, Metabolism and Cardiovascular Diseases, 25, 651–658. 
https://doi.org/10.1016/j.numecd.2015.04.006 
von Bernhardi, R., Heredia, F., Salgado, N., & Munoz, P. (2016). Microglia function in the 
168 
 
normal brain. In von Bernhardi (Ed.), Glial cells in health and disease of the cns. advances 
in experimental medicine and biology (Vol. 949, pp. 183–201). 
https://doi.org/10.1007/978-3-319-40764-7 
Voormolen, D. C., Polinder, S., von Steinbuechel, N., Vos, P. E., Cnossen, M. C., & Haagsma, J. 
A. (2019). The association between post-concussion symptoms and health-related quality 
of life in patients with mild traumatic brain injury. Injury, 50(5), 1068–1074. 
https://doi.org/10.1016/j.injury.2018.12.002 
Vormund, K., Braun, J., Rohrmann, S., Bopp, M., Ballmer, P., & Faeh, D. (2015). Mediterranean 
diet and mortality in Switzerland: an alpine paradox? European Journal of Nutrition, 54, 
139–148. https://doi.org/10.1007/s00394-014-0695-y 
Wang, M. P., Thomas, G. N., Ho, Y., Kan Lai, H., Tai, A., & Lam, H. (2011). Fish consumption and 
mortality in Hong Kong Chinese the LIMOR study. Annals of Epidemiology, 21, 164–169. 
https://doi.org/10.1016/j.annepidem.2010.10.010 
Webb, T. S., Whitehead, C. R., Wells, T. S., Gore, R. K., & Otte, C. N. (2015). Neurologically-
related sequelae associated with mild traumatic brain injury. Brain Injury, 29(4), 430–437. 
https://doi.org/10.3109/02699052.2014.989904 
Wechsler, D. (2008). Wechsler Adult Intelligence Scale (4th ed.). San Antonio, TX: Pearson 
Assessment. 
Wechsler, D. (2009). Wechsler memory scale(4th ed.). (WMS-IV). San Antonio, TX: Pearson 
Assessment. 
Weiser, M. J., Butt, C. M., & Mohajeri, M. H. (2016). Docosahexaenoic acid and cognition 
throughout the lifespan. Nutrients, 8(2), 1–40. https://doi.org/10.3390/nu8020099 
Whitney, E.; Rolfes, S. R.; Crowe, T.; Cameron-Smith, D.; & Walsh, A. (2011) Understanding 
nutrition, Australia and New Zealand Edition. Albany, New Zealand: Cengage learning 
Wills, S., & Leathem, J. (2004). The effects of test anxiety, age, intelligence level, and arithmetic 
ability on Paced Auditory Serial Addition Test performance. Applied Neuropsychology, 
169 
 
11(4), 180–187. https://doi.org/10.1207/s15324826an1104_2 
Wilson, B. A., Watson, P. C., Baddeley, A. D., Emslie, H., & Evans, J. J. (2000). Improvement or 
simply practice? The effects of twenty repeated assessments on people with and without 
brain injury. Journal of the International Neuropsychological Society, 6(4), 469–479. 
https://doi.org/10.1017/S1355617700644053 
Woodcock, T., & Morganti-Kossmann, M. C. (2013). The role of markers of inflammation in 
traumatic brain injury. Frontiers in Neurology, 4, 1–18. 
https://doi.org/10.3389/fneur.2013.00018 
World Health Organization. (2004). ICD-10: International statistical classification of diseases 
and related health problems: Tenth revision (2nd ed.). Geneva: World Health Organization. 
World Health Organization. (2019). ICD-11: International statistical classification of diseases 
and related health problems: Eleventh revision. Retrieved from: https://icd.who.int/en 
World Medical Association. (2013). World Medical Association Declaration of Helsinki: ethical 
principles for medical research involving human subjects. JAMA, 310(20), 2191-2194. 
https://doi.org/10.1001/jama.2013.281053 
Wu, A., Ying, Z., & Gomez-Pinilla, F. (2011). The salutary effects of DHA dietary 
supplementation on cognition, neuroplasticity, and membrane homeostasis after brain 
trauma. Journal of Neurotrauma, 28(10), 2113–2122. 
https://doi.org/10.1089/neu.2011.1872 
Yang, C-C., Yuen, K-M., Huang, S-J., Hsiao, S-H., Tsai, Y-H., & Lin, W-C. (2014). “Good-old-days” 
bias: A prospective follow-up study to examine the preinjury supernormal status in 
patients with mild traumatic brain injury. Journal of Clinical & Experimental 
Neuropsychology, 36(4), 399–409. https://doi.org/10.1080/13803395.2014.903899 
Zendedel, A., Habib, P., Dang, J., Lammerding, L., Hoffmann, S., Beyer, C., & Slowik, A. (2015). 
Omega-3 polyunsaturated fatty acids ameliorate neuroinflammation and mitigate 
ischemic stroke damage through interactions with astrocytes and microglia. Journal of 
170 
 
Neuroimmunology, 278, 200–211. https://doi.org/10.1016/j.jneuroim.2014.11.007 
Zhang, J., Sasaki, S., Amano, K., & Kesteloot, H. (1999). Fish consumption and mortality from all 
causes, ischemic heart disease, and stroke: An ecological study. Preventive Medicine, 28, 




Appendix A  
Study One Contact Log 
 
Date Mode Direction 
Organisation/ 
Designation Outcome 
7/02/2017 Email Outbound 
Taranaki 
Psychologist Providing study information 
7/02/2017 Email Outbound Wai/Bop Director Providing study information 
7/02/2017 Email Outbound 
Well/Auk 
Psychologists Providing study information 
13/02/2017 Email Thread 
Taranaki 
Psychologist Arranged locality assessment  
14/02/2017 Email Thread 
Wai/Bop 





Service Team Presented study information to Wai/Bop team 
1/03/2017 Email Thread 
Wai/Bop 
Manager Organised ethics locality assessment 
6/03/2017 Email Outbound 
Christchurch 
Psychologist Providing study information 
9/03/2017 Email Thread 
Wai/Bop 
Manager Discussion of expectations - 24 participants by the end of June possible 
20/03/2017 Email Outbound 
Wai/Bop 
Manager Forms with 0800 number finalised and provided 
23/03/2017 Email Thread 
Wai/Bop 
Manager Organised 18 packs of supplements to be distributed to 4 clinicians 
27/03/2017 Email Thread Wai/Bop OTs Check to ensure supplements received and if any questions. 3x replies of received. 
7/04/2017 Email Inbound Wai/Bop OT Replied that supplements received 
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10/04/2017 Email Inbound 
Wai/Bop 
Manager Request for remaining 6 supplement packs to be sent to 2 clinicians 
19/04/2017 Email Outbound Wai/Bop OTs Follow up on receipt of supplements. Supplements received 
26/04/2017 Email Inbound Wai/Bop OT Recruitment of participant  
26/04/2017 Call Outbound Participant 121 Voicemail x2- message left 
28/04/2017 Email Outbound Participant 121  Introduction and requesting a time to call 
3/05/2017 Call Outbound Participant 121 Introduction and Baseline testing calls 
31/05/2017 Email Thread Participant 121 Prescribed 10 mg/d Amitriptyline and queried need to withdraw, I advised Ok to continue 
5/06/2017 Email Outbound Participant 121 Queried good time for a catch up call 
9/06/2017 Call Outbound Participant 121 Catch up, no problems with supplements, still experiencing many symptoms 
10/05/2017 Email Outbound Wai/Bop OTs Discussed slow recruitment and queried any barriers to participation or presenting study 
10/05/2017 Email Reply Wai/Bop OT Has had ‘odd’ referrals and clients not meeting criteria 
10/05/2017 Email Reply Wai/Bop OT 
Clients haven’t met criteria due to age or severe mental health difficulties that affect 
cognitive testing 
10/05/2017 Email Reply Wai/Bop OT Had few new concussion referrals. Of two, one already on supplements, one too young. 
12/05/2017 Email Reply Wai/Bop OT Clients too young, severe mental health difficulties, and vegetarian. 
15/06/2017 Email Outbound Wai/Bop OTs Group email asking specific questions about barriers to recruitment 
19/06/2017 Email Reply Wai/Bop OT 
7 new referrals, 3 not concussion, 2 on supplements already, 1 child, 1 too severe to 
discuss study with  
19/06/2017 Email Outbound 
Waikato 
Psychologist Providing study information 
21/06/2017 Email Outbound 
Taranaki 
Psychologist 
Update on project - continuing as normal. Queried participation and whether it would be 
useful to recruit via local concussion service OTs 
21/06/2017 Email Thread 
Wai/Bop 
Manager 
Discussed recruitment issues and few clinicians replying. Manager advised the contract 
changed this year and offers less time but more paperwork, so clinicians are feeling 
stretched. Advised one OT away and two accepting more child clients. Discussed changing 
the eligibility questionnaire to a self-administered form, manager thought this was a good 
idea 
23/06/2017 Call Outbound Wai/Bop OT Voicemail-message left 
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23/06/2017 Call Outbound Wai/Bop OT Voicemail-message left 
23/06/2017 Call Outbound Wai/Bop OT 
Full case load but has two clients to ask next week. Barriers = busy, neurologist prescribing 
fish oil, mental health diagnoses 
23/06/2017 Call Outbound Wai/Bop OT Voicemail-message left 
23/06/2017 Email Reply Wai/Bop OT 
12 concussion clients - 4 children, 2 severe MH problems, 2 on fish oil already, 1 no 
cognitive problems, 3 to ask about study next time 
29/06/2017 Email Inbound Wai/Bop OT 
Had asked 2 clients about the study, one no cognitive problems, the other trying to 
conceive 
29/06/2017 Call Outbound 
Taranaki 
Psychologist Unavailable, call back 
29/06/2017 Call Outbound 
Taranaki 
Psychologist Voicemail-message left 
29-Jun Call Inbound 
Taranaki 
Psychologist 
Office manager will phone past referrals next week to ask if they'd like an info pack, I will 
email new questionnaire to post out, psychologist thinks own service better placed to 
recruit than local OT service 
3-Jul Email Thread 
Waikato 
Psychologist Follow up on information. Has been sent to management who are busy 
3-Jul Email Outbound 
Taranaki 
Psychologist Provided new eligibility questionnaire to be sent out to potential participants 
3-Jul Email Outbound 
Wellington 
Psychologist Providing study information. Forwarded to research management team 
6/07/2017 Call Outbound Participant NYR 
Discussed symptoms and situation. Will call and hang up or text before calling to give time 
to get to a reception area. Set time of 8:30am 7/7 for baseline testing  
6/07/2017 Email Thread 
Taranaki 
Psychologist 
Advised neurologist with concussion service prescribes all concussion patients fish oil, 
organisation of pre-paid envelopes 
7/07/2017 Email Inbound 
Taranaki 
Psychologist Advised 4 info sets sent out 
7/07/2017 Call Outbound Participant NYR Called and hung up as requested. Called again 3x no answer. 
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Advised of receipt of info, asked questions and provided research sign off forms. Replied 
with answers and advised of supervisor's absence therefore a delay in completing the 
forms 
20/07/2017 Call Outbound Participant 121 Voicemail - no message left x2 
20/07/2017 Call Outbound Wai/Bop OT Voicemail stated unavailable until 24th July 
20/07/2017 Call Outbound Wai/Bop OT Caseload full with other contracts, also many child cases. One client may be interested 
20/07/2017 Call Outbound Participant NYR Voicemail - no message left x2 
25/07/2017 Call Outbound Participant 121  Voicemail - no message left 
25/07/2017 Call Outbound Participant NYR Call back at 12 please 
25/07/2017 Call Outbound Participant NYR 
1st call unanswered. 15 mins later answered. Too stressed to take part, forgetting 
appointments and having trouble with OT, ACC, and work. Return to work difficult and 
exacerbating symptoms. Discussed benefits and costs, decided on withdrawal. Hasn't 
started supplements, will attempt to have OT collect them 
25/07/2017 Email Outbound 
Taranaki 
Psychologist Follow up on information packs - no information received back. 
1/08/2017 Call Inbound 
Waikato 
Psychologist 
Information went to wrong person, has forwarded to correct person who is interested in 
participation. Will hopefully hear in 2 weeks 
2/08/2017 Call Outbound Participant 121 
Testing call as previously agreed - receiver lifted and hung up, next 2 calls unanswered - 
message left 
4/08/2017 Email Inbound 
Taranaki 
Psychologist 
Information for potential participant received, with verbal consent to contact him as the 
consent form hadn't been returned 




Discussed fish consumption - determined ok to participate. Discussed requirements and 
possibility of being in placebo group. Will think about participation and talk to partner 
before deciding 
7/08/2017 Email Outbound Wai/Bop OT Follow up regarding a potential participant - received consent form 
7/08/2017 Email Outbound Wai/Bop OTs Check in. Reply from one OT: caseload full, no new clients 
8/08/2017 Call Outbound 
Potential 
Participant  
Discussed symptoms, medications, and requirements of participation. Agreed, and set 
time for baseline testing - 14/8/17 10am 
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14/08/2017 Email Outbound 
Well/Kāpiti 
research 
manager Sign off forms sent 
14/08/2017 Call Outbound 
Potential 
Participant 
Taranaki Voicemail-message left 
14/08/2017 Call Outbound Participant 121 Voicemail-message left 
14/08/2017 Call Outbound Participant 146 Baseline testing and discussion. Will have OT deliver supplements at appt. 16/8/17.  
15/08/2017 Call Outbound 
Potential 
Participant 
Taranaki Voicemail - no message left 
15/08/2017 Call Outbound Participant 121 1st 2 calls no ring or VM, 3rd call child answered by child, participant unavailable 
15/08/2017 Email Outbound Participant 121  Request for good time to call for second test session 
15/08/2017 Call Outbound Wai/Bop OT Reminder to take supplements to participant 146 tomorrow 
16/08/2017 Email Reply Participant 121 
Explained she had work last week so missed the session. Advised she wants to withdraw 
as she has missed too many of the capsules and this is unfair for me and the study. 




Keen to participate in trial and can drop into clinic to collect supplements. Set baseline 
testing for 18/8 at 9:30am. 
16/08/2017 Call Outbound Participant 121 Voicemail - message left requesting call back or email 
16/08/2017 Email Outbound Participant 121  
Advised she could possibly continue with the study, or if withdrawing it would be good to 
do second testing. Asked about barriers to taking the supplements. 




Called for testing at set time. No answer. Called twice more at 15 minute intervals, no 
answer, message left. 
18/08/2017 Call Outbound Participant 121 Voicemail, no message left. 
21/08/2017 Call Inbound 
Waikato 
Psychologist 
Project given OK by branch manager, just need to check with local ACC, invitation to team 
meeting tomorrow to give a talk and have Q&A. 
21/08/2017 Email Thread 
Waikato 
Psychologist Provided letter from ACC. Psychologist called her and will hear back tomorrow. 
176 
 
21/08/2017 Email Outbound 
Well/Kāpiti 
research 
manager Follow up and provided ACC letter. 
21/08/2017 Call Outbound Participant 121 Voicemail, no message left. 
21/08/2017 Call Outbound 
Potential 
Participant 
Taranaki Voicemail, no message left. 
22/08/2017 Meeting Face to Face Waikato team Gave talk to full team and fielded questions. 
22/08/2017 Email Thread 
Waikato 
Psychologist Organised and completed locality assessment for HDEC 




Hospital sign off forms hadn't been received despite being correctly attached, happened 
twice. Converted to PDF and sent again. 
23/08/2017 Email Outbound 
Wellington 
Psychologist Follow up to advise what has been happening with DHB application. 




Advised he didn't want to go ahead with the study as too busy with work and wedding 
planning and has improved greatly over the last few months. Stated he is a “yes man" and 
needs to say no more often, so he will say no this time. He apologised several times for 
"leading me on" 
24/08/2017 Email Inbound 
Well/Kāpiti 
research 
manager Questions from medical team 
25/08/2017 Email Thread 
Well/Kāpiti 
research 
manager Answered questions, manager advised nothing further would be needed. 
25/08/2017 Call Inbound 
Wellington 
Psychologist 
Advised it looks like we can go ahead, invited to MDT meeting to give a talk and field 
questions 
28/08/2017 Email Outbound 
Wellington 
Psychologist Advised I could attend this Wednesday's MDT 
28/08/2017 Call Outbound Participant 121 Voicemail, left message 
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28/08/2017 Call Outbound Wai/Bop OT Voicemail, left message re withdrawn participant 
28/08/2017 Call Outbound Wai/Bop OT Voicemail, left message re catch up 
28/08/2017 Call Outbound Wai/Bop OT Voicemail, left message re catch up 
28/08/2017 Call Outbound Wai/Bop OT Answered but busy and will call back. Full case load and no luck with recruitment 
28/08/2017 Email Outbound 
Taranaki 
Concussion 
Service #2 Sending study information 
28/08/2017 Email Inbound Wai/Bop OT Withdrawn participant's case closed, send courier to collect supplements 
30/08/2017 Meeting Face to Face Well/Kāpiti team 
Attended MDT. Delivered supplements and cleared up confusion around recruitment 
process. Team Leader spoke with Research Manager who said OK to proceed 
30/08/2017 Email Inbound 
Taranaki 
Psychologists 
Office manager advised unable to find further participants and “no longer sustainable to 
hold onto supplies”, requested pick up 
1/09/2017 Email Thread 
Wellington 
Psychologist Confirmed there would be no overlap of verbal fluency measures 




Following up study information. OT thanked for opportunity and advised it was run past 
team who were interested, now with psychologist for checking of measures 
18/09/2017 Call Outbound Participant 146 
Difficulty with compliance and experienced nausea, advised to try taking 2x twice per day 
or try taking in the evenings after dinner, as she's not a 'breakfast person'. Long discussion 
about RTW and difficulties in the office 
1/09/2017 Email Outbound 
Taranaki 
Concussion 
Service #2 Following up study information with psychologist 
22/09/2017 Email Inbound Waikato OT Consent forms for participant 
25/09/2017 Email Thread 
Taranaki 
Psychologists Confirming arrangements and final pick-up of materials by freight-forwarding courier 
25/09/2017 Call Outbound Participant 107 Call to introduce and organise baseline test 
25/09/2017 Call Inbound Participant 140 Returned my voice message from same day, introduced and organised baseline testing 
25/09/2017 Email Thread 
Wellington 
Psychologist 
Follow up for Well/Kāpiti service recruitment and any barriers, psychologist unsure but 
advised one potential participant 
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26/09/2017 Call Outbound Participant 140 Baseline testing 
27/09/2017 Call Outbound Participant 107 Baseline testing 
28/09/2017 Email Thread Well/Kāpiti team 
1x participant consent, advised barriers are fatigue at end of session making it hard to 
review study info, not wanting to take the placebo, and concern about time requirements 
when not managing daily life 
29/09/2017 Email Inbound Participant 146 
Advised she suffered another GI reaction and would now withdraw. Requested no phone 
call and offered journal for review. Replied apologising for the distress and thanking for 
her time and consideration  
4/10/2017 Email Inbound Well/Kāpiti OT 1x participant consent  
5/10/2017 Email Inbound Well/Kāpiti OT 1x participant consent 
6/10/2017 Call Outbound Participant 142 Intro and discussion of symptoms, organised baseline testing for 20/10 
9/10/2017 Email Inbound Well/Kāpiti OT 1x participant consent 
10/10/2017 Email Inbound Well/Kāpiti OT 
1x participant consent with additional background info - client suffers bipolar I disorder 
and alcohol dependence, though is reportedly no longer drinking. 
10/10/2017 Email Inbound Waikato OT 1x participant consent 
11/10/2017 Call Outbound Participant 147 Voicemail – message left 
11/10/2017 Call Outbound Participant 189 Voicemail – message left 
11/10/2017 Call Outbound Participant 145 Intro and discussion of symptoms, will take some time to consider participation 
16/10/2017 Call Outbound Participant 147 Intro and arranging baseline testing 
16/10/2017 Call Outbound Participant 189 Intro and arranging baseline testing 
16/10/2017 Call Outbound Participant 145 Voicemail – unnamed so no message left 
20/10/2017 Call Outbound Participant 142 Baseline test call to voicemail – message left 
21/10/2017 Call Outbound Participant 145 Decided not to participate as too busy and stressed, and cognitive symptoms much better 
24/10/2017 Call Outbound Participant 142 Voicemail, no message. Followed up with email. 
25/10/2017 Email Inbound Participant 142 Apologies, lost phone. New number provided and baseline scheduled for 6/11 
26/10/2017 Call Outbound Participant 140 Catch up call went to voicemail – message left 
26/10/2017 Call Outbound Participant 107 Catch up call, doing well but still experiencing some symptoms, working more this month. 
27/10/2017 Call Outbound Participant 140 Voicemail – no message left 
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31/10/2017 Email Outbound Participant 140 Check-in email and request for a good time to call 
3/11/2017 Email Thread WAI/BOP OT Not taking further referrals so cannot continue to recruit. Organised collection of materials 
3/11/2017 Call Inbound Participant 140 Returning call/email. Doing well, no issues with supplements, working full time hours 
6/11/2017 Call Outbound Participant 142 Baseline testing 
7/11/2017 Email Thread Participant 125 
Organising a time to talk and then conduct baseline testing after several failed attempts at 
phone contact 
11/11/2017 Call Outbound Participant 147 Baseline testing 
22/11/2017 Call Outbound Participant 189 Baseline testing 
23/11/2017 Email Thread Well/Kāpiti team 1x participant consent and discussion of potential trial changes 
24/11/2017 Call Outbound Participant 125 Baseline testing 
29/11/2017 Call Outbound Participant 139 Intro and discussion of symptoms, organised baseline testing for tomorrow 
29/11/2017 Call Outbound Participant 140 Catch up call to voicemail – message left 
29/11/2017 Call Outbound Participant 107 Catch up call to voicemail – message left 
29/11/2017 Call Outbound Participant 147 Catch up call to voicemail – message left 
29/11/2017 Call Outbound Participant 189 Catch up call to voicemail – message left 
29/11/2017 Call Outbound Participant 142 Catch up call to voicemail – message left 
29/11/2017 Call Outbound Participant 125 
Catch up call returned after several attempts. Discussed trial changes and participant 
happy to receive fish oil supplements and continue. Organised courier for active treatment 
30/11/2017 Call Outbound Participant 139 Child answered, not available, left message to phone back on 0800 number 
1/12/2017 Call Outbound Participant 140 
Catch up call to discuss progress and trial changes. Advised 140 is placebo and provided 
options, participant decided to remain as a control and advised doing much better 
1/12/2017 Call Outbound Participant 107 
Catch up call to discuss progress and trial changes. Advised 107 is placebo and provided 
options, participant decided to withdraw without receiving fish oil 
1/12/2017 Email Thread Wai/Bop team 
Advised of changes to trial and requested any recruitment efforts paused, team happy 
with this – no potential participants currently 
4/12/2017 Call Inbound Participant 139 Apologised for missing session, was working. Rescheduled for 12/12 
4/12/2017 Email Outbound Participant 147 




4/12/2017 Email Outbound Participant 189 
Advised of study changes and active group status, provided options and requested a call 
back 
4/12/2017 Email Outbound Participant 142 
Advised of study changes and active group status, provided options and requested a call 
back 
4/12/2017 Email Thread 
Waikato 
psychologist 
Discussion of proposed trial changes - Waikato would be happy to continue once provided 
with updated materials. Stated her OTs found several clients were taking supplements 
already. 
12/12/2017 Call Outbound Participant 147 Voicemail, message left 
12/12/2017 Call Outbound Participant 142 Voicemail, message left 
12/12/2017 Call Outbound Participant 139 Answerphone for numerous people, no message left 
12/12/2017 Call Outbound Participant 189 Voicemail, message left 
15/12/2017 Call Outbound Participant 139 
Rescheduled baseline testing for 3/1. Participant advised he’s busy at work, going away, 
and feeling better though still experiencing some symptoms 
18/12/2017 Email Thread Participant 125 
Supplements received and started, some GI upset including nausea and vomiting, changed 
to 2x twice a day and this stopped. Agreed to catch up call in January and to contact ASAP 
if any further side effects or other issues 
19/12/2017 Email Thread Well/Kāpiti team Provided participant consent and details of supplements still held at the DHB 
28/12/2017 Call Outbound Participant 140 Time 2 testing call to voicemail, message left  
28/12/2017 Email Outbound Participant 140 Request to organise time 2 testing 
3/01/2018 Call Outbound Participant 139 Baseline testing 
3/01/2018 Call Outbound Participant 107 Time 2 testing to voicemail, message left 
17/01/2018 Call Outbound Participant 125 Voicemail, message left 
17/01/2018 Call Outbound Participant 147 Voicemail, message left 
17/01/2018 Call Outbound Participant 142 Voicemail, message left 
17/01/2018 Call Outbound Participant 189 Voicemail, message left 
23/02/2018 Email Outbound 
Remaining 
participants Notification of cancellation of trial, thanked for participating 
23/02/2018 Email Outbound 
Remaining 
organisations Notification of cancellation of trial, thanked for participating 
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17/04/2018 Email Thread Wai/Bop Organising return/disposal of materials 
 
Notes: OT= Occupational Therapist, Wai/Bop = Waikato/Bay of Plenty based service, Well/Kāpiti = Wellington/Kāpiti coast based service, NYR= Not Yet 




Study One Self-Report Eligibility Questionnaire 
 
Eligibility Questionnaire 
If you answer yes to any of the following questions, you may not be eligible to participate. If 







Do you take a fish oil supplement already, or have you regularly taken one 
in the last 6 months? 
  
Do you eat more than 3 servings of oily fish or shellfish (e.g. salmon, 




Do you have an allergy to fish or shellfish? 
  
 
Are you vegetarian or pescatarian (eat fish but no other meat)? 
  
 
Are you pregnant or breastfeeding? 
  
 
Have you been diagnosed with any neurological or learning disorders? 
  
 
Are you taking any blood thinning medications? 
  
 




If you answered no to all of these questions, you may be eligible to participate in the study. If 
you wish to discuss your participation further please phone 0800 279 533 or email 
Brylee.Cresswell.1@uni.massey. ac.nz. If you have decided to participate, please complete the 
additional information form and the consent form, and return them to your occupational 




Additional Information Form 
If you have decided to participate in the study, please return the following information form, 
along with your signed consent form and your questionnaire, to your occupational 
therapist/keyworker. 
 
Name      Sex 
Date of Birth     Ethnicity  
Level of Education (total years at school/polytech/university) 
Date of Injury 
Mechanism of Injury (how it happened) 
 
Are you taking any medications? If so, please list: 
 
*Are you taking any other (non-fish oil) supplements? If so, please list:  
 
 
*It is important that you avoid beginning any new supplements while taking part in the trial, 





Study Two Information Sheet and Survey  
We are seeking to assess the information that is provided to people who have suffered a 
mild Traumatic Brain Injury (mTBI), sometimes also known as concussion. Our aims are to 
find out what information is made available to mTBI sufferers by their healthcare providers 
and in what form that information is provided, and compare written information with 
recommended patient information guidelines.  
What is involved? 
Completing the survey will take approximately 10 minutes. If you provide patients/clients 
with a non-ACC information sheet we request that you upload a copy of this to the survey 
when prompted. Your responses will contribute to research evaluating the provision of 
information to patients who have suffered a mild Traumatic Brain Injury. 
Click on the next button at the bottom of this page which will take you to the survey. 
Thank you for taking the time to complete this survey. 
Who is doing this research? 
My name is Brylee Cresswell, I am a Doctor of Clinical Psychology candidate at Massey 
University, under the supervision of Professor Janet Leathem. 
Who can participate? 
You need to be a staff member in an organisation that treats patients who have suffered 
mTBI/concussion. Multiple staff members from the same organisation are welcome to 
participate. 
Your rights as a participant: 
You are under no obligation to accept this invitation. If you decide to participate, 
completion and submission of the questionnaire implies consent. You have the right to 
decline to answer any particular question. In order to protect your privacy the survey is 
anonymous. 
Data resulting from this research will be securely stored at Massey University for 5 years, 
after which it will be destroyed. The information you provide will be used in my doctoral 
thesis and submitted for assessment, and the findings may be published in scientific 
journals or presented at scientific conferences in New Zealand and overseas. 
Contact information: 
If you have any further questions please feel free to contact the researcher or supervisor. 
A detailed report outlining the findings of this research study will be available to all 
participants, on request, once the study is complete. 
Brylee Cresswell – Doctoral Candidate and Lead Researcher  
Email: Brylee.Cresswell.1@uni.massey.ac.nz 
 
Professor Janet Leathem – Supervisor  
Email: J.M.Leathem@Massey.ac.nz 
This project has been evaluated by peer review and judged to be low risk. Consequently it 
has not been reviewed by one of the University's Human Ethics Committees. The 
researcher(s) named in this document are responsible for the ethical conduct of this 
research. 
If you have any concerns about the conduct of this research that you want to raise with 
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someone other than the researcher(s), please contact Dr Brian Finch, Director (Research 
Ethics), email humanethics@massey.ac.nz.  
Survey Questions 
First, we’d like to know a little about your practice and profession 
What is your profession? 
General Practitioner 






Other (please state) 
 
What type of organisation do you work in? 
Hospital Emergency Department 
Accident and Medical Centre 
General Practice 
Concussion Service 
Other: (please state) 
 




Counties Manukau Hutt Valley 
Waikato Wellington/Kāpiti 
Bay of Plenty Nelson/Marlborough 
Lakes district West Coast 
Tairāwhiti Canterbury 
Hawkes Bay South Canterbury 
Taranaki Otago 
 
Is your service in an urban or rural location? 
Urban 
Rural 
The remaining questions focus on your practice with mTBI/Concussion patients. You may 
feel as though you cannot answer some questions if you do not work directly with the 
patients. If this is the case, feel free to skip any questions that do not apply to you. 
In the last month, approximately how many patients with confirmed or suspected 











Do you provide patients with confirmed or suspected mTBI/concussion with written 




Do you provide ACC leaflets? If yes, tick all that apply 
ACC 572: Caring for yourself after a… Head Injury 
ACC 4154: Knowing about your Mild Traumatic Brain Injury (TBI) 
ACC 7639: Returning to Activity from a Concussion/Mild Traumatic Brain Injury 
Other: (please state) 
No, we do not supply these 
 












Do you have information available in the following formats? Tick all that apply 
English 
Te Reo Māori 




How are your information sheets provided? Select all that apply 
Handed to patient by consulting healthcare provider 
Handed to patient by reception staff 
Available for patients to take from the waiting room if they wish 
 




Do you routinely provide mTBI/concussion patients information relating to the 
following, in any format (e.g., written, verbal, audio)? Please tick all that apply and 
outline the advice you provide 
Symptoms that may occur (please state)  
Symptom management (please state) 
Symptom duration (please state) 
Indicators of an emergency (please state) 
Driving (please state) 
Returning to work/study (please state) 
Returning to sport/exercise (please state) 
Substance use (please state) 
Social support (please state) 
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Medications (please state) 
Other: (please state) 
 
Do you direct patients to health-related websites for their mTBI/concussion symptoms? 
Yes (please state) 
No 
 
Which symptoms tend to be the most concerning for the patients you see. Please 
prioritise the list from the most frequently presenting symptom to the least. 
Headaches Frustration/impatience 
Dizziness Forgetfulness/poor memory 
Nausea/vomiting Poor concentration 
Noise sensitivity Taking longer to think 
Light sensitivity Blurred vision 
Fatigue Double vision 
Sleep disturbance Restlessness 
Depression/tearfulness Other (please state)  
 
If you prescribe or advise the use of certain medications or supplements, please tick all 
that apply and outline the advice you provide for their use (e.g., nightly for sleep until 
symptoms subside; as required for headaches) 
Paracetamol 
Non-Steroidal Anti-Inflammatory Drugs 
Tricyclic Antidepressants  
Omega 3s/Fish Oil 
Magnesium 
Other: (please state) 
N/A I do not recommend medications or supplements 
 
What barriers do you face when it comes to providing your patients with information 
about mTBI/concussion? Please select as many as necessary and prioritise your 
selections in order of significance. 
Lack of appropriate materials 
Time constraints during consultations 
It is the role of others within my organisation to pass on information (please state) 
It is the role of others outside of my organisation to pass on information (please state) 
Lack of patient interest in information 
Patients have difficulty concentrating on what I tell/give them 
Patient distress or feeling overwhelmed during consultations  
Language barriers between myself and my patients 
Language barriers between the information available and my patients 
Other (please state) 
Other (please state) 
Other (please state) 
 
Do you routinely refer patients with confirmed or likely mTBI to concussion services? 
No, don’t refer to concussion service 
Yes, refer upon initial presentation 
Yes, refer if symptoms continue for several weeks 
Yes, refer if symptoms continue for several months 
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N/A I work for a concussion service 
 
Any further comments about your practice with patients who have suffered 
mTBI/concussion? (please state) 
 




DHB Research Approval Communications 
 
13 June 2019 
 
Brylee Cresswell 
Doctoral of Clinical Psychology Candidate  
Massey University  
 
Dear Brylee 
I refer to your application for research titled “Information Provision for Mild Traumatic 
Brain Injury”. The other researchers involved are listed as Janet Leathem and Ross Flett.  
Carla O’Keeffe has agreed to be you clinical site lead for this research. For any clinical 
information you require please contact Carla Carla.okeeffe@wdhb.org.nz 
The application has been approved by the Whanganui District Health Board’s Clinical 
Board.  




Rebecca Moody  












Brylee Cresswell  




   
Dear Brylee, 
 
Re:  Information Provision following Mild Traumatic Brain Injury. 
The MidCentral DHB Research Support Office would like to thank you for the 
opportunity to review your study and has given approval for your research project.   
Your Institutional approval is dependent on the Research Office having up-to-date 
information and documentation relating to your research and being kept informed of 
any changes to your study.  It is your responsibility to ensure you have kept Ethics and 
the Research Office up to date and have the appropriate approvals.  
MDHB approval may be withdrawn for your study if you do not keep the Research 
Office informed of the following: 
• Any communication from Ethics Committees, including confirmation of annual 
ethics renewal 
• Any amendment to study documentation 
• Study completion, suspension or cancellation 
 




Research Support Officer  










Doctoral Candidate and Lead Researcher 
Massey University 
 




I am pleased to advise you that your research proposal, Mild Traumatic Brain Injury, 








Dr Greg Simmons 












































Appendix E  
Case Study 
The Neuropsychological Assessment of a 33-year-old Male with Historic Traumatic Brain Injury: 




Massey University Doctor of Clinical Psychology Candidate 




This case study represents the work of Brylee Cresswell during her internship in 2018. Clinical 
supervision was received during the assessment of this individual. All names and identifiable 
information within the case study have been changed to protect the anonymity of the client. 
Candidate: Brylee Cresswell……………………………………………………….Date:…………………………… 




The present case study outlines the effects that my doctoral research has had on my work as an 
Intern Psychologist. To demonstrate this I have discussed a client from the Department of 
Corrections Prison Service, whose assessment benefitted from learning that I took from the 
theoretical and practical components of my research with individuals who have suffered from 
Mild Traumatic Brain Injury. The case study begins with a summary of my research, followed by 
the assessment report for my client, and concludes with a discussion of how my research 
contributed to my work with this client, and as an intern clinician in general.  
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Summary of Research 
 Mild Traumatic Brain Injury (mTBI) represents 70-90 percent of all TBI in New Zealand. 
Key mechanisms of injury include motor vehicle accidents, falls, and assaults. Typical 
symptoms in the acute phase of mTBI include headache; dizziness; nausea; confusion; focal 
neurological signs such as tinnitus; and cognitive symptoms such as memory, attention, and 
executive function difficulties. These symptoms usually abate within days or weeks post-injury, 
however 20-30% of sufferers develop ongoing symptoms that can persist for months or years 
(Barker-Collo et al., 2015; Heitger et al., 2009) and delay an individual’s return to normal 
functioning. Ongoing symptoms are also associated with increased rates of anxiety and 
depression (Macleod, 2010; McCauley et al., 2008; Mickeviciene et al., 2002; Styrke et al., 
2013).  
 Post-concussion syndrome (PCS) is the common term for the experience of ongoing 
symptoms after mTBI, however debate exists about both the classification and causation of 
post-concussion symptoms. There are no symptoms unique to PCS, frequently reported 
symptoms such as headache and fatigue are common in the general population, and 
individuals experience similar symptoms after other forms of trauma, therefore, some argue, it 
should not be a diagnostic entity specific to brain injury (Meares et al., 2011; Rathbone et al., 
2015). Personality and psychological factors, rather than direct injury related phenomena, are 
commonly considered the cause of PCS. Various phenomena such as premorbid anxiety or 
depression (Meares et al., 2011), negative injury beliefs and attributions (Hou et al., 2012; Kay, 
Newman, Cavallo, Ezrachi and Resnick (1992); Macleod, 2010; Snell, Hay-Smith, Surgenor, & 
Siegert, 2013), low cognitive reserve (Oldenburg et al., 2016), all or nothing behaviour after 
injury (Hou et al., 2012), or iatrogenic factors (Broshek et al., 2015; Macleod, 2010) increase 
the odds of developing PCS.   
 Omega 3 polyunsaturated fatty acids (n-3 PUFA) have been found to have many health 
benefits and recent research suggests that they may have a role to play in the recovery of 
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cognitive function following brain injury. The n-3 PUFA are essential fatty acids – they must be 
obtained through the diet. Alpha-linolenic acid (ALA) is obtainable from many plant sources, 
while both Docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA) are more commonly 
found in marine sources (Lunn & Theobald, 2006). DHA comprises the majority of the brain’s 
lipids; while EPA is less abundant within the brain, it exerts important effects peripherally 
(Dyall, 2015; Mueller et al., 2015). Supplementing the diet with n-3 PUFA in the form of fish oil 
capsules has been effective for both enhancing cognitive performance in healthy individuals 
low in DHA (Stonehouse, 2014) and attenuating decline in those with mild cognitive 
impairment (Otaegui-Arrazola, Amiano, Elbusto, Urdaneta, & Martinez-Lage, 2014).  
 The study aimed to evaluate whether n-3 PUFA supplementation was an effective 
adjunct to standard treatment following mTBI. Further aims included assessing whether any 
cognitive effects were moderated by changes in mood, and whether illness perceptions and 
coping mechanisms predict outcomes. Participants were randomly assigned to receive either a 
n-3 PUFA supplement containing 1988 mg of DHA + 468 mg of EPA per day, or the placebo 
supplement containing 4000 mg of sunflower oil per day. Supplements were in the form of fish 
oil capsules. The trial duration was intended to be six months and consist of telephone based 
testing sessions at baseline, three and six months. To maximise the sensitivity of testing it was 
essential to assess the domains of functioning most commonly impaired after mTBI. Particular 
attention was given to memory and executive function as studies have found that speed and 
ease of processing (Kay et al., 1992), learning and remembering (Shanmukhi & Panigrahi, 
2003), executive ability, complex attention, cognitive flexibility and memory (Barker-Collo et 
al., 2015) may be affected in the first 12 months post-injury. In addition, depression, anxiety, 
and stress are frequent mood-related post-injury difficulties (Barker-Collo et al., 2015; Bay et 
al., 2009; J.-K. Chen et al., 2008; Styrke et al., 2013) that may benefit from fish oil 
supplementation (Jacka et al., 2012; Meyer et al., 2013; Sarri et al., 2008) 
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During the course of recruitment and data collection for this study, it became apparent 
that individuals with mTBI had little understanding of their injury, symptoms, or prognosis. As 
it proved difficult to recruit an adequate sample for the initial study, a further survey style 
study was generated to consider the provision of information to patients who have suffered 






Reason for Referral 
Mr Timothy Sanson was referred for cognitive testing to assess his current functioning 
across multiple domains. Mr Sanson had expressed difficulties with attention, memory, and 
clarity of thought, as well as his mental health. While he has suffered numerous injuries during 
his life, perhaps the most severe was sustained during a car accident in 1997, when Mr Sanson 
was 11 years old. He sustained a significant coup and contre coup injury to the temporo-
parietal area, with the initial force to the left side. Mr Sanson was unconscious for four to five 
days and spent 19 days in hospital. It was not clear whether neuropsychological testing took 
place following this injury, and no follow up was received 12 months after the accident.  
Sources of Information 
The following sources of information were used to inform the assessment: 









Psychometric testing with Mr Sanson1011121314 Brylee Cresswell (Intern 
Psychologist) 
26/4/18 Psychometric questionnaire15 Brylee Cresswell (Intern 
Psychologist) 
2/5/18 List of life events Mr Sanson 
18-27/8/97 Clinical notes  Various,  Palmerston 
North Hospital 
27/8/97 Discharge Summary Palmerston North 
Hospital 
27/8/97 Ophthalmologist report S. Migde 




Paediatrician reports Marlene Cliffe 
8/10/97 
9/4/98 
Neurosurgeon reports Marlon Hunt 
 
10 Wechsler Adult Intelligence Scale, Fourth Edition, Australia and New Zealand Version (WAIS-IVA&NZ) 
11 Delis-Kaplan Executive Function System (D-KEFS) 
12 Rey Auditory Verbal Learning Test (RAVLT) 
13 Rey Complex Figure Test (RCFT) 
14 Logical Memory I and II subtests from the Wechsler Memory Scale, Fourth Edition, Australia and New 
Zealand Version (WMS-IVA&NZ) 




Mr Sanson is a 33 year old male of New Zealand European and Cook Island Māori 
descent. He is of average build, and appeared well groomed. Mr Sanson exhibited 
psychomotor agitation throughout the interviews, particularly when thinking back to events in 
his childhood and speaking about his difficulties with anxiety. While this agitation was noted in 
each interview, it tended to subside with time and when engaged with non-verbal testing 
tasks. While his mental status was not formally assessed, Mr Sanson appeared oriented to 
time, place, person, and situation. Mr Sanson struggled with word-finding at times, and 
frequently repeated the final word from sentences spoken to him; although Mr Sanson was 
not aware of this tendency, it may be a strategy for attending to and thus recalling the end of 
sentences. Neither the content nor the pattern of his speech was suggestive of formal thought 
disorder, and no perceptual abnormalities were apparent.  
Current Situation 
Mr Sanson currently resides in Waikeria Prison’s Kauri unit where he is serving a two 
year nine month sentence for Aggravated Robbery. Mr Sanson advised that he keeps his cell 
clean and organised, and often cleans common areas such as the showers. He dedicates time 
each day to physical training, as fitness and strength are important to him, and undertakes 
agricultural/horticultural work within the unit compound. 
Mr Sanson is a ‘returned offender’ who was deported from Australia while serving 
time in prison, and later a detention centre. His key support people reside in Australia and he 
maintains some telephone contact with them. He has a partner, daughter and step-daughter in 
Queensland, and his mother in New South Wales. In addition, his father, brothers, and son also 
live in Australia. Mr Sanson has few support people in New Zealand, though some extended 




Mr Sanson reported numerous difficulties with anxiety, clarity of thought, and 
memory. He reported instances of racing thoughts and struggling to maintain focus or order 
tasks when too much information is presented to him (e.g., multi-step instructions or a long 
paragraph of text) which often leads to heightened anxiety, anger, and outbursts. Mr Sanson 
advised that he sometimes has outbursts of verbal frustration with himself, but no longer 
lashes out physically at property or people; previously, he would “smash” anyone or anything 
in his path of escape from an overwhelming situation. However, he also spoke about being 
able to problem solve with practical work when he did not understand instructions (e.g. 
constructing an object himself when he did not understand the plans).  
Mr Sanson reported beginning new tasks before completing what he was previously 
working on, then becoming frustrated with the mounting tasks he has to complete, as well as 
instances of narrow focus, when he will spend however much time is necessary completing a 
task he is engaged in. He also advised that his mind “goes blank” at times, leading him to 
forget what he had been doing previously, or what had been said to him.  
Mr Sanson stated that his short-term memory is poor, and showed difficulty 
remembering many elements of his childhood years. He spoke of “flashes” of memories – 
some traumatic, others ordinary, coming to him both during interviews and everyday life. He 
advised that at times these have raised his anxiety levels.   
Mr Sanson reported that he has taken amitriptyline for approximately 12 years, and 
has recently begun taking Epilim (sodium valproate) after requesting a mood stabiliser for his 
anxiety. He advised that this medication regime has helped him to feel calmer and think more 
clearly, however anxiety remains a significant difficulty.     
Relevant Background Information 
Developmental and Family History 
Mr Sanson raised the possibility that his mother abused drugs during her pregnancy 
with him, but advised that this may have been a rumour heard from another family member. 
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He was uncertain if he met his developmental milestones, but had no information to the 
contrary.  
Mr Sanson advised that he lived with his Mother and Father until approximately age 
eight, when his mother “abandoned” the family and moved to Australia. He has two brothers, 
approximately two years older and younger than himself; all three children remained in the 
care of their father. After Mr Sanson’s mother left, his father remarried a woman with children 
of her own; Mr Sanson stated that he did not get along with his stepmother. This reportedly 
happened twice; Mr Sanson’s father divorced and remarried another woman with her own 
children who Mr Sanson “hated”. Over the course of these three marital relationships, the 
children were reportedly exposed to a considerable degree of domestic violence.    
Mr Sanson reported that he and his brothers were frequently beaten by both 
biological parents, though more so their father, and Mr Sanson wrote “I think he belted fear 
into us, I do know I remember being really scared and sore”. He went on to detail his father 
then comforting him after physical punishments, telling him that he punished the children like 
that because he loved them and wanted them to learn. Mr Sanson made a point of saying that 
despite the abuse, he loves both of his parents, and that he is grateful to his father for 
teaching him practical skills for daily living (e.g., cooking, home maintenance). 
In addition to physical abuse, Mr Sanson reported suffering sexual abuse perpetrated 
by an older male family member. This included both performing and witnessing sexual acts. In 
the context of the referral request it was not deemed necessary or appropriate to explore this 
disclosure in further detail, however Mr Sanson was advised of the sexual abuse specific 
support available to him and how to access this should he wish. As well as “sexual things”  Mr 
Sanson advised that this family member made him do many other “bad things” such as 
smoking an entire packet of cigarettes around the age of 10, sneaking out at night, fighting, 
and using drugs. Mr Sanson spoke about then forcing a younger family member to do the same 
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things. Aside from both being subjected to and witnessing violence in the home, Mr Sanson 
advised that he has few memories of his childhood.  
Education/Occupation 
Mr Sanson had difficulty recalling his school years, though advised that he was 
“naughty” and may have had learning difficulties after his accident in 1997. He attended 10 
years of schooling, mostly in New Zealand and a brief period in Australia. A Social Worker’s 
letter to ACC in October 1997 indicated that Mr Sanson’s stepmother had been informed of 
difficulties at school, and teacher concerns about moving forward to high school the next year, 
however medical reports from 1998 note that Mr Sanson was reading at his age level, and 
while his parents believed he was slower to register new information and had more difficulty 
expressing himself than he had before the accident, he was doing well in school and had no 
obvious learning difficulties. Mr Sanson advised that he became a bully in school, and was 
“kicked out” of all of his schools. 
Mr Sanson began working at age 14 in Australia. His employment history consists of 
manual work such as panel-beating and spray-painting, working in an abattoir, concreting, and 
drain laying. During his prison sentences Mr Sanson has obtained certificates in English, 
mathematics, health and fitness, and workplace safety. He has worked in prison gyms, 
laundries, kitchens, and agricultural services.  
Medical 
Mr Sanson described difficulties sleeping, particularly getting to sleep, as well as a 
fluctuating appetite. He advised that both of these problems have been alleviated by taking 
Epilim and believes they are related to anxiety. He stated that he is otherwise healthy, and 
ensures that he is physically fit and strong by training every day. Mr Sanson spoke of his 
physical training regime as a kind of meditation for him. 
Mr Sanson was not aware of any serious physical or mental health difficulties among 




At age 11 Mr Sanson was an unrestrained back seat passenger in a car vs. power pole 
motor vehicle accident. Medical notes state that he was found lying unconscious and 
unresponsive to pain or voice, and on admission was moving to pain but exhibited no 
spontaneous eye opening. No Glasgow Coma Scale score was provided. Mr Sanson was air 
lifted to Wellington hospital where he stayed for several days before being transferred to 
Palmerston North. He remained unconscious for four to five days, and spent a total of 19 days 
in hospital.  
Mr Sanson took the force of the accident on the left side of his body and head; a CT 
scan showed petechial haemorrhage of the posterior limb of the left internal capsule and 
blood lying on the tentorium cerebelli. Mr Sanson suffered a period of left hemiparesis and left 
sided neglect, and recalled that he “had to learn to do everything again”. This weakness 
improved significantly over the following months. Noted ongoing effects included occasional 
confusion, forgetfulness, and clumsiness, though according to the reports this did not impact 
his schooling or sporting ability. 
Mr Sanson reported receiving many further blows to the head throughout his life. 
These have come from fighting, including being hit with a pole on one occasion, and falling. He 
reported vague memories of being “knocked out”, though could not detail any of his injuries.  
 
Mental Health 
Mr Sanson reported a history of significant anxiety, which he described as racing 
thoughts, being jumpy (both in body and mind), and an urge to escape. He said he would 
“smash anything in the way” of his escape, and often finds himself feeling anxious in group 
situations. Mr Sanson stated that he has had problems with anger, which has led to violence 
against people and property. He advised that he has suffered from depression in the past for 
which he was prescribed SSRI medication, however this made him “flip out” and increased his 
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agitation and anxiety. Mr Sanson reported that his current medication regime of Amitriptyline 
and Epilim is successfully improving the above difficulties. 
Mr Sanson spoke about periods of hearing voices. These voices were sometimes 
insults and sometimes commands, and were present both with and without the influence of 
substances. He mused during the interview that while the voices were not the sound of his 
father, the derogatory comments were similar to what he experienced from him in childhood. 
Mr Sanson stated that the voices began in his teenage years and were experienced 
periodically, but he had not heard them for several years. Similarly, he spoke of “seeing weird 
things” flying past him out of the corner of his eye, then turning to find nothing present; it was 
not clear if these were illusions or hallucinations or whether they occurred under the influence 
of substances.  
Mr Sanson described having “flashes” of memories during the course of everyday life, 
as well as during the interview. He advised that they were very intense, and often made him 
feel anxious. At other times he experienced “mind blanks” which prevented him from engaging 
with tasks or conversations. When queried about nightmares, Mr Sanson reported that he had 
experienced recurring nightmares in the past – both as a child and as an adult, but was 
uncertain of their content.  
 
Social and Emotional 
Mr Sanson could not recall much of his social situation from childhood, but 
remembered having a best friend, whom he saw briefly after his deportation from Australia. 
He also recalled being a bully at school. 
Mr Sanson described romantic relationships involving violence, infidelity, and 
emotional dependence. He stated that he has had a tendency to become “clingy” with women 
he is romantically involved with. He also outlined numerous occasions of infidelity, domestic 
violence, and “rough” sexual encounters. Mr Sanson currently has a partner in Australia who 
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has provided him with support throughout two of his prison sentences; he wishes to enjoy a 
healthy relationship with his partner upon release.  
Mr Sanson is currently serving his third prison sentence. He received two seven year 
sentences in Australia – the first for Grievous Bodily Harm with Intent, and the second for 
multiple Aggravated Robberies. During his second sentence, Australian law was changed to 
allow for the deportation of offenders who were not Australian citizens. Mr Sanson was moved 
to a detention centre in Western Australia, where he spent eighteen months. After this time 
he signed his deportation order and was returned to New Zealand. Mr Sanson obtained work 
in Palmerston North and later Tauranga, before reoffending with a further Aggravated Robbery 
leading to his current sentence. Regarding this offence, he stated that he “didn’t even need to” 
as he was earning a comfortable living. Mr Sanson stated that he has spent over 12 years in 
prison and has had enough; he believes that he is capable of living safely in the community 
though he worries that he has become “institutionalised”. 
Although he had seen numerous counsellors and other professionals, and completed 
several anger management/violence prevention programmes, Mr Sanson had not spoken 
about his childhood sexual abuse until recently. He also had not disclosed hearing voices, nor 
the extent of his emotional difficulties. Mr Sanson advised he felt significantly calmer after 
disclosing these difficulties. He stated that he now understands that asking for help is 
beneficial for him, so will not hesitate to do this after his release.  
Substance Use 
Mr Sanson detailed an extensive substance use history, beginning with smoking 
cigarettes from age 10. He advised that he began using cannabis around the age of 12 or 13, 
and after leaving school in Australia began growing and dealing cannabis with his mother. He 
reported becoming dependent on cannabis for daily life, as it made him feel good and his 
“worries went away”. Mr Sanson’s heavy use of cannabis ceased with his first prison sentence, 
and he has now not used it for five to six years. He also outlined his use of amphetamines and 
214 
 
methamphetamine, which included injecting amphetamine at 16 or 17 years old. Mr Sanson 
advised that he used these substances heavily after his first release from prison; they made 
him feel “invincible”, sometimes “amped up” and other times “level”. He described 
occasionally drinking coffee to help him get to sleep at night, though did not notice calming 
effects from coffee during the day. Mr Sanson has had periods of heavy alcohol consumption, 
though drugs were noted as his key substance use problem.  
Strengths 
Mr Sanson has developed several techniques for coping with his difficulties. He 
described being orderly and clean, which assists him with structuring his time and activities; he 
uses physical exercise as a means of focusing his mind and remaining physically healthy; and 
repeats the end of sentences possibly as a way to help him recall and respond appropriately 
during conversation. These are strategies that Mr Sanson has developed over the course of his 
life, and have not been taught to him. This, alongside his numerous recent disclosures and 




Mr Sanson’s current levels of cognitive and behavioural function were assessed using 
the Wechsler Adult Intelligence Scales, fourth edition, Australia and New Zealand version 
(WAIS-IVA&NZ), selected subtests from the Delis-Kaplan Executive Function System (D-KEFS), the 
Logical Memory I and II subtests from the Wechsler Memory Scales, fourth edition, Australia 
and New Zealand version (WMS-IVA&NZ), the Rey Complex Figure Test (RCFT), and the Rey 
Auditory Verbal Learning Test (RAVLT). Please see below for a description of his results, and 




While verbal tests or subtests are frequently used to assess premorbid functioning, 
this was not deemed appropriate for Mr Sanson given his difficulties with verbal expression 
and low level of schooling. Reports from after his accident state that he was reading at a 13 
year level (at 12-13 years of age) and had no obvious learning difficulties at school. This 
suggests that Mr Sanson had been functioning at or around the average level before his 
accident.  
Test Taking Behaviour 
Mr Sanson was eager for testing to take place and appreciative of the opportunity to 
discover his cognitive strengths and difficulties. At times during testing Mr Sanson became 
anxious, which was exhibited through psychomotor agitation and tended to occur during 
verbal subtests when he was uncertain of the answer or numerous pieces of information were 
presented at once. Mr Sanson frequently initiated discussion between subtests, usually about 
what he was experiencing during the previous test or about situations from his past that the 
test had reminded him of. There were no concerns regarding the level of effort Mr Sanson was 
exerting during testing.  
Full Scale Intelligence Quotient 
The Full Scale Intelligence Quotient (FSIQ) is a composite score that measures 
cognitive functioning across multiple domains: verbal comprehension, perceptual reasoning, 
working memory, and processing speed. The FSIQ score is considered the most reliable 
indicator of general intellectual functioning. Relative to others of a similar age, Mr Sanson’s 
FSIQ is in the low average range (12th percentile). While this is a broad overview of Mr 
Sanson’s cognitive functioning at this time, considering his performance in each individual 
domain will allow for a more thorough understanding of his abilities. 
 Verbal Comprehension 
The Verbal Comprehension Index (VCI) measured Mr Sanson’s verbal reasoning and 
concept formation. His score on this index fell within the borderline range (7th percentile). The 
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VCI is comprised of three subtests, and Mr Sanson’s score across these subtests was varied. He 
scored higher on the Similarities subtest – which required him to use abstract thinking, 
concept formation, and verbal reasoning skills to verbalise the similarity between two words – 
than the Vocabulary and Information subtests. (Similarities – average range, 37th percentile; 
Vocabulary – low average range, 9th percentile; Information – very low range, <1st percentile). 
The latter two subtests rely more heavily on cultural and educational experiences, alertness to 
the environment, and retrieval of information from long-term memory. Given Mr Sanson’s low 
level of schooling and history of trauma during his school years, it is unsurprising that he 
showed more difficulty with these tasks.  
Perceptual Reasoning  
The Perceptual Reasoning Index measured Mr Sanson’s nonverbal concept formation, 
visual perception and organisation, and visual-motor coordination. Mr Sanson’s score was in 
the average range (61st percentile). His performance on the subtests comprising this index 
(Block Design, Matrix Reasoning, and Visual Puzzles) were all within the average range thus 
comparable, suggesting that his skills in this domain are developed to similar levels. 
Interestingly, his poorest performance was one the Block Design subtest, the only timed test in 
the PRI. 
Processing Speed 
The Processing Speed Index (PSI) measures the ability to process simple visual 
information quickly and effectively. Both the Symbol Search and Coding subtests require visual 
and motor speed. Mr Sanson’s score on this index was in the low average range (18th 
percentile) and his scores on both subtests were comparable.  
Working Memory 
The Working Memory Index (WMI) is a measure of an individual’s ability to sustain 
attention, concentrate, and exert mental control. Mr Sanson scored in the borderline range (3rd 
percentile) on this index. This indicates that he may have difficulties with auditory recall and 
217 
 
mental manipulation of information. The majority of people can hold seven (plus or minus 
two) items in their working memory, Mr Sanson was able to hold a maximum of five. 
During the Arithmetic subtest, which is a timed test of solving verbally presented 
mathematical problems without the use of pen and paper, Mr Sanson frequently asked for the 
question to be repeated. He advised that his mind was “stuck” on previous problems, 
particularly when he knew he’d given an incorrect answer. He also experienced “mind blanks” 
that prevented him from attending to the full question. His score on this subtest – very low 
range (<1st percentile) – lowered his score for this index. On the Digit Span subtest, which 
required Mr Sanson to recall and mentally manipulate strings of numbers increasing in length, 




The Digit Span Forward subtest is a measure of verbal attention, a skill required for 
many everyday tasks such as following verbal instructions and holding a conversation. Mr 
Sanson scored in the average range (37th percentile), indicating an ability to attend to simple 
verbal information.  
Visual Memory 
The Rey Complex Figure Test required Mr Sanson to copy a novel drawing, and later 
recreate it from memory. This test requires visual attention, visual-motor coordination, and 
long term visual memory. He produced an accurate copy of the figure to score in the high 
average range (91st percentile), and a delayed re-creation in the average range (50th 
percentile).  
Verbal Memory 
The Logical Memory subtest required Mr Sanson to verbally recall two stories 
immediately after their presentation, and again approximately 30 minutes later. This measures 
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verbal attention, short-term verbal memory and long-term verbal memory. Mr Sanson scored 
in the low average range (9th percentile) for the immediate recall trial, and in the low range (1st 
percentile) for the delayed trial. This may indicate a difficulty with long term verbal memory, 
however his score was likely impacted by the degree of anxiety Mr Sanson experienced during 
this test. He had stated that he struggled when presented with large amounts of information 
at once, and upon the presentation of the first story, Mr Sanson experienced a memory “flash” 
of similar story recall tasks in school. He required encouragement to continue his recall after 
quickly stating he could not remember any further details for the first story. With further 
encouragement to allow himself time to search his memory and provide his answers, Mr 
Sanson performed better on the immediate recall trial of the second story. For the delayed 
recall condition, he could not remember any details of the first story. 
The delayed trial of the Rey Auditory Verbal Learning Test (RAVLT) also assessed Mr 
Sanson’s long-term verbal memory, with his score falling in the low average range (9th 
percentile). The discrepancy between this score and his score on the delayed trial of Logical 
Memory may relate to Mr Sanson’s anxiety, the lower amount of information presented in the 
RAVLT, or the opportunity for repetition and practice with the RAVLT.  
Memory and Learning 
The Rey Auditory Verbal Learning Test assessed Mr Sanson’s ability to retain and 
integrate more information with repeated presentation of a list of words. Also assessed were 
proactive and retroactive interference, and his recognition ability. Mr Sanson’s recall after the 
initial presentation of words was in the average range (25th percentile), however he learned 
few further words over successive trials and his total score from learning over trials fell within 
the low range (1st percentile). No proactive interference was evident with Mr Sanson’s score 
on learning a new word list (borderline range, 5th percentile), however he was able to recall 
only two words before stating that he had “lost all of that”. This may represent difficulty 
processing new information whist inhibiting previously learned responses. His immediate free 
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recall of the initial list (borderline range, 2nd percentile) included one instance of retroactive 
interference from the second list, however this was not a word he had recalled when required 
to. His delayed recall was in the low average range (9th percentile) and recognition in the 
borderline range (2nd percentile). When presented with a page of written words, Mr Sanson 
was able to recognise most of the words he had consistently recalled from list one, with one 
list B intrusion. This indicates that he had successfully encoded his consistently recalled words 
into memory, while the others may not have been attended to.  
Verbal Fluency 
The Verbal Fluency subtest of the D-KEFS consists of three conditions – Letter Fluency, 
Category Fluency, and Switching. The Letter Fluency condition required Mr Sanson to name as 
many words as possible beginning with a particular letter within 60 seconds, while adhering to 
a set of rules about which type of words were allowed. This measures initiation, simultaneous 
processing, speed of processing, and vocabulary knowledge. His score on this condition was in 
the average range (63rd percentile). The Category Fluency condition required the production of 
words within a certain category within 60 seconds, it measures the same skills as the Letter 
Fluency task, but is supposedly less effortful, as tasks that access semantic knowledge are less 
novel. Mr Sanson’s score on this condition was in the borderline range (5th percentile), 
indicating difficulty accessing semantic knowledge, which is potentially due to focal injury to 
the left temporal region.  
Cognitive Flexibility 
Several subtests of the D-KEFS assessed Mr Sanson’s cognitive flexibility, including the 
switching condition of Verbal Fluency, the Number-Letter sequencing trial of the Trail Making 
Test, and the Inhibition/Switching trial of the Colour Word Interference Test. Cognitive 
flexibility is necessary for ‘higher order’ skills such as multi-tasking, simultaneous processing, 
and divided attention. Significant difficulties with cognitive flexibility can be due to frontal or 
diffuse brain injury.  
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Mr Sanson’s score for the switching condition of the Verbal Fluency test was in the 
very low range (<1st percentile). This condition required him to name items from alternating 
categories, and while his switching was accurate it was also slow. His pattern of scores 
indicates that Mr Sanson had difficulty switching between categories over and above the 
difficulty he experienced simply naming items based on their semantic properties as in the 
Category Fluency condition. 
The Trail Making Test involves scanning and drawing a line through or between items 
ordered on a page. Mr Sanson scored in the average range for the number sequencing and 
letter sequencing conditions (75th percentile and 50th percentile, respectively) and the high 
average range for the visual scanning and motor speed conditions (84th percentile for both). 
On the Letter-Number sequencing condition, which requires switching between numbers and 
letters with each line connection, Mr Sanson scored in the low range (1st percentile). This 
indicates significant difficulty with flexibility. 
The Colour Word Interference Test required Mr Sanson to name colours, read the 
names of colours, name the colour of the ink a word (which was the name of a colour) was 
printed in – requiring the inhibition of the automatic task of reading the word as it is written, 
and finally to switch between naming the colour of words and reading them. His score on the 
colour naming condition was in the low average range (16th percentile) which may represent 
his difficulty with semantic retrieval. His scores on the word reading and inhibition conditions 
were in the average range (63rd percentile for both), and his score on the switching condition 
was in the very low range (<1st percentile). Midway through the final condition Mr Sanson 
made an error and stated he thought he was doing it wrong, he paused and appeared 
uncertain of what to do, but with prompting was able to complete the test.  
Problem Solving 
Both the Sorting and 20 Questions subtests from the D-KEFS assess problem solving. 
The Sorting subtest measured Mr Sanson’s concept formation and problem solving skills by 
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asking him to sort sets of cards into two categories and describe the categories. He scored in 
the average range for both the number of sorts made (37th percentile) and for his ability to 
describe the sorting categories (50th percentile). Mr Sanson did show difficulty describing the 
sort categories, which seemed related to his ability to find the necessary words, however when 
allowed sufficient time he was able to provide adequate information. 
The 20 Questions subtest required Mr Sanson to identify specific objects on a page 
using as few yes/no questions as possible. This requires categorical processing and the use of 
feedback to guide problem solving behaviour. The initial abstraction score indicates how 
efficient an individual was at eliminating as many objects as possible with their first question, 
which requires categorical processing. Mr Sanson scored in the average range (37th percentile) 
for this. The weighted total score is an indication of how efficient the individual was with their 
questioning, while taking into account the possibility of ‘lucky guesses’, Mr Sanson’s weighted 
total score was in the high average range (91st percentile).    
Visual-Spatial Skills 
The D-KEFS Tower test measured Mr Sanson’s visual attention, visual-spatial skills, and 
spatial planning. It required him to build towers of varying complexity whilst adhering to a set 
of rules and using as few moves as possible. His score fell within the average range (25th 
percentile) and indicated that Mr Sanson possesses a degree of advanced spatial planning 
ability.  
The Block Design subtest of the WAIS-IV also measures visual-spatial ability and spatial 
planning, by having the individual copy two-dimensional designs presented in a book, using 
blocks. Mr Sanson’s score for this subtest was in the average range (37th percentile).   
For both of the visual-spatial tests, Mr Sanson provided some correct responses after 




Mr Sanson completed the Conners’ Adult ADHD Rating Scale, which is a self-report 
questionnaire of symptoms and behaviours related to Attention Deficit Hyperactivity Disorder. 
Mr Sanson’s scores on all scales fell within the non-clinical range, though there was some 
inconsistency with his responding that necessitates caution when interpreting the responses. 
His highest elevated score related to inattentive symptoms, which may be better explained by 
the sequelae of trauma and injury than a neurodevelopmental disorder. 
 
Summary 
Mr Sanson’s overall cognitive functioning was in the low average range. He exhibited 
significant difficulties with memory and learning in the verbal domain, as well as cognitive 
flexibility. He showed difficulty with semantic retrieval and processing on the Verbal Fluency 
test, which required rapid responses. Mr Sanson had less difficulty with these processes on the 
Colour Word Interference, Sorting, and 20 Questions tests. This may relate to the visual nature 
of these tests, as well as the lack of a time requirement with the latter two, on which Mr 
Sanson scored higher than the Colour Word Interference test. A discrepancy between Mr 
Sanson’s motor speed and processing speed is apparent, which may account for some of the 
confusion and frustration he reports feeling towards himself. Mr Sanson showed relative 
strengths in the visual domain, particularly visual memory and problem solving with visual 
materials.  
Formulation 
Mr Sanson described difficulties relating to racing thoughts, ordering tasks, verbal 
recall, thinking 'clearly', completing tasks before moving on, anxiety, psychomotor 
agitation, 'flashes' of memories, and 'mind blanks'. In addition, he reported a recent 
history of violent physical and verbal outbursts. These symptoms and behaviours stem 
from a combination of significant left sided and diffuse brain injury; trauma from 
emotional, physical, and sexual abuse; and social learning. 
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Mr Sanson suffered numerous adverse events during his formative years. From a 
young age he was witness to domestic violence and subjected to excessive physical 
punishment from both parents; his father provided comfort and affection after beating him. 
He was also subjected to sexual abuse from his older brother. Mr Sanson felt abandoned when 
his mother left the family, and witnessed further domestic violence when his father remarried. 
These events normalised violence and provided Mr Sanson with distorted models of love and 
relationships, as well as a disorganised attachment style, all of which formed the template for 
his own romantic relationships. As an adult Mr Sanson’s relationships have involved violence, 
infidelity, and “clinginess”.   
The turbulent upbringing and physical and sexual abuse Mr Sanson suffered likely led 
to beliefs about the world being dangerous and unpredictable and a consistently heightened 
state of arousal. This state is necessary for keeping safe, as it allows the environment to be 
constantly scanned for danger. However, less energy is then available for other tasks of normal 
academic and social learning, and thus such learning opportunities are missed. In this way Mr 
Sanson’s childhood trauma may have impaired his ability to attend to information for long 
enough to commit it to memory. Traumatic memories tend to be encoded in a fragmented 
rather than sequential form and this accounts for difficulties with recalling a traumatic event in 
its full detail, intrusive memories, nightmares, and flashbacks. Due to this, Mr Sanson’s 
continued traumatic experiences may have impaired his memory function further, as 
evidenced by the “flashes” of both traumatic and everyday memories he now experiences. In 
addition, when a traumatic experience is inescapable many people, especially children, 
experience dissociative reactions which recur during episodes of re-experiencing. Mr Sanson 
may continue to have such reactions, which he experiences as brief “mind blanks”.  
A combination of autonomic hyperarousal and normalised violence may have led to his 
disruptiveness in the classroom and reputation as a “bully”. Mr Sanson is unlikely to have 
learned to express his emotions verbally, and this ability may have been impaired due to his 
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traumatic experiences as Broca’s area – the brain region responsible for expressive language – 
often ‘shuts down’ during traumatic events and traumatic re-experiencing. In addition, he 
suffered a significant injury to the left temporal and parietal areas of the brain, which have 
likely further impaired his expressive ability. Rather than verbally expressing his emotions and 
experiences, Mr Sanson used violence or escape behaviours when situations activated his fear 
response. As these behaviours were reinforced, either by avoiding difficult situations or 
discharging his negative emotions, his propensity to use them grew stronger and they became 
significant difficulties in his life.  
On top of the negative emotions associated with polyvictimisation, Mr Sanson also 
experienced the guilt and shame of subjecting his younger brother to the same antisocial and 
sexual behaviours he himself had endured. This likely compounded his negative emotional 
experiences and lead to depression, as well as avoidance behaviours such as substance abuse 
and thrill-seeking. Mr Sanson’s thrill-seeking, violent, and other criminal behaviours may have 
stemmed from his difficulties with cognitive flexibility and information processing – as he 
struggled to process the information in his environment and consider the consequences of 
numerous possible courses of action, he resorted to behaviours that were well learned, or 
succumbed quickly to peer pressure. Such behaviours likely also reinforced the belief that the 
world is not safe and one must always be on high alert for danger. As such, he continues to 
experience significant hyperarousal, sleep difficulties, and other anxiety related sequelae. The 
combination of trauma, drug use, and his brain injury likely also led Mr Sanson to experience 
auditory and visual hallucinations.  
The injury Mr Sanson suffered at age 11 likely compounded difficulties he was already 
experiencing due to the effects of trauma. Trauma, drug abuse, and injury all have the ability 
to impair numerous cognitive domains. Due to the left sided focus of the injury, it is likely 
responsible for the semantic processing and verbal memory difficulties Mr Sanson showed in 
the present assessment. Although medical notes at the time indicated a good recovery, it is 
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also possible that Mr Sanson ‘grew into’ difficulties as his frontal lobe functions developed in 




• Due to Mr Sanson’s difficulties with anxiety and self-reported discomfort in the group 
environment, any treatment he engages in should occur in an individual setting.  
• Cognitive remediation therapy (CRT) can teach many strategies for learning cognitive 
skills or compensating for cognitive deficits. This may be beneficial for Mr Sanson’s 
difficulties with flexibility, memory, and verbal processing. However, as this approach 
frequently utilises specialised software, access to CRT may prove difficult, particularly 
in the prison environment.  
• An important support for Mr Sanson may be helping him to understand his functional 
difficulties and learn to explain them to others in a manner both comfortable and 
useful to him.  
• Mr Sanson has difficulty holding more than five pieces of verbal information in his 
working memory. The use of simple instructions involving one or two key points may 
be an effective compensatory strategy to prevent overloading Mr Sanson’s working 
memory and help to remain focused when receiving instructions.  
• Mr Sanson’s visual skills are better developed than his verbal skills. Using written lists 
and/or picture cues to help him perform tasks in a step by step fashion may help him 
to perform tasks without becoming confused or jumping forward in the task sequence 
before completing all necessary prior steps. Writing down, or otherwise recording, 
information will also allow him to use this as a form of external recall, rather than 
relying on his own long-term verbal memory. 
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• Mr Sanson showed a tendency to provide correct answers after the testing time limits, 
perform more poorly on timed tests, and perform better once encouraged to take his 
time on non-timed tests. In addition, his motor speed was assessed as faster than his 
information processing speed. As such, taking his time when performing tasks will 
likely be beneficial for the final results and help him to prevent the frustration he 
experiences towards himself. Strategies that may help with this include mindfulness, 
verbal self-instruction, and paced breathing during moments of confusion or racing 
thoughts. 
• Mr Sanson experiences considerable anxiety and trauma related symptoms which 
include psychomotor agitation, emotional dysregulation, and experiential avoidance 
(e.g., escape behaviours, dissociation). There is an association between cognitive 
flexibility and self-awareness and the understanding and expression of emotions. In 
addition, flexibility impairments appear to be higher with greater levels of 
psychological distress. As such, treating these psychological difficulties will likely 
enhance Mr Sanson’s ability to respond to his surroundings. Numerous treatment 
modalities may assist with these difficulties; schema therapy operates from an 
emotional standpoint and may be beneficial for processing emotional trauma without 
relying too heavily on higher level cognitive functions. Dialectical Behaviour Therapy 
(DBT) may also be an appropriate treatment modality, due to its focus on 
psychological flexibility and skills training. 
• It is recommended that Mr Sanson be supported to access the ACC sensitive claims 
service to process the sexual abuse he suffered in childhood. This difficult work should 
be undertaken with a clinical psychologist, to prevent any delays in his assessment, to 
allow him to form a trusting relationship with his assessor rather than having to re-tell 
his story for the assessment process, and due to his complex cognitive and emotional 
needs.   
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• It is also recommended that upon release from prison Mr Sanson take part in an 
assessment with an Occupational Therapist to assess how his difficulties with 




Effects of my Research on my Clinical Practice 
 Undertaking research relating to concussion has enhanced my practice as an Intern 
Psychologist in a number of ways. Firstly, it has deepened my understanding of neuroanatomy 
and the neurobiological processes that underpin brain injury symptoms; secondly, interacting 
with the participants has shown me how I need to alter my practice to account for both 
symptoms and the trauma of the accident itself; and finally, I have seen that clients often have 
minimal knowledge of what has happened to them, why they are experiencing symptoms, and 
what this means for their future.  
 Having an understanding of the anatomy and neurobiological processes that underpin 
brain injury symptoms has assisted me with test selection, formulation, and explaining 
difficulties to clients. Due to Mr Sanson’s complex history I selected tests to assess a broad 
range of functioning, but with an emphasis on executive function, memory and language. This 
was due to the possibility of left focal injury affecting his language processing and verbal 
memory abilities, and the possibility of executive function deficits becoming apparent as he 
matured rather than at the time of injury. In addition, the use of subtests from the WAIS-IV, 
WMS-IV, and D-KEFS in my research test selection meant I was comfortable with administering 
many of the tests I utilised with Mr Sanson. This allowed me to administer the tests in a more 
natural and relaxed manner, which Mr Sanson responded to well. As Mr Sanson’s case was 
complicated by significant trauma in childhood, drug use, and potentially further injury, it was 
not possible to clearly state which events have caused which symptoms. With some knowledge 
of the anatomy of both brain injury and trauma, I could state that his semantic processing, 
verbal memory, and cognitive flexibility deficits were likely caused or significantly worsened by 
the injury. However, it is also likely that the brain injury and trauma symptoms have 
maintained one another.  
 Working with my research participants taught me to slow down, and allow clients the 
space they need to express themselves. I found that many of my research participants had had 
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little chance to discuss their accident and its sequelae in depth, and allowing them to do so 
was an exercise in building rapport. As a naturally fast speaker I also found I needed to slow 
my own speech to allow for constructive conversation with participants’ who may have had 
information processing difficulties. With Mr Sanson, who could not recall any 
neuropsychological assessment after his injury, had only very recently begun speaking openly 
about his past, and had a history of “smashing” his way out of stressful situations, I felt that 
this approach would be imperative to our work together. In our initial session, I was prepared 
with numerous areas of inquiry, but tried to use open questions and allow him plenty of time 
to respond as I had suspected that word finding may have been a difficulty for him. Even when 
responding to injury related questions he frequently returned the conversation to other past 
traumas, at which times I altered my line of questioning to gather information relating to his 
history and emotional functioning. Mr Sanson seemed grateful for this, as in that session and 
future sessions he thanked me for listening, conducting the assessment, and simply showing 
up for the appointment.  
 Despite having the professional input of General Practitioners, Occupational 
Therapists, Physiotherapists, and sometimes Neurologists and Psychologists, many of the 
injured individuals I spoke to regarding my research did not appear to understand their injury. 
They were uncertain of whether their injury experience was ‘normal’ (e.g. if feeling ok the day 
of the injury, and very unwell the next day was related to the injury or not), which symptoms 
might relate to the injury, and what their symptoms meant for their recovery. Many stated 
that they learned more every time they spoke with someone about their symptoms, but it 
could be weeks between opportunities for such discussions. Due to this, I suspected that Mr 
Sanson might have a lot of questions about his injury and which of his present difficulties 
relate to it. This turned out to be correct, and my understanding of injury processes and the 
need to slow down to deliver information clearly was useful in this situation. He was however, 
very receptive to the notion that the testing would help us to discern where his difficulties and 
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strengths lie and which functions may have been affected by the injury. I was sure to repeat 
this information in each session, and this appeared to put Mr Sanson more at ease with the 
testing situation.    
 In conclusion, my doctoral research involved the assessment of individuals who had 
suffered from a mild traumatic brain injury. This provided valuable experience for my work as 
an Intern Psychologist by deepening my understanding of the mechanisms of brain injury, 
experience with cognitive testing, and experience working with individuals who are suffering 
the effects of brain injury. In my work with Mr Sanson these learnings proved valuable for 
building and maintaining rapport, conducting the testing, producing the report and helping 
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